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Summary 
Infections due to multi-drug resistant organisms (MDROs) are a major concern 
worldwide. With very few new antibiotics on the market, infection prevention and control 
measures, including the use of biocides, are paramount to limit the spread of MDROs. Little 
is known about the impact of biocide overuse and the selective pressure they exert on 
adaptive mechanisms (co-selection) within bacteria. This study evaluated the effects of 
biocides commonly used in the UK on antibiotic susceptibility and on the mechanisms they 
might trigger within carbapenemase-producing Enterobacteriaceae (CPE). 
The minimum inhibitory concentrations (MICs) of a wide range of antibiotics and 
four biocides (benzalkonium chloride, chlorhexidine digluconate [CHX], copper sulphate 
and silver nitrate) were determined for multi-drug resistant, carbapenemase-producing 
Escherichia coli and Klebsiella pneumoniae isolates collected from UK hospitals. Regarding 
biocides, MICs were found to be much lower than in-use concentrations found in most 
commercial products (e.g. CHX MICs: 0.5-16 μg/mL; CHX concentration in a skin 
decontamination product: 40,000 μg/mL). Correlation were detected between antibiotic and 
biocide MICs, especially between CHX and carbapenems, cephalosporins, ciprofloxacin and 
tetracycline in K. pneumoniae. Exposure to CHX for 50 strains led to increased lag phase 
duration and changes in growth rate. Addition of efflux-pump inhibitor reduced the CHX 
MICs. These findings seemed to indicate the involvement of efflux in reduced susceptibility 
to CHX and antibiotics. Overexpression of efflux-related genes (acrB, extruding a wide 
range of antibiotics; smvA, for cationic compounds) was observed following exposure to 
sub-MIC CHX concentrations for two K. pneumoniae isolates. However, the molecular 
changes did not necessarily translate at the phenotypical level, with unchanged susceptibility 
towards CHX and several antibiotics. 
This work highlighted the involvement of efflux pumps following CHX exposure in 
CPE; while it did not result in reduced susceptibility to antimicrobials, precautions should 
still be taken, considering the extensive use of biocides. 
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Chapter 1. General introduction 
1.1 Definitions 
The term ‘antimicrobial’ encompasses both antibiotics and biocides (Scientific 
Committee on Emerging and Newly Identified Health Risks, SCENIHR, 2009; Harbarth et 
al., 2014). On one hand, antibiotics are defined as active substances of synthetic or natural 
origin harbouring anti-infective activity against bacteria in human or animal tissues 
(SCENIHR, 2009; Wales & Davies, 2015). On the other hand, biocides are active chemical 
substances able to destroy, render harmless, prevent the action of, or exert a controlling effect 
on harmful organisms (SCENIHR, 2009; Wales & Davies, 2015). 
Biocides targeting bacteria include disinfectants, antiseptics and preservatives, and 
can also be referred to as microbicides (Maillard et al., 2013); in this study, the term ‘biocide’ 
will be used in its narrow meaning, i.e. microbicide. Disinfectants are used on inanimate 
objects to reduce their amounts of micro-organisms; high-level disinfectants are referred to 
as sterilants (Wales & Davies, 2015; Beier et al., 2016). Antiseptics are used for skin 
decolonisation or to treat infections in surface wounds but cannot be used within the body 
(SCENIHR, 2009; Harbarth et al., 2014). Preservatives are chemicals added to products 
such as cosmetics or food to inhibit the growth of micro-organisms within the products 
(SCENIHR, 2009; Wales & Davies, 2015). 
1.2 Rise of antibiotic resistance: a global public health threat 
1.2.1 Current status and international guidelines 
Since the discovery of penicillin in the late 1920s (Fleming, 1929), antibiotics have 
been heavily used and relied upon, especially for the treatment of severe infections (World 
Health Organization, WHO, 2018a). However, resistance has now been found to emerge all 
around the world for almost all the currently available classes of antibiotics (Ventola, 2015; 
WHO, 2018a). 
The development of antibiotic resistance naturally occurs, as most antibiotics derive 
directly or indirectly from microbial products; genes similar to the ones involved in antibiotic 
resistance have been found in samples aged several millions of years. The ability of bacteria 
to develop adaptation mechanisms existed well before the introduction of antibiotics in 
human health (Iredell et al., 2016; Alav et al., 2018). However, the rise of antibiotic 
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resistance has been accelerated by the extended use and misuse of these compounds, and 
seems to be mainly linked to the selective pressure applied by both human and animal 
medicines, as reported by the World Health Organization (WHO) in 2014 (WHO, 2014). In 
veterinary medicine, antibiotics belonging to the same classes as the ones prescribed in 
human medicine are used to prevent infections, but also as growth factors (Chattopadhyay, 
2014). The United Kingdom (UK) Department of Health estimated however that the 
antibiotic consumption in human health had a more important impact on antibiotic resistance 
than veterinary medicine (UK Department of Health, 2013). 
Without regards to the factors involved in the emergence and spread of resistance 
among bacteria, the increasing number of non-treatable infections due to multi-drug resistant 
organisms (MDROs) is now a public health threat and a major challenge to overcome (WHO, 
2018a). Infections caused by MDROs engender adverse impacts on clinical outcomes such 
as higher morbidity and mortality rates (MacVane, 2017; WHO, 2018b), and are estimated 
to account for up to 10 million deaths by 2050 (Review on Antimicrobial Resistance, 2014). 
International (WHO, United Nations) and national (Review on Antimicrobial Resistance, 
2016; UK Department of Health, 2019) commissions, in addition of groups of experts 
(Wilson et al., 2016), highlighted key aspects and edited guidelines for the current and future 
management of resistance to antibiotics. The UK Department of Health’s 2019 to 2024 plan 
of action developed three main courses of actions (UK Department of Health, 2019), 
including the reduction of the need for and unintentional exposure to antibiotics (where 
infection prevention and control measures are paramount, among other measures), the 
optimisation of the use of the current antibiotics in both human and animal health 
(highlighting the importance of antibiotic stewardships and data surveillance), and the need 
for innovation (including new antibiotics, new diagnostic tools and vaccines). 
In addition to the human perspective, resistance to antibiotics involves higher costs 
due to consumption of healthcare resources. This cost is estimated at 1.5 billion euros per 
year in Europe (UK Department of Health, 2013; WHO, 2014), and could reach more than 
100 trillion US dollars in the whole world by 2050 (Review on Antimicrobial Resistance, 
2014). Few antibiotics have been developed over the last decades (corresponding to the so-
called ‘discovery void’), mostly based on existing molecules or antibiotic-inhibitor 
combinations, and a minority of them target the MDROs involved in the most severe 
infections such as carbapenemase-producing bacteria (Review on Antimicrobial Resistance, 
2015; WHO, 2020). Most of the current antibiotics have been discovered during the 1940s 
and 1960s (Coates et al., 2002). Nowadays, the antibiotic market is not the most attractive 
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for economic reasons: antibiotic therapy is a short-term process, lasting several days, and 
resistance is likely develop, reducing the lifetime of treatments (Lewis, 2013; Review on 
Antimicrobial Resistance, 2015; Laws et al., 2019). 
1.2.2 Multi-drug resistant organisms on priority list for the development of new 
antibiotics 
The WHO reported in its communication in 2014 several MDROs of particular 
concern (WHO, 2014), and more recently classified them according to their importance 
(level three being medium priority and level one being critical priority; WHO, 2017; 
Tacconelli et al., 2018). Medium priority organisms include penicillin-resistant 
Streptococcus pneumoniae (worldwide leading cause of community-acquired pneumonia), 
fluoroquinolones-resistant Shigella spp. (major cause of diarrhoea and dysentery) and 
ampicillin-resistant Haemophilus influenzae. MDROs in high need for new antibiotics (level 
two) include, among others, non-typhoidal Salmonella species (involved in foodborne illness 
through the ingestion of contaminated water and/or food but also in enteric fever) and 
Neisseria gonorrhoea with reduced susceptibility to cephalosporins and fluoroquinolone 
(involved in sexually transmitted infections able to lead to severe complications related to 
the reproductive tract), alongside some members of the ‘ESKAPE’ group (Boucher et al., 
2009; Laws et al., 2019). The high priority ESKAPE organisms include vancomycin-
resistant Enterococcus faecium (‘E’), which is a major organism involved in bloodstream 
infections, and methicillin-resistant Staphylococcus aureus (MRSA, ‘S’) with reduced 
susceptibility to vancomycin. MRSA treatment options become limited, due to the 
combination of toxicities outcomes and resistance (WHO, 2014). The following MDROs are 
identified as critical priority for the need of new antibiotics (level one): Acinetobacter 
species (‘A’), including carbapenem-resistant Acinetobacter baumannii; Pseudomonas 
aeruginosa (‘P’), associated with an increasing incidence of resistances to quinolones, 
carbapenems but also aminoglycosides and polymyxins (important threat especially for 
ventilator dependent patients and individuals suffering from cystic fibrosis); carbapenem-
resistant Enterobacteriaceae (CRE), including extended-spectrum β-lactamase (ESBL)-
producing E. coli and Klebsiella species (‘K’, but also stands for KPC [Klebsiella 
pneumoniae carbapenemase]-producing Enterobacteriaceae) and Enterobacter species (‘E’), 
especially found in healthcare-associated infections (Boucher et al., 2009; Lewis, 2013; 
WHO, 2014; WHO, 2017). 
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The present work will focus on Enterobacteriaceae species, especially E. coli and 
K. pneumoniae. 
1.2.3 Focus on Enterobacteriaceae 
Multi-drug resistant Gram-negative bacteria were defined as resistant to at least three 
different classes of antibiotics (Magiorakos et al., 2012). CRE are increasingly reported, 
especially in urine samples (Fitzpatrick et al., 2014; Wilson et al., 2016). Both the UK 
Department of Health and the WHO expressed a high level of concern about E. coli and 
K. pneumoniae harbouring important resistances in their reports, as major contributors for 
healthcare-associated and community-acquired infections (UK Department of Health, 2013; 
WHO, 2014). 
Infections due to those particular organisms are mainly bloodstream infections, 
followed by respiratory and urinary tracts infections (Lee & Burgess, 2012; Drekonja et al., 
2014; Pitout et al., 2015). Several major clones, identified by multilocus sequence typing 
(MLST) are reported in the literature worldwide. Regarding E. coli, the most successful 
isolates produce ESBLs and/or belong to the sequence type (ST) ST131 often associated to 
fluoroquinolone resistance (Woodford et al., 2011; Wilson et al., 2016). For K. pneumoniae, 
the predominant ST is ST258, its variants (ST11, ST340, ST512) being less common. The 
K. pneumoniae ST258 clone is strongly associated with KPC production (Naparstek et al., 
2012; Pitout et al., 2015; David et al., 2019), especially KPC-2 (clade I) and KPC-3 (clade 
II) (Peirano et al., 2017). 
1.3 Antibiotics 
1.3.1 Mechanisms of action 
Antibiotics exert their antimicrobial properties through different mechanisms, as 
illustrated in Figure 1-1. However, most molecules seem to interfere with three main 
pathways: cell wall synthesis (essential to maintain the integrity of the organism and for 
osmoregulation), ribosome sub-units (translation step for protein syntheses) and DNA 
(deoxyribonucleic acid) gyrases and topoisomerases (involved in the chromosomal 
replication; Lewis, 2013). The β-lactams, including penicillins (e.g. penicillin, amoxicillin), 
cephalosporins (e.g. cefepime, ceftazidime), carbapenems (e.g. imipenem, ertapenem) and 
monobactams (e.g. aztreonam) are part of the most often prescribed antibiotics (Iredell et 
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al., 2016) and target the cell wall synthesis through inhibition of the penicillin-binding 
proteins (PBPs) (Hazra et al., 2014). 
 
Figure 1-1. Bacterial targets for antibiotics. 
Figure from Lewis, 2013. Most antibiotics target major bacterial functions, such as protein 
synthesis (e.g. by targeting either the 50S or 30S sub-units of the ribosomes), cell-wall 
synthesis (e.g. by inhibiting penicillin-binding proteins [PBPs], which is the case for 
β-lactam antibiotics), or chromosomal replication (e.g. through the inhibition of DNA 
gyrases or topoisomerases). 
1.3.2 Resistance to antibiotics 
Some bacterial species are intrinsically less susceptible than others due to specific 
properties, e.g. mycobacteria and Gram-negative bacteria are less susceptible than Gram-
positive bacteria due to their cell wall structures (Denyer & Maillard, 2002; Wales & Davies, 
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2015; Nasiri et al., 2017). Antibiotic resistance mechanisms can also be acquired, through 
horizontal gene transfer (HGT) or mutation (Andersson & Hughes, 2012; Lewis, 2013), to 
counteract the deleterious effects of antibiotics. They can result in a decreased entry of the 
molecules, an increased efflux, the alteration and/or overproduction of the target or the 
enzymatic modification or destruction of the antibiotic, as illustrated in Figure 1-2 (Poole, 
2002; Lewis, 2013); these mechanisms will be further detailed in the following sections. 
Additional mechanisms include metabolic changes leading to the formation of persister cells. 
Persisters are non-growing (dormant) but still viable bacteria with importantly reduced 
susceptibility to antibiotics, and are found to be a frequent cause of chronic infections 
(Lewis, 2013; Wood et al., 2013). Persisters can be found within biofilms; bacteria living 
within a biofilm are also less susceptible to antibiotics than their planktonic-growing 
counterparts. Indeed, the biofilm matrix acts as an additional barrier, limiting the amount of 
antibiotic able to reach its target (Laws et al., 2019), and bacterial growth rates are usually 
lower within biofilms, rendering antibiotics of which the mechanism of action affects an 
active target (e.g. cell wall synthesis for β-lactams) inefficient (Das et al., 1998; Lewis, 2013; 
Alav et al., 2018). 
 
Figure 1-2. General mechanisms of resistance to antibiotics within bacteria. 
Figure from Alav et al., 2018. Main antibiotic resistance mechanisms result in the limitation 
of the antibiotic impact on its target (target alteration or overproduction), the decrease in 
intracellular antibiotic concentration (decreased intake or increased efflux), or the antibiotic 
inactivation (modification or destruction). 
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1.3.2.1 Resistance mechanisms limiting the impact of antibiotics on their target 
Target modification or overproduction are involved in resistance to several 
antibiotics as a way to limit their impact on the bacterial target (Denyer & Maillard, 2002). 
Indeed, modification of lipid A has been reported to reduce the affinity of polymyxins to 
their target (Liu et al., 2016). Target modification has also been seen to affect susceptibility 
to aminoglycosides and fluoroquinolones, with modified 16S ribosomal RNA (ribonucleic 
acid) methylases and DNA gyrase/topoisomerase, respectively (Iredell et al., 2016). 
1.3.2.2 Resistance mechanisms decreasing the intracellular antibiotic concentration 
In order to decrease the intracellular concentration of antibiotics, bacteria can either 
reduce the amount of antibiotics entering the cell, increase the amount expelled from the 
cell, or a combination of both. Changes in membrane permeability (especially outer 
membrane for Gram-negative bacteria) include changes in lipopolysaccharide (LPS), fatty 
acid or protein compositions and changes in hydrophobicity (Denyer & Maillard, 2002; 
Ortega Morente et al., 2013; Wales & Davies, 2015). However, altered membrane 
permeability does not seem to confer resistance on its own but can become significant when 
additional resistance mechanisms are involved (Denyer & Maillard, 2002; Poole, 2002). 
Porins (also referred to as outer membrane proteins; OMPs) are hydrophilic channels 
spanning the outer membrane of Gram-negative bacteria enabling the specific or non-
specific entry of several compounds depending on their size and charge (Fernandez & 
Hancock, 2012; Choi & Lee, 2019). Several porins have been described in E. coli, including 
OmpC, OmpF and PhoE (Denyer & Maillard, 2002; Choi & Lee, 2019). A mutation in the 
sequence or a downregulation of the expression of porin-encoding genes can lead to a 
decrease in porin availability (loss of porins); alone, or in combination with an alteration of 
the porin’s channel size, this can result in a decreased entry of antibiotics. Examples of both 
phenomena can be found among Enterobacteriaceae, with the loss of OmpF involved in β-
lactam resistance in E. coli (Denyer & Maillard, 2002; Choi & Lee, 2019), or a decreased 
susceptibility to cefoxitin in K. pneumoniae after inactivation of the ompK36 gene following 
insertion in the sequence (Denyer & Maillard, 2002; Iredell et al., 2016). 
Bacterial efflux pumps are able to expel a wide range of substrates, from antibiotics 
(e.g. fluoroquinolones, tetracyclines) to biocides and dyes (Nikaido & Pages, 2012; Venter 
et al., 2015). They can be classified into five superfamilies: the multidrug and toxic 
compound extrusion (MATE) family, the small multidrug resistance (SMR) family, the 
major facilitator superfamily (MFS), the ATP (adenosine triphosphate)-binding cassette 
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(ABC) superfamily and the resistance-nodulation-division (RND) family (only found in 
Gram-negative bacteria) (Marquez, 2005; Alav et al., 2018), as illustrated in Figure 1-3. In 
Gram-negative bacteria, the RND family is of particular importance, with the example of 
AcrA-AcrB-TolC in E. coli, as they are associated with high levels of resistance to 
antibiotics (Poole, 2007; Sun et al., 2014; Slipski et al., 2018). 
 
Figure 1-3. Bacterial efflux pump superfamilies. 
Figure from Alav et al., 2018. Efflux pumps expel their substrates to the extra-cellular 
environment through antiport mechanisms (mostly protons but also sodium ions) or using 
ATP. ADP: adenosine diphosphate; OM: outer membrane; IM: inner membrane. 
1.3.2.3 Resistance mechanisms resulting in antibiotic inactivation 
The modification or destruction of antibiotics by bacterial enzymes have been 
reported for several antibiotics and aim to avoid their binding to their target. For instance, 
the predominant mechanism of resistance to β-lactams is the hydrolysation of the β-lactam 
ring of these compounds by β-lactamases (Poole, 2002; Lewis, 2013), and modifications of 
aminoglycosides (acetylation, phosphorylation) has been found to impair their ability to bind 
to their target (ribosomes), rendering these antibiotics inefficient (Poole, 2002; Iredell et al., 
2016). 
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1.3.3 Focus on carbapenems and carbapenemases 
1.3.3.1 Carbapenems 
Carbapenems belong to the superfamily of β-lactam antibiotics. Their pioneer 
molecule, thienamycin, produced by Streptomyces cattleya, was first reported in 1976. Due 
to low rates for the purification of this natural product and stability issues, synthesis of 
derivatives was investigated (Queenan & Bush, 2007; Papp-Wallace et al., 2011). The first 
developed was imipenem, released on the market in 1985 for the treatment of severe bacterial 
infections (Ventola, 2015). Imipenem was however administered with an inhibitor of a 
human renal enzyme which was able to degrade it. Nevertheless, this led to the development 
of more stable compounds, including meropenem, ertapenem and doripenem, the main 
carbapenems referred to in the literature (Martinez et al., 2010; Papp-Wallace et al., 2011). 
The mechanisms of action of carbapenems are similar to the ones of the other β-
lactams; they inhibit PBPs, stopping cell wall synthesis and resulting in the weakening of 
peptidoglycan, which is not able to protect the cell from osmotic pressure anymore (Papp-
Wallace et al., 2011; Hazra et al., 2014). Nonetheless, they exert a broader antimicrobial 
spectrum than β-lactams and their combinations due to their ability to bind several different 
PBP subtypes (Sauvage & Terrak, 2016), while being stable to hydrolysis by almost all 
ESBLs and AmpC (ampicillin-hydrolysing enzymes), which are other β-lactamases 
(Thomson, 2010). Indeed, they are used as ‘last-resort treatments’ for severe infections 
including the ones caused by ESBL-producing Enterobacteriaceae (Martinez et al., 2010; 
Djahmi et al., 2014; Morrill et al., 2015). Some of them are more active against Gram-
negative bacteria (ertapenem and meropenem) or against Gram-positive ones (e.g. 
imipenem), while doripenem shows good antimicrobial properties against both. Their 
properties also differ in terms of potency and stability, with doripenem less susceptible to 
degradation by carbapenemases, or a narrower spectrum for ertapenem, which is not 
effective for the treatment of infections caused by P. aeruginosa (Martinez et al., 2010; 
Papp-Wallace et al., 2011; Bassetti & Righi, 2015). 
1.3.3.2 Carbapenemases 
Now, carbapenemase-producing Enterobacteriaceae (CPE), among other MDROs, 
constitute a major threat, compromising the efficacy of these last-line treatments (David et 
al., 2019). The resistance mechanisms involved include a reduced permeability through loss 
of porins and/or expression of efflux pumps, alteration, reduction and/or elimination of the 
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target (common mechanisms with other β-lactams) but also production of carbapenemases. 
Combinations of these mechanisms can result in synergistic activities against carbapenems 
(Martinez-Martinez & Gonzalez-Lopez, 2014; MacVane, 2017). Carbapenemases can 
belong to Ambler classes A, B and D β-lactamases (Thomson, 2010; Canton et al., 2012); a 
brief overview is presented in Table 1-1. They will be further detailed in the following 
sections, albeit they will not constitute an exhaustive list of all the existing carbapenemases. 
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Table 1-1. Key carbapenemases mediating resistance in Enterobacteriaceae. 
Table adapted from MacVane, 2017. Not all existing carbapenemases are listed in this table. 
GES: Guiana extended-spectrum β-lactamase; IMI: imipenem-hydrolyzing 
β-lactamase; IMP: active on imipenem β-lactamase; KPC: Klebsiella pneumoniae 
carbapenemase; NDM: New-Delhi metallo-β-lactamase; OXA: oxacillinase; 
SME: Serratia marcescens enzyme; VIM: Verona integron-encoded metallo-β-lactamase. 
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1.3.3.2.1 Class A carbapenemases: penicillinases 
The class A carbapenemases became of major importance with the discovery and 
subsequent massive spread of KPC-producing bacteria around the world. KPC enzymes 
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were first reported in 1996 in North America (Yigit et al., 2001) and the blaKPC gene family 
includes now more than 40 variants according to the National Database of Antibiotic 
Resistant Organisms (NDARO), a tool published by the National Center for Biotechnology 
Information (NCBI), with blaKPC-2 and blaKPC-3 being the most commonly found variants 
(Martinez-Martinez & Gonzalez-Lopez, 2014). However, after re-sequencing blaKPC-1, it 
was found that its firstly established sequence was wrong, making blaKPC-1 and blaKPC-2 the 
same variant (Nordmann et al., 2009; Pitout et al., 2015). KPC enzymes confer low to 
moderate resistance to carbapenems, while they are highly active against penicillins and 
cephalosporins. The genetic determinants coding for KPC enzymes are mainly found in 
Tn4401, a transposon found in a wide range of transferrable plasmids, allowing it to quickly 
spread among other strains and species (Djahmi et al., 2014; Nordmann, 2014). 
Other members of the class A carbapenemases are the Serratia marcescens enzymes 
(SME) and imipenem-hydrolysing β-lactamases (IMI). They are able to hydrolyse a wide 
range of substrates like penicillins, some cephalosporins and carbapenems (Djahmi et al., 
2014; Martinez-Martinez & Gonzalez-Lopez, 2014). According to the NDARO, five 
variants of blaSME have been described to date, as well as 18 variants of blaIMI (including 
blaNMC-A; non-metallo carbapenemase). 
Guiana extended-spectrum β-lactamases (GES) were first considered as ESBLs. 
About 40 variants of blaGES have been identified to date (according to the NDARO), but only 
some GES enzymes, including GES-2, GES-4, GES-5, GES-6, GES-11, GES-14 and 
GES-18 are categorised as carbapenemases. The genes coding these enzymes are mainly 
present as genes cassettes on class 1 integrons but have also been found on some 
Enterobacteriaceae chromosomes (Martinez-Martinez & Gonzalez-Lopez, 2014). They 
confer resistance to broad-spectrum cephalosporins and, for several variants, to 
carbapenems, as mentioned earlier (Nordmann & Poirel, 2014). 
1.3.3.2.2 Class B carbapenemases: metallo-β-lactamases 
Metallo-β-lactamases (MBLs) are able to hydrolyse almost all β-lactams, with the 
exception of monobactams. Their activity relies on the presence of zinc ions in their core. 
The first plasmid-encoded MBL, IMP-1 (for ‘active on imipenem β-lactamase’), was 
detected in P. aeruginosa in the late 1980s (Watanabe et al., 1991). Since then, IMP enzymes 
have spread worldwide and more than 70 variants of blaIMP have been described (NDARO). 
Their corresponding genes are mainly present within class 1 integrons gene cassettes, but 
also on class 3 integrons and, less commonly, on chromosomes. Another subclass of MBL, 
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VIM (Verona integron-encoded metallo-β-lactamase), is also known to be disseminated 
through the spread of class 1 integrons (Nordmann & Poirel, 2014). To date, about 60 
different blaVIM variants have been identified (NDARO). 
The most recently discovered MBLs are NDM enzymes (New-Delhi metallo-β-
lactamase), in the late 2000s (Yong et al., 2009). Since then, NDM enzymes have been 
progressively identified on all continents, with a dissemination especially associated with 
travel (including medical tourism) in Asia (Zmarlicka et al., 2015). Twenty-six variants have 
been reported so far according to the NDARO. Genes coding for these enzymes can be found 
either on chromosomes (mainly for Acinetobacter species) or plasmids belonging to different 
incompatibility groups, mediating an efficient spread among bacteria (Djahmi et al., 2014; 
Martinez-Martinez & Gonzalez-Lopez, 2014). 
1.3.3.2.3 Class D carbapenemases: oxacillinases 
OXA (oxacillinase) enzymes are narrow-spectrum β-lactamases. Among the 
approximately 800 enzymes (according to the NDARO), not all of them are carbapenemases, 
and other members of this family are ESBLs (Nordmann & Poirel, 2014). They harbour a 
weaker activity against carbapenems than the previously described carbapenemases. 
However, resistant phenotypes can be observed when OXA are present along with another 
resistance mechanism like porin loss, expression of efflux pumps or ESBLs (Djahmi et al., 
2014). 
The main OXA enzymes with carbapenemase activity are OXA-48 and its 
derivatives (OXA-48-like); these variants differ by a small number of amino acid 
substitutions (Mathers et al., 2015). The corresponding genes are flanked by two copies of 
the same insertion sequence within the transposon Tn1999. This genetic context favours both 
the expression and the mobilization of the genetic determinants (Martinez-Martinez & 
Gonzalez-Lopez, 2014; Pitout et al., 2015). 
1.4 Biocides 
1.4.1 General 
Biocides englobe a wide range of unrelated chemical families, offering various 
possible uses, from food preservatives to high-level disinfection compounds. Examples of 
biocide families, biocidal compounds and possible uses are listed in Table 1-2. 
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Table 1-2. Biocide families and their associated uses. 
Data extracted from Fraise et al., 2013 (chapter 2). Not all existing families of biocides, 
biocidal compounds or uses are listed in this table. QAC: quaternary ammonium compound. 
Chemical families Examples of compounds Examples of uses 
Alcohols Ethanol, phenoxy ethanol Surface disinfection, skin decolonization 
Aldehydes 
Glutaraldehyde, 
formaldehyde High-level disinfection 
Biguanides Chlorhexidine, alexidine 
Surface disinfection, skin decolonization, 
dental care 
Halogens 
Iodine compounds, chlorine 
compounds 
Wound treatment, skin decolonization, 
sanitizing agents in the food industry 
Heavy metal 
derivatives Copper, silver 
Fungicide/algicide and other 
microbicidal properties, burn wound 
treatment 
Microbicidal dyes 
Acridines, triphenylmethane 
dyes Wound treatment, local antiseptics 
Organic and 
inorganic acids Acetic acid, salicylic acid 
Food preservatives, insecticides, 
fungicides 
Peroxygens 
Hydrogen peroxide, peracetic 
acid High-level disinfection 
Phenols Triclosan 
Preservatives, disinfectants for 
manufactured products 
Surface-active agents QACs 
Surface disinfection, preservation of 
pharmaceutical and cosmetic products 
 
While being around for decades, biocides were put aside during the antibiotic golden 
era; however, there is a revival of interest for these compounds with the rise of antibiotic 
resistance and the subsequent need for improved infection control and prevention practices 
(Maillard et al., 2013). The extensive use and misuse of biocides, now found in hospitals 
settings but also in home-cleaning products, cosmetics and textiles among others, is now 
questionable regarding the hypothetic detrimental effect on human health of these 
compounds and their possible involvement in driving antibiotic resistance (Maillard, 2005; 
SCENIHR, 2009; Morrissey et al., 2014). 
The present work will focus mainly on four biocidal compounds. Chlorhexidine 
digluconate (CHX) and benzalkonium chloride (BZC; a quaternary ammonium compound 
[QAC]), both cationic compounds, are amongst the most commonly used biocides in 
healthcare settings (Russell, 1986; Buffet-Bataillon et al., 2012b; Ortega Morente et al., 
2013; Kampf, 2016). Copper and silver, two heavy metals, were also included as they seem 
to harbour less toxicity to both humans and the environment and are involved in more recent 
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technologies through the development of antimicrobial surfaces and nanoparticles, 
respectively (O'Gorman & Humphreys, 2012; SCENIHR, 2014; Cavassin et al., 2015; Hans 
et al., 2015). 
1.4.2 Mechanisms of action 
As opposed to antibiotics, biocides usually possess multiple targets within the 
bacterial cell (Figure 1-4), which is thought to limit the possibility to develop mechanisms 
resulting in reduced susceptibility to these compounds (Bloomfield, 2002; Yazdankhah et 
al., 2006). 
 
 
Figure 1-4. Different biocides' mechanisms of action in bacteria. 
Figure from Fraise et al., 2013 (chapter 5, page 96). Biocides possess several targets within 
bacteria, and their mechanisms of action can depend on their concentrations. 
BZC and CHX, both cationic compounds, share some similarities in their 
mechanisms of action. Indeed, they are attracted by the negative charges on the bacterial 
membrane and displace the metal cations (Mg2+, Ca2+) ensuring its stability (Maillard, 2002; 
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Gilbert & Moore, 2005). QACs are then able to integrate into the membrane thanks to their 
hydrophobic tail, disturbing the lipid bilayer, resulting into a progressive leakage of cellular 
content (Buffet-Bataillon et al., 2012b). The activity of QACs, including BZC, depends on 
their concentrations: low concentrations would result in the loss of proton and sodium 
gradients and of the subsequent ability to regulate osmosis; indeed, the proton-motive force, 
relying on proton gradient, is a cytoplasmic membrane-located process upon which several 
major cell functions rely (Maloney et al., 1974; Kashket, 1985). At medium concentrations, 
more severe effects are observed on membrane-located processes, including respiration, cell 
wall synthesis and solute transport; high concentrations of QACs are able to solubilise the 
membranes and release the entire cell content, resulting in bacterial death (Gilbert & Moore, 
2005; Buffet-Bataillon et al., 2012b). 
The mechanism of action of CHX differs to the one of QACs in the fact that CHX 
does not integrate the membrane but bridges pairs of adjacent polar heads groups in the 
membrane to displace the metallic cations (Gilbert & Moore, 2005). Like QACs, the activity 
of CHX is dose-dependent: at lower concentrations, a reduction in membrane fluidity, as 
well leakage of cellular constituents (including potassium ions and protons) are observed. 
Low concentrations of CHX also affect respiratory functions and solute transport. At high 
concentrations of CHX, the cytoplasmic constituents are coagulated associated with the loss 
of the membrane’s structural integrity, resulting in its bactericidal effect (Gilbert & Moore, 
2005; Fraise et al., 2013 page 20). 
Silver and copper ions interact especially with thiol groups, which are essential for 
the activity of various enzymes (Fraise et al., 2013 page 42). Reaction with these groups can 
lead to cell inhibition or inactivation through interference with electron transport (then 
inhibiting cellular respiration) for example (Maillard, 2002; Glasser et al., 2010). Silver salts 
also cause membrane damage as can be indicated by potassium leakage, and inhibit cell 
division mechanisms (Fraise et al., 2013 page 42). 
1.4.3 Mechanisms involved in reduced susceptibility to biocides 
Mechanisms leading to reduced susceptibility to biocides are similar to the ones 
involved in antibiotic resistance. Firstly, it can be driven by degradation, dilution or 
modification of the biocide; examples include the enzymatic degradation of triclosan in 
Pseudomonas putida (Schweizer, 2001; Yazdankhah et al., 2006), or the presence of catalase 
or superoxide dismutase for oxidizing agents (Maillard, 2018). Target alteration has also 
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been reported for triclosan, with mutations in fabI, rendering the biocide inefficient 
(Schweizer, 2001; Yazdankhah et al., 2006). 
Changes in membrane permeability, including in the cell wall composition and the 
loss of porins can be involved in reduced susceptibility to biocides, while usually not being 
the sole mechanisms (Maillard, 2018). For example, deficiency in OmpF and/or OmpC has 
been described to contribute to the reduced susceptibility to silver in E. coli (Li et al., 1997). 
Efflux has also been reported for biocides, e.g. QAC efflux can be mediated by the Qac 
efflux pumps belonging to the SMR family, with the importance of the qacE and qacΔE 
genes in Enterobacteriaceae; these determinants are commonly found on class 1 integrons, 
allowing their wide dissemination (Tezel & Pavlostathis, 2015). Another efflux pump, 
CepA, confers CHX protection in K. pneumoniae (Ortega Morente et al., 2013). Copper and 
silver efflux can be mediated through the Cus and Sil systems in E. coli (Nies, 2003). 
Physiological and metabolic changes, including biofilm formation, can be involved 
in the development of reduced susceptibility to biocides as well, as bacteria harbouring a 
low to null metabolism are less susceptible than the ones with an important metabolic 
activity (Ortega Morente et al., 2013; Maillard, 2018). 
1.4.4 Role of biocides in antibiotic resistance 
1.4.4.1 Co-selection mechanisms 
Reduced susceptibility to different classes of antimicrobials can be due to several 
mechanisms including co-resistance, cross-resistance and co-regulation; they constitute the 
different co-selection mechanisms between biocides and antibiotics found in bacteria 
(Baker-Austin et al., 2006; Buffet-Bataillon et al., 2012a).  
Co-resistance mechanisms depend on the presence of several genetic determinants 
responsible for the reduced susceptibility to several antimicrobials on the same mobile 
genetic element, like a plasmid or a transposon; the selective pressure exerted by one 
compound would select for both genetic determinants to be expressed or transferred (Baker-
Austin et al., 2006). In Gram-negative bacteria, the qacΔE gene, involved in QAC efflux, is 
widely found on class 1 integrons, along with other genetic determinants such as sulI, 
conferring resistance to sulphonamides (Fluit & Schmitz, 1999; Domingues et al., 2012). 
Co-resistance mechanisms are also thought to be involved between susceptibility to 
antibiotics and heavy metals (Baker-Austin et al., 2006; Jakobsen et al., 2011; Pal et al., 
2015). 
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Cross-resistance happens when several antimicrobials share the same target, initiate 
a common pathway leading bacterial inhibition and/or death, or share a common access route 
(Fernández-Fuentes et al., 2012). Such mechanisms depend on the presence and the ability 
of a common resistance mechanism to counteract the different antimicrobials; as a 
consequence, if a cross-resistance mechanism is developed following exposure to one 
compound, resistance or reduced susceptibility to the other compound will arise as well 
(Buffet-Bataillon et al., 2012a). As previously highlighted in both ‘antibiotic resistance’ and 
‘biocide resistance’ sections, efflux pumps are widely distributed and can expel an important 
range of substrates. The efflux pump AcrA-AcraB-TolC, found in E. coli for example, can 
extrude different antibiotics and biocides, especially QACs (Poole, 2007; Sun et al., 2014). 
Co-regulation mechanisms would occur when the exposure to an antimicrobial 
impacts one or several regulatory responses, themselves impacting bacterial susceptibility to 
other unrelated compounds (Baker-Austin et al., 2006); they can result in the induction of 
stress response or an increased efflux among others (Bore et al., 2007; Osei Sekyere & 
Amoako, 2017). For example, the mar operon can be expressed following copper exposure, 
resulting, among other consequences, in an alteration of the outer membrane permeability 
(Hao et al., 2014). 
1.4.4.2 Current controversy and clinical relevance 
It is to date not clear whether or not the use of biocides has an influence on the 
maintenance and spread of antibiotic resistance genes. Indeed, a long-term exposure to sub-
inhibitory concentrations of biocides has been shown to impact several regulation pathways, 
including the SOS response within bacteria, boosting gene transfer and facilitating mutations 
(Jutkina et al., 2018). This is exacerbated with bacteria growing in biofilms, where 
exchanges are enhanced within the populations (Tezel & Pavlostathis, 2015; Buffet-
Bataillon et al., 2016). The scientific community is divided, with several studies claiming 
the linkage between antibiotic and biocide susceptibility, mainly due to efflux pumps, while 
others report no correlation between reduced susceptibility between these antimicrobials 
(Oggioni et al., 2013; Harbarth et al., 2014; Kampf, 2016; Kampf, 2018). Without 
consensus, it seems reasonable to assume that the overuse and misuse of biocides could 
present a risk for resistance selection, even if none has been observed to date; in order to 
keep biocides efficient at controlling infections, precaution principles should be applied 
(SCENIHR, 2010; Oggioni et al., 2013; Ortega Morente et al., 2013; Harbarth et al., 2014; 
Gupta et al., 2018). 
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1.5 Scope of the study 
This study, entitled ‘Impact of commonly used antimicrobial biocides on resistance 
and cross-resistance in carbapenemase-producing Enterobacteriaceae’, aimed to understand 
the role played by several biocides frequently used within healthcare settings, including in 
infection control and prevention regimens (BZC, CHX, copper and silver ions) in the 
maintenance of antibiotic resistance genes among clinical, carbapenemase-producing E. coli 
and K. pneumoniae. The subsequent objectives were: 
• To establish the baseline susceptibility to the four biocides investigated and 
to a wide range of antibiotics 
• To look for potential links between susceptibility to biocides and antibiotics 
and select representative isolates for further experimental work 
• To measure the impact of exposure to sub-inhibitory concentrations of 
biocide on the phenotypic and molecular levels 
Impact of commonly used antimicrobial biocides on resistance and cross-resistance in 
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Chapter 2. Bacterial susceptibility profiles to antimicrobials 
2.1 Introduction 
2.1.1 Bacterial susceptibility profiles to chemotherapeutic antibiotics 
The determinations of the minimum inhibiting concentration (MIC; the lowest 
concentration able to inhibit bacterial growth) and of the minimum bactericidal 
concentration (MBC; the lowest concentration able to kill a micro-organism) are routinely 
used, easy to implement (including high-throughput testing) techniques to estimate the in 
vitro effect of antimicrobials (Turnidge & Paterson, 2007; Wiegand et al., 2008). 
Establishing susceptibility profiles to antibiotics is of particular importance to define the 
susceptible (‘high likelihood of therapeutic success using a standard dosing of the agent’), 
intermediate (‘high likelihood of therapeutic success when exposure to the agent is increased 
either by adjusting the dosing regimen or by its concentration at the site of infection’) or 
resistant (‘high likelihood of therapeutic failure even when there is increased exposure’) 
status of a bacterium (European Committee on Antimicrobial Susceptibility Testing, 
EUCAST, 2019d) and therefore to choose the appropriate treatment for a bacterial infection 
(Turnidge & Paterson, 2007; Iredell et al., 2016). However, these assays do not reflect 
clinical conditions: they are usually performed with rapidly growing bacteria belonging to a 
single bacterial species with a standardised inoculum, in rich media and controlled 
conditions, while in reality bacteria usually grow slower than in the testing conditions 
(Mouton, 2018); in addition, as examples, bacteria could also be growing in biofilms with 
other species instead of their planktonic counterparts, or form an abscess with higher 
bacterial density and deleterious conditions for some antibiotics (pH variations or additional 
barriers limiting the antibiotic penetration among others) (Brook, 1989; Iredell et al., 2016). 
National and international commissions, including the Clinical and Laboratory 
Standards Institute (CLSI), the European Union Committee on Antimicrobial Susceptibility 
Testing (EUCAST) and the British Society for Antimicrobial Chemotherapy (BSAC), 
propose standard protocols for antibiotic susceptibility testing (Andrews, 2001; CLSI, 2012; 
EUCAST, 2019c) and set breakpoints, which are cut-off values enabling to decipher between 
susceptible, intermediate and resistant isolates (BSAC, 2015; CLSI, 2019; EUCAST, 
2019b). MIC values indicated for a reference strain (e.g. E. coli American Type Culture 
Collection [ATCC] 25922) are usually in accordance between the different standards. This 
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is partly due to wide ranges of concentrations the MIC obtained for the quality control strain 
can fall into: despite the target MIC for few antibiotics being different between standards, 
the authorised ranges of concentrations overlap (Table 2-1). However, when considering the 
clinical breakpoints, more discrepancies are observed between the different standards’ 
recommendations, which could have an impact on the subsequent susceptibility profile of 
the tested organism (Table 2-2). In order to facilitate international standardisation of 
susceptibility testing, BSAC ceased to develop its own recommendations in January 2016 
and redirected laboratories towards EUCAST standards. However, as this work started 
before this event, antibiotic susceptibility testing had already been performed following 
BSAC’s protocol, hence the need for highlighting the differences between the various 
commissions. 
Table 2-1. Target MICs and authorised ranges of concentrations for several antibiotics 
given by BSAC (2015), EUCAST (2019) and CLSI (2019) guidelines for E. coli ATCC 
25922. 
Target values and ranges were included when available. Antibiotics for which MIC 
target/range values were not indicated for the three standards, and antibiotics presenting the 
same MIC target/range for the three standards were not included in this table. The fold-
change observed between the different standards is indicated as a range, from the minimum 
to the maximum fold-change observed. BMD: broth microdilution; ISA: Iso-Sensitest agar; 
CAMHB: cation-adjusted Mueller-Hinton broth. 
Standard BSAC EUCAST CLSI Fold-
change 
between 
different 
standards 
Method Agar-dilution BMD BMD 
Media ISA CAMHB CAMHB 
  Target Target Min Max Min Max 
  µg/mL µg/mL µg/mL 
Aztreonam 0.25 0.125 0.06 0.25 0.06 0.25 1-4 
Cefixime 0.25 0.5 0.25 1 0.25 1 1-4 
Cefpodoxime 0.25 0.5 0.25 1 0.25 1 1-4 
Ciprofloxacin 0.015 0.008 0.004 0.016 0.004 0.016 1-4 
Ertapenem 0.015 0.008 0.004 0.016 0.004 0.016 1-4 
Meropenem 0.008 
0.016-
0.03 0.008 0.06 0.008 0.06 
1-8 
Trimethoprim 0.25 1 0.5 2 0.5 2 1-4 
 
  
Chapter 2 – Bacterial susceptibility to antimicrobials 
Page 23 
Table 2-2. Breakpoints for several antibiotics given by BSAC (2015), EUCAST (2019) 
and CLSI (2019) commissions for Enterobacteriaceae. 
Antibiotics for which breakpoints were not indicated for the three standards and antibiotics 
presenting the same breakpoints between the three standards were not included in this table 
The fold-change observed between the different standards is indicated as a range, from the 
minimum to the maximum fold-change observed. S: susceptible; R: resistant. 
Standard BSAC EUCAST CLSI Fold-
change 
between 
different 
standards 
Method Agar-dilution BMD BMD 
Media ISA CAMHB CAMHB 
  S ≤ R > S ≤ R > S ≤ R > 
  µg/mL µg/mL µg/mL 
Amikacin 8 16 8 16 16 32 1-2 
Ampicillin 8 8 8 8 8 16 1-2 
Aztreonam 1 4 1 4 4 8 1-2 
Cefepime 1 4 1 4 2 8 1-2 
Cefixime 1 1 1 1 1 2 1-2 
Cefpodoxime 1 1 1 1 2 4 1-4 
Ceftazidime 1 4 1 4 4 8 1-4 
Chloramphenicol 8 8 8 8 8 16 1-2 
Ciprofloxacin 0.5 1 0.25 0.5 0.25 0.5 1-2 
Ertapenem 0.5 1 0.5 0.5 0.5 1 1-2 
Fosfomycin 32 32 32 32 64 128 1-4 
Gentamicin 2 4 2 4 4 8 1-2 
Imipenem 2 8 2 4 1 2 1-4 
Mecillinam 8 8 8 8 8 16 1-2 
Meropenem 2 8 2 8 1 2 1-4 
Nitrofurantoin 64 64 64 64 32 64 1-2 
Ofloxacin 0.5 1 0.25 0.5 2 4 1-4 
Piperacillin 8 16 8 16 16 64 1-4 
Tobramycin 2 4 2 4 4 8 1-2 
Trimethoprim 2 4 2 4 8 8 1-4 
 
Several factors are known to influence MIC and MBC values, as well as disk 
diffusion methods. The protocol used, as highlighted previously, is of importance. For 
example, regarding colistin susceptibility testing, broth dilutions methods are recommended 
by the CLSI and EUCAST over agar-based (agar-dilution or disk-/gradient-diffusion) 
protocols due to the poor diffusion of colistin in agar (Giske & Kahlmeter, 2018; Matuschek 
et al., 2018). The broth composition, including the amount of nutrients available and the pH, 
can impact the MIC (Green, 1978; Buchta & Otcenasek, 1996; Wiegand et al., 2015; 
Mouton, 2018); the cation concentrations seem to be particularly relevant when testing 
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cationic compounds (Chow et al., 1989; Bock et al., 2018). The material of the plates and 
their coating can impact the availability of certain compounds like polymyxins, whose 
binding onto the surface depends on the plastic used (Wiegand et al., 2008; Bock et al., 
2018). The MIC values obtained can also depend on the initial inoculum used for the 
antimicrobial susceptibility testing: this phenomenon is referred to as the inoculum effect, 
and is well described for several antibiotic/micro-organism combinations, including for 
example β-lactams and β-lactamase-producing isolates (Brook, 1989; Argemi et al., 2013; 
Smith & Kirby, 2018). The growth phase the micro-organisms are in when the test is carried 
out can also have an impact on the kill rate of some agents (Argemi et al., 2013). The 
incubation conditions (temperature, duration of incubation, agitation; Buchta & Otcenasek, 
1996; Sawer et al., 1997; Argemi et al., 2013) and the precision in the preparation of the 
assay (Turnidge & Paterson, 2007) are other factors influencing MIC determination and 
impacting inter-laboratory variability in measurements (Mouton et al., 2018). 
It is important to note that MICs and MBCs represent a range of concentrations rather 
than discrete values: for two-fold dilution series, if a MIC value is indicated as 1 μg/mL, it 
corresponds in reality to a concentration strictly greater than 0.5 μg/mL and lower or equal 
to 1 μg/mL (Turnidge & Paterson, 2007). In addition, it seems commonly admitted that MIC 
determinations within ‘plus or minus one two-fold dilution’ from each other are within the 
acceptable error range (Turnidge & Paterson, 2007; Wesgate et al., 2016; Mouton et al., 
2018). 
2.1.2 Bacterial susceptibility profiles to biocides 
Breakpoints are well-defined for a wide range of antibiotics (as shown previously), 
however this is not the case for biocides (Morrissey et al., 2014). Indeed, biocides are used 
at concentrations much higher than the ones investigated in vitro for MIC determination, as 
shown with a few examples in Table 2-3 below. The definition of a breakpoint as a cut-off 
value able to distinguish between susceptible and resistant isolates and, therefore, indicating 
a success or failure of treatment is then inadequate in the case of biocides (Horner et al., 
2012; Maillard et al., 2013; Harbarth et al., 2014). 
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Table 2-3. Examples of MICs obtained for several E. coli reference strains in the 
literature for different biocides and corresponding in-use concentrations of biocides. 
Non-exhaustive lists of commercial products and their corresponding biocide concentrations 
(when available) are indicated for different biocides. BZC: benzalkonium chloride; CHX: 
chlorhexidine digluconate; CS: copper sulphate; ISB: Iso-Sensitest broth; MHB: Mueller-
Hinton broth; SN: silver nitrate; TSB: tryptone soya broth. 
Reference 
Design of the 
assay Biocide MIC Strain tested 
Examples of in-use 
concentrations 
Hammond 
et al., 1987 
Agar-dilution 
with ISA 
BZC 20-50 
µg/mL 
E. coli ATCC 
10536 and 
ATCC 11776 
Dettol Cleansing 
Surface Wipes 
(Dettol) for surface 
disinfection: 0.4 % 
w/w 
 
Dermax Therapeutic 
Shampoo (Dermal 
Laboratories) for 
scalp conditions: 
5,000 µg/mL 
 
Beechams Max 
Strength Sore Throat 
(GSK): 
1,200 µg/lozenge 
Bock et 
al., 2018 
Microdilution 
with different 
broth/plates 
BZC 8-16 
µg/mL 
E. coli ATCC 
10536 
Bore et al., 
2007 
Microdilution 
with TSB 
BZC 13 
µg/mL 
E. coli ATCC 
47076 
Biagi et 
al., 2014 
Microdilution 
with CAMHB 
CS 12,500 
µg/mL 
E. coli CCUG 
50175 
Copper and copper 
alloys surfaces 
(≥ 60 % copper) as 
antibacterial surfaces 
(Hans et al., 2015) 
Sutterlin et 
al., 2018 
Microdilution 
with ISB 
CS 1,024-
2,048 
µg/mL 
E. coli ATCC 
25922 
Sutterlin et 
al., 2018 
Microdilution 
with ISB 
SN 16-32 
µg/mL 
E. coli ATCC 
25922 
Avoca Silver Nitrate 
Applicator (Bray) 
for wart treatment: 
75 % w/w (up to 
22.5 mg SN released 
on treatment site) 
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Table 2-3 – Continued. 
Reference 
Design of the 
assay Biocide MIC Strain tested 
Examples of in-use 
concentrations 
Naparstek 
et al., 2012 
Agar-dilution 
with CAMHA 
CHX 2 µg/mL E. coli ATCC 
25922 
HiBiScrub® 
(Mölnlycke) for skin 
disinfection: 
40,000 µg/mL 
 
Medipal® 
Chlorhexidine 
Surface Wipes (Pal) 
for surface 
disinfection: 
2 %/wipe 
 
Corsodyl Treatment 
Mouthwash 
(Corsodyl) for 
gingivitis: 
2,000 µg/mL 
Hammond 
et al., 1987 
Agar-dilution 
with ISA 
CHX 1.5 
µg/mL 
E. coli ATCC 
10536 and 
ATCC 11776 
Tetz & 
Tetz, 2015 
Macrodilution 
(broth?) 
CHX 2 µg/mL E. coli ATCC 
25922 
Braoudaki 
& Hilton, 
2004 
Macrodilution 
with nutrient 
broth 
CHX 4 µg/mL E. coli ATCC 
700728 
O'Driscoll 
et al., 2014 
Macrodilution 
with nutrient 
broth 
CHX 0.6 
µg/mL 
E. coli NCTC 
4174 
Thomas et 
al., 2000 
Macrodilution 
with nutrient 
broth 
CHX 0.2 
µg/mL 
E. coli ATCC 
10536 
Wesgate et 
al., 2016 
Microdilution 
(broth?) 
CHX 7 µg/mL E. coli ATCC 
8739 
Grare et 
al., 2010 
Microdilution 
with CAMHB 
CHX < 1 
µg/mL 
E. coli ATCC 
25922 
Bock et 
al., 2018 
Microdilution 
with different 
broth/plates 
CHX 0.125-2 
µg/mL 
E. coli ATCC 
10536 
Koburger 
et al., 2010 
Microdilution 
with MHB 
CHX 8 µg/mL E. coli ATCC 
35218 
McBain et 
al., 2004 
Microdilution 
with nutrient 
broth 
CHX 13 
µg/mL 
E. coli ATCC 
8729 
In order to decipher between wild-type and isolates exhibiting reduced susceptibility 
to a biocide, researchers have established epidemiological cut-off values (ECOFF) based on 
the distribution of MIC of wild-type isolates for a given biocide/organism combination 
(Turnidge & Paterson, 2007; Iredell et al., 2016); isolates presenting MIC values higher than 
the ECOFF (corresponding to the concentration at which 95 to 99.9 % of the population 
would be inhibited or killed for unimodal distributions, or the concentration between the two 
sub-populations for bi-modal distributions) would then be considered as tolerant (Morrissey 
et al., 2014; Lavilla Lerma et al., 2015). However, with the lack of a standardised method 
for biocide susceptibility testing (Maillard et al., 2013), and the different factors impacting 
MIC determination (mentioned in the previous section for antibiotic susceptibility testing), 
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the variability of MIC values for biocides found in the literature is important, as highlighted 
in Table 2-3. In spite of this, MIC determination for biocides seems to be preferred to other 
biocide-testing protocols such as time-kill studies or suspension tests for example (British 
Standards Institution, 1997; British Standards Institution, 2005; Maillard et al., 2013) in the 
literature, especially with the possibility of high-throughput testing (Maillard et al., 2013; 
Wales & Davies, 2015). 
2.1.3 Aim 
In this work, MICs for a wide range of antibiotics and MICs and MBCs for four 
commonly used biocides were determined for a collection of 210 isolates. The aim was to 
establish a susceptibility baseline enabling the selection of representative organisms for 
further investigations. 
2.2 Material and methods 
2.2.1 Bacterial isolates and cultivation 
2.2.1.1 Bacterial isolates 
A total of 210 carbapenemase-producing isolates (160 Klebsiella pneumoniae and 50 
Escherichia coli) provided by Public Health England, were considered for this study. Their 
detailed information is presented in appendix I. Three collection strains were also included 
as elements of comparison for susceptibility profiles and/or as quality controls when 
required: K. pneumoniae ATCC 13883 (used in a similar study; Naparstek et al., 2012), 
E. coli ATCC 25922 and E. coli NCTC (National Collection of Type Cultures) 13846 
(recommended by EUCAST and CLSI for antibiotic susceptibility testing). 
The 210 isolates were collected from 69 different hospitals across the United 
Kingdom between July 2010 and August 2015. They were mainly isolated from rectal swabs 
(27.1 %), urine (20.5 %), faeces (10.5 %) and blood cultures (9.0 %). Four isolates were 
collected from the hospital environment and the isolation sites of 10 isolates were not 
indicated. Whole-genome sequencing (WGS; Illumina) was performed by Public Health 
England prior to this study, enabling the identification of carbapenemase-encoding genes 
and multi-locus sequence types (MLSTs) of the different strains. 
The selection of these isolates by Katie Hopkins from Public Health England was 
based on several criteria indicated in appendix I. Firstly, representative strains from recent 
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outbreaks (notably in North-West England) were included. Moreover, the sequence types 
(STs) and their combinations with carbapenemase-encoding genes were of particular interest 
in this process to ensure a wide variety of isolates for this study. ‘High risk’ clones, like 
K. pneumoniae ST258 and E. coli ST131, are widely distributed internationally and show 
enhanced abilities to spread, colonize and persist (Chen et al., 2014; Mathers et al., 2015; 
Pitout et al., 2015). ‘International’ clones corresponded to clones which were also identified 
outside the UK in the literature. Strains indicated as ‘successful clones’ were labelled as such 
when they were referred by multiple laboratories and associated with different 
carbapenemases, while not being described as ‘high risk’ in the literature at the time. 
Frequently found ST/carbapenemase combinations among carbapenemase-producing 
Enterobacteriaceae in the United Kingdom were tagged as ‘common clones’ by Public 
Health England. Finally, several isolates with unusual MLST profiles, infrequently 
identified, indicated as ‘outlier clones’, were included as additional comparison elements. 
Among the selected E. coli isolates, blaNDM-5 (excluding combination with others, 
24.0 %) and blaKPC-2 (22.0 %) were the most commonly encountered carbapenemase-
encoding genes. One isolate possessed both blaNDM-4 and blaOXA-181 and another one 
harboured blaNDM-5 and blaOXA-181. Out of 24 STs, the most frequent ones were ST636 
(12.0 %) and ST131, ST38, ST405 and ST410 (8.0 % each). This information was unknown 
for three isolates. Regarding the K. pneumoniae isolates, amongst the 11 carbapenemase-
encoding genes or combinations present, blaKPC-2 (31.9 %), blaNDM-1 (23.8 %) and blaOXA-48 
(19.4 %) were the most represented. Two isolates presented a combination of blaNDM-1 and 
blaOXA-232 and another one possessed both blaNDM-1 and blaOXA-181. The K. pneumoniae 
population covered 57 different STs (the ST of four isolates was unknown), the most 
encountered ones being ST14 and ST15 (7.5 % each), ST231 (6.3 %), and ST11, ST258 and 
ST307 (5.6 % each). 
2.2.1.2 Storage and cultivation 
The different isolates were stored frozen at -80ºC in cryopreservative tubes (Protect, 
Technical Service Consultants Ltd, Heywood, UK). A single colony grown on tryptone soya 
agar (TSA, E&O Laboratories Ltd, Bonnybridge, UK) was transferred into a tube containing 
ceramic beads in a cryopreservative fluid according to the manufacturer’s protocol. After 
vortexing, the suspension was left at room temperature for 5 to 10 min. The liquid was 
removed and the tube placed at -80ºC. When needed, strains were defrosted by taking one 
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bead out of the cryopreservative tube and used to inoculate a TSA plate and incubated at 
37 ± 1ºC overnight. 
Liquid cultures were inoculated by transferring several colonies from a TSA plate 
into 25 mL of tryptone soya broth (TSB, Oxoid, Basingtoke, UK) and incubated overnight 
at 37 ± 1ºC. The cultivation of several colonies was chosen to avoid picking a single mutant 
colony which could have affected a strain’s behaviour. 
2.2.2 Biocides 
Four biocides were investigated in this study: benzalkonium chloride (BZC), 
chlorhexidine digluconate (CHX; both from Sigma-Aldrich, Gillingham, UK), copper(II) 
sulphate pentahydrate (CS) and silver nitrate (SN; both from Acros Organics, Geel, 
Belgium). Stock solutions were prepared from powder for BZC, CS and SN and from a 
liquid solution (20 % w/v) for CHX in deionized water, sterilized by filtration through 
0.20 μm cellulose acetate sterile filters and kept at room temperature in the dark for a 
maximum of two weeks or less if any visible degradation was observed (precipitation or 
change in coloration). Stock solution concentrations corresponded to 10 times the working 
solution concentrations, the latter being obtained by dilution in R2A broth (LabM, Heywood, 
UK). 
2.2.3 Minimum inhibitory concentration determination for antibiotics 
Determination of antibiotic MICs was performed prior to this study by Public Health 
England (Colindale). The protocol was based on the BSAC agar dilution method (Andrews, 
2001). The investigated antibiotics were ampicillin (AMP), piperacillin (PIP), temocillin 
(TEMO), imipenem (IPM), meropenem (MEM), ertapenem (ETP), cefoxitin (FOX), 
cefotaxime (CTX), ceftazidime (CAZ), cefepime (CPM), aztreonam (ATM), amikacin 
(AK), gentamicin (CN), tobramycin (TOB), ciprofloxacin (CIP), tigecycline (TIG), 
minocycline (MIN) and colistin (COL). Agar plates containing serial doubling dilutions of 
antibiotics (Sigma-Aldrich, Gillingham, UK) were prepared in Iso-Sensitest agar (Oxoid, 
Basingstoke, UK). 
2.2.3.1 Preparation of inoculum by direct colony suspension 
A minimum of five individual, well-isolated colonies growing on a non-inhibitory 
agar plate were touched with a swab and resuspended in Iso-Sensitest broth (ISB; Oxoid, 
Basingstoke, UK) until reaching a turbidity equivalent to a 0.5 McFarland standard, 
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corresponding to a bacterial density of approximately 1.5 x 108 CFU (colony forming 
unit)/mL. Suspensions were stored at 4ºC until used. 
2.2.3.2 Plate inoculation 
Suspensions were diluted 1/3 in Iso-Sensitest broth in microtitre plates. The 
microtitre plate was then placed on a multipoint inoculator (Mast Group Ltd, Merseyside, 
UK). Pins inoculated 0.33 μL of the suspensions in the microtitre plates onto the antibiotic-
containing agar plates in ascending concentrations. Control plates containing no antibiotics 
were also inoculated as controls and a 1 μL loopful from each microtitre well was streaked 
on a cystine-lactose-electrolyte-deficient (CLED; Oxoid, Basingstoke, UK) agar plate to 
control the purity of the suspensions. Each spot resulting from the inoculation corresponded 
to approximately 1.5 x104 CFU. Plates were incubated at 36 ± 2ºC for 18-20 hours. 
2.2.3.3 MIC determination for antibiotics 
Plates were read by the Sorcerer™ Colony Counter (Perceptive Instruments Ltd., 
Suffolk, UK) with the Sorcerer MIC software and the MICs calculated were double-checked 
by eye. The MIC was defined as the lowest concentration of antibiotic inhibiting visible 
growth. One or two colonies, as well as hazes of inhibited growth, were not taken into 
account. 
2.2.4 Minimum inhibitory concentration determination for biocides 
The protocol detailed in the following sections was adapted from the ISO 20776-
1:2006 microdilution broth protocol (International Organization for Standardization, 2006), 
recommended by EUCAST (EUCAST, 2019c) and the CLSI M07-A9 standard (CLSI, 
2012). The assay was performed in polystyrene, tissue-culture treated, round bottom 96-well 
microtitre plates (Corning, Ewloe, UK) using the Viaflo Assist pipetting assistant (Integra, 
Zizers, Switzerland) in order to allow high-throughput testing. The experiments were 
conducted in triplicate. 
The cation-adjusted Mueller-Hinton broth (CAMHB) recommended in the standard 
protocol was replaced by R2A broth for both broth and diluent uses. The CAMHB possessed 
a high content in salts, which was not compatible with the range of CHX concentrations 
tested here, causing precipitation. The biocide working solutions pH were between 7.2 and 
7.4, except for CS. The pH measured for the different CS solutions are listed in Table 2-4. 
They could not be increased due to precipitation issues. The effects of this acidic 
Chapter 2 – Bacterial susceptibility to antimicrobials 
Page 31 
environment on bacterial growth were assessed by performing growth curves in R2A broth 
adjusted to different pH values. Fifty μL of bacterial suspension (K. pneumoniae ATCC 
13883 or E. coli ATCC 25922) containing approximately 106 CFU/mL (as described further 
in section 3.2.3.1 page 66) was added to 50 μL of a pH-adjusted R2A solution in a Bioscreen 
Honeycomb microplate (Fisher Scientific, Loughborough, UK). The plate was incubated in 
a Bioscreen C Analyzer (Oy Growth Curves Ab Ltd, Helsinki, Finland) for 24 hours at 37ºC 
with continuous shaking. The optical density (OD) was measured at 600 nm every 4 min. 
Table 2-4. pH values measured for different concentrations of copper sulphate 
solutions. 
CS solutions were prepared in R2A broth to reflect the experimental conditions of the assay. 
CS concentrations (µg/mL) pH 
15,979.5 3.56 
7,989.8 3.67 
3,994.9 3.81 
1,997.4 3.98 
998.7 4.22 
499.4 4.63 
249.7 5.37 
124.8 6.25 
62.4 6.70 
31.2 6.91 
15.6 7.01 
7.8 7.06 
2.2.4.1 Bacterial suspension wash and optical density adjustment 
Bacteria were grown overnight in 25 mL TSB at 37 ± 1ºC. The suspensions were 
centrifuged at 5,000 g for 10 min at 20ºC. Each pellet was resuspended in 10 mL R2A broth 
and subsequently diluted to reach an OD625nm value between 0.150 and 0.175. This range 
was higher than the one recommended in the ISO 20776-1:2006 (0.080 to 0.130) in order to 
ensure a high enough bacterial density for the 96-well plate inoculation. 
The OD625nm-adjusted suspension was diluted at 1/100 in R2A broth, corresponding 
to approximately 106 CFU/mL. This suspension, referred to as the inoculum test suspension, 
was kept at 4ºC until needed. 
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2.2.4.2 Viable counts 
Viable counts were performed to ensure a high enough bacterial concentration in the 
inoculum suspensions. According to the ISO 7218:2007, viable counts are considered 
reliable when comprised between 10 and 300 CFU (International Organization for 
Standardization, 2007). Below 10 CFU, the number would not be statistically significant 
(not representative of the sample), while above 300 CFU colonies would be too close to be 
able to distinguish different colonies. 
A 1/500 dilution from each inoculum suspension was performed in R2A broth. Two 
volumes, 40 μL and 100 μL, were spread on TSA plates. With an inoculum suspension of 
106 CFU/mL, these volumes would result in 80 and 200 CFU on the plates, respectively. 
Colonies were enumerated after an overnight incubation of the TSA plates at 37 ± 1ºC. The 
means of counts within 10 and 300 CFU were used to determine the real bacterial 
concentrations. 
2.2.4.3 96-well plate inoculation 
The layout of the 96-well microtitre plates is presented in Figure 2-1. The plates were 
first filled with 50 μL of R2A broth. Two-fold serial dilutions of the biocides, one over the 
top four rows, another over the bottom four rows, were performed across the plates, except 
in the last column where no biocide was added. Fifty μL of the inoculum suspension was 
then added to each well, resulting in a final bacterial concentration of approximately 
5.5 x105 CFU/mL, except for the top and bottom rows where 50 μL of R2A broth was added 
as negative controls for each biocide. Two plates were necessary in order to determine the 
MIC of each strain for the four tested biocides. Additional plates were included to enable the 
testing of both K. pneumoniae ATCC 13883 and E. coli ATCC 25922, used as quality 
controls. Microtitre plates were incubated for 16 to 24 hours at 37 ± 1ºC. 
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Figure 2-1. 96-well microtitre plate layout. 
Testing for one strain and two biocides with three technical replicates each was performed 
on one 96-well plate. 
Due to the design of this protocol, biocides underwent a ¼ dilution in the first 
column. Four-times more concentrated solutions were then needed to fill in the plates. The 
highest tested concentration for BZC, CHX and SN being 128 μg/mL (concentrations range: 
128 to 0.125 μg/mL), each solution used to fill in the 96-well plates had to contain 
512 μg/mL of the corresponding biocide, except when stated otherwise. In a similar way, 
two CS solutions reaching 15,979.5 μg/mL and 3,994.9 μg/mL were used for the MIC testing 
of the studied strains (concentration range: 3,994.9 to 3.9 μg/mL) and the ATCC strains 
(concentration range: 998.7 to 1.0 μg/mL), respectively. 
2.2.4.4 MIC determination for biocides 
The MIC was defined as the lowest concentration of the active agent able to inhibit 
growth of the considered organism. The MIC therefore corresponded to the lowest 
concentration of biocide where neither turbidity nor growth at the bottom of the well was 
observed with a naked eye. 
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2.2.5 Minimum bactericidal concentration determination for biocides 
The MBC was defined as the lowest concentration of an active agent able to kill the 
considered organism. In order to determine the MBC, the biocides needed to be neutralised 
to allow the recovery of any viable bacteria which growth could be inhibited. 
2.2.5.1 Neutraliser composition 
Biocides were neutralised both by dilution and by the use of a universal neutraliser 
recommended by the standard BS EN 1276:1997 (British Standards Institution, 1997). Its 
composition was as follow: 30 g/L polysorbate 80, 30 g/L saponin, 3 g/L lecithin (all three 
from Acros Organics, Geel, Belgium), 5 g/L sodium thiosulfate (Fisher Scientific, 
Loughborough, UK) and 1 g/L L-Histidine (Sigma-Aldrich, Gillingham, UK) in tryptone 
sodium chloride (TSC) buffer. Sodium thiosulfate was used to quench the effects of the 
heavy metals. Lecithin was used to counteract the activity of CHX, while both lecithin and 
polysorbate 80 neutralised BZC, a QAC (Johnston et al., 2002; Sutton et al., 2002; Koburger 
et al., 2010). The TSC was prepared by mixing 8.5 g/L sodium chloride (Fisher Scientific, 
Loughborough, UK) and 1 g/L tryptone (Oxoid, Basingtoke, UK) in deionized water. The 
neutraliser was sterilized by autoclaving at 121 ± 3ºC for a minimum holding time of 15 min. 
2.2.5.2 Neutraliser efficacy and toxicity assessments 
The efficacy of the neutraliser to quench the activity of the tested biocides was tested 
by adding 10 μL of the highest concentration of the biocide used (512 μg/mL for BZC, CHX 
and SN, 15,797.5 μg/mL for CS) to 180 μL of neutraliser, except when stated otherwise. In 
a similar way, the neutraliser toxicity was evaluated by mixing 10 μL of R2A broth to 180 μL 
of neutraliser. After brief mixing and 5-30 min contact, 10 μL of an inoculum test suspension 
(as described in section 2.2.4.1 page 31; either K. pneumoniae ATCC 13883 or E. coli ATCC 
25922) was added. The suspension was briefly mixed and, after 5 min, a 1/50 dilution in 
R2A broth was performed and 200 μL and 80 μL were spread on two distinct TSA plates for 
viable counts. Colonies were enumerated after an overnight incubation at 37 ± 1ºC. A viable 
count was also performed on the inoculum suspensions without any contact with a biocide 
(as described previously in section 2.2.4.2 page 32) to determine the original bacterial 
concentration. 
The neutraliser was considered efficient if less than one log10 reduction was observed 
when comparing the bacterial concentration in the neutralised biocide solutions to the 
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untreated control. It was considered toxic if more than one log10 reduction was observed 
compared to the untreated control (Knapp et al., 2013). 
2.2.5.3 MBC determination for biocides 
The MBC determination was based and adapted from a previous study performed by 
Knapp and colleagues (2015). After reading the MIC, the wells corresponding to the three 
concentrations immediately above the MIC and the one corresponding to the MIC were 
neutralised as described below. The two wells corresponding to the concentrations 
immediately below the MIC were also neutralised as controls. After neutralisation, the 
microtitre plates used for MIC determination were kept at 4ºC for a maximum of 24 hours 
in case further testing was needed. 
Twenty μL from each selected well was removed and transferred to 180 μL of 
neutraliser. After brief mixing and 5-30 min contact, 20 μL from each suspension was 
removed and dropped on a TSA plate (except stated otherwise), as shown in Figure 2-2. TSA 
plates were incubated overnight at 37 ± 1ºC and the MBC corresponded to the lowest 
concentration of biocide where no growth was observed on TSA. If growth was observed on 
TSA for all the tested concentrations, the wells containing higher concentrations of biocides 
were neutralised following the same protocol. 
  
Hélène Hérault Cardiff University 2019 
Page 36 
 
Figure 2-2. MBC determination protocol steps. 
After determining the MIC as the lowest concentration of biocide where no growth was 
observed (red circle), six wells (three above the MIC, the one corresponding to the MIC and 
two below the MIC; red rectangle) were neutralised to determine whether the bacteria were 
killed or if their growth was inhibited by the biocide. The MBC was read as the lowest 
concentration of biocide where no growth was observed on TSA (green circle). 
2.2.6 Statistical analysis 
Statistical analysis was performed using Prism GraphPad 5 for Windows. 
Calculations of mean and minimum to maximum values were realised for each species and 
each biocide, separately for MICs and MBCs. The lowest concentrations able to inhibit 50% 
(MIC50) or 90% (MIC90) of the total number of tested isolates were also determined. 
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Similarly, the lowest concentrations able to kill 50% (MBC50) or 90% (MBC90) were 
calculated. D’Agostino and Pearson normality test was used to verify the nature of the 
distribution of the values. Comparison between MIC and MBC distributions of the four 
biocides for both species were performed using Kruskal-Wallis test followed by Dunn’s 
multiple comparison post-test. 
2.3 Results 
2.3.1 Impact of pH on bacterial growth 
Due to low pH issues encountered with CS at high concentrations, the growth of both 
K. pneumoniae ATCC 13883 and E. coli ATCC 25922 was assessed by performing growth 
curves in pH-adjusted R2A solutions (Figure 2-3). Mean of three replicates are presented in 
the figure below. For both species no growth was observed at pH 3.24 and below, while 
growth was obtained in all cases for pH 6.09 and above. At pH 4.53, E. coli ATCC 25922 
was not able to grow over a 24-hour period, while in 2/3 repeats growth was observed for 
K. pneumoniae ATCC 13883. Solutions harbouring pH values between 4.53 and 6.09 were 
not obtained probably due to the buffering capacity of the broth. Two CS solutions in R2A 
harboured pH values within that range: 499.4 μg/mL (pH=4.63) and 249.7 μg/mL 
(pH=5.37). Solutions containing 124.8 μg/mL CS (pH=6.25) or less corresponded to pH 
values able to support growth for K. pneumoniae and E. coli isolates. 
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Figure 2-3. Growth curves performed in different pH-adjusted R2A solutions for both 
K. pneumoniae ATCC 13883 and E. coli ATCC 25922. 
The y axis corresponds to blanked OD600nm values. Each point represented the mean of three 
values (n=3). In the case of K. pneumoniae ATCC 13883, growth in R2A at pH 4.53 was 
obtained in 2/3 repeats. 
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2.3.2 Neutraliser efficacy and toxicity assessments 
The neutraliser was efficient in quenching the activities of each biocide at the 
concentrations tested (0 to 0.3 log10 reduction for both species for the four biocides). 
However, for one isolate (Kp-94), the SN concentration range had to be increased to 
1,024 μg/mL. This concentration was not neutralised (1.0 log10 reduction for both reference 
strains) in the described conditions and the protocol had to be altered. In this case, 20 μL 
from the selected wells was added to 980 μL of neutraliser. Forty μL of the obtained 
suspensions was dropped on TSA plates. Neutralisation of 1,024 μg/mL SN was obtained in 
these conditions (0.3 log10 reduction). 
Regarding the toxicity assessment, 0 to 0.2 log10 reduction was observed for either 
K. pneumoniae or E. coli ATCC strains. The neutraliser was not toxic for both reference 
strains. By extent, the neutraliser was considered as not toxic for the studied species, as these 
strains were susceptible strains, more likely to be inhibited by low concentrations of 
compounds than resistant isolates. 
2.3.3 Susceptibility profiles to antibiotics 
Regarding the antibiotic susceptibility testing performed by Public Health England, 
MIC values are presented in appendix II for K. pneumoniae isolates and in appendix III for 
E. coli isolates. The resistant / intermediate / susceptible status of each isolate for each 
antibiotic were based on breakpoints established by BSAC for Enterobacteriaceae, when 
available (BSAC, 2015). The breakpoint for FOX and a ECOFF for MIN were obtained from 
EUCAST recommendations (EUCAST, 2009; EUCAST, 2019b). 
A summary of the susceptibility status of K. pneumoniae and E. coli isolates for the 
different antibiotics tested in presented in Table 2-5. Regarding K. pneumoniae isolates, 
12/160 strains were not tested against any of the investigated antibiotics. Eighty-four to 93 % 
of the 160 K. pneumoniae isolates have been tested for each antibiotic. Regarding the E. coli 
strains, 6/50 did not possess any antibiotic susceptibility data. Except for MIN, 76 to 88 % 
of the 50 E. coli isolates have been tested for each antibiotic. 
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Table 2-5. Susceptibility profiles to antibiotics for the overall K. pneumoniae and E. coli 
populations. 
The percentage of the tested strains corresponding to each category (R: resistant; 
I: intermediate; S: susceptible) is indicated for each antibiotic tested, for both species. 
Isolates without MIC values for specific antibiotics were not included in the percentage 
calculations for the corresponding antibiotics. AMP: ampicillin; PIP: piperacillin; TEMO: 
temocillin; TOB: tobramycin; AK: amikacin; CN: gentamycin; CTX: cefotaxime; CAZ: 
ceftazidime; CPM: cefepime; FOX: cefoxitin; IPM: imipenem; MEM: meropenem; ETP: 
ertapenem; ATM: aztreonam; CIP: ciprofloxacin; TIG: tigecycline; MIN: minocycline; 
COL: colistin; N/A: not available. 
  K. pneumoniae E. coli 
  R I S R I S 
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s 
AMP 100 0 0 100 0 0 
PIP 100 0 0 100 0 0 
TEMO 85 0 15 82 0 18 
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TOB 70 1 28 57 9 34 
AK 32 11 57 32 0 68 
CN 57 1 42 48 2 50 
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CTX 91 5 4 95 2 2 
CAZ 84 5 10 80 14 7 
CPM 73 14 13 70 16 14 
FOX 84 0 16 80 0 20 
C
ar
b
a-
p
en
em
s IPM 56 32 12 43 36 20 
MEM 61 22 16 43 20 36 
ETP 100 0 0 98 2 0 
O
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ATM 88 1 11 81 0 19 
CIP 76 3 21 52 7 41 
TIG 18 27 56 0 0 100 
MIN 46 0 54 N/A N/A N/A 
COL 8 0 92 0 0 100 
 
All of the tested isolates were resistant to AMP, AUG, PIP and ETP (with the 
exception of Ec-181 for ETP, showing an intermediate status). In addition, resistance to 
TEMO, TOB (K. pneumoniae only), cephalosporins, ATM and CIP (K. pneumoniae only) 
was observed for at least two thirds of the tested population for both species, except stated 
otherwise. Approximately half of the tested isolates showed resistance for CN, IPM, MEM 
and MIN (K. pneumoniae only). Intermediate profiles were not commonly detected (0 to 
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32 % of the tested population depending on the antibiotic). Susceptibility for more than 50 % 
of the tested population was observed only for AK, CN (E. coli only), TIG (56 % for 
K. pneumoniae, 100 % of the tested isolates for E. coli) and COL (92 % for K. pneumoniae 
and 100 % for E. coli). 
2.3.4 Susceptibility profiles to biocides 
2.3.4.1 Klebsiella pneumoniae isolates 
Results obtained for the reference strain K. pneumoniae ATCC 13883 are presented 
in Table 2-6. The data obtained for the overall population are grouped in appendix IV and 
summarised in Table 2-7. The reference strain MICs and MBCs were below the mean and 
the MIC50 of the overall population for each biocide. Regarding the clinical isolates, data 
obtained for BZC, CHX, and to some extent SN, were similar, as opposed to CS where 
higher values were obtained. According to D’Agostino and Pearson normality test, MIC and 
MBC values were not normally distributed for any of the biocides tested (p<0.05). 
Table 2-6. Mean biocide MIC and MBC for the reference strain K. pneumoniae ATCC 
13883. 
MICs and MBCs were determined at least in triplicate for each biocide (n≥3). SD: standard 
deviation. 
    Mean SD 
BZC MIC 3.2 0.7 
µg/mL MBC 3.6 0.4 
CHX MIC 1.4 0.4 
µg/mL MBC 1.6 0.5 
CS MIC 38.1 6.0 
µg/mL MBC 59.0 6.0 
SN MIC 1.6 0.5 
µg/mL MBC 1.7 0.3 
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Table 2-7. Summary of the MICs and MBCs obtained for the four investigated biocides 
on the overall K. pneumoniae population. 
For each isolate, MICs and MBCs were determined at least in triplicate for each biocide 
(n≥3). 
 BZC CHX CS SN 
 µg/mL µg/mL µg/mL µg/mL 
 MIC MBC MIC MBC MIC MBC MIC MBC 
Mean 7.3 8.8 6.2 7.2 157.0 171.4 4.9 5.0 
Minimum 2.0 3.3 2.0 2.7 7.8 15.6 2.0 2.0 
Maximum 16.0 32.0 16.0 16.0 417.0 417.0 256.0 256.0 
MIC50/MBC50 8.0 8.0 6.7 8.0 167.3 207.2 4.0 4.0 
MIC90/MBC90 10.7 13.3 8.0 10.7 249.7 249.7 4.0 4.0 
 
The distributions of the overall population of K. pneumoniae isolates according to 
their MIC and MBC for the different investigated biocides are presented in Figure 2-4. 
Regarding BZC and CHX, MIC and MBC values followed similar uni-modal distributions 
(Dunn’s test; p>0.05), while a wide-range, bi-modal distribution was observed for CS. With 
the exception of Kp-94 exhibiting a MIC of 256 μg/mL, the repartitions of MICs and MBCs 
for SN were narrow (2-4 μg/mL). Distributions of MICs and MBCs for both CS and SN 
were significantly different when compared to the other investigated biocides (Dunn’s test; 
p<0.05). MBC were usually equivalent or double the MIC for each biocide (no statistically 
significant difference between their distributions according to Dunn’s test). An MBC/MIC 
ratio higher than two was obtained for Kp-5 (MBC/MIC ratio: 3.2), Kp-78 (2.5), Kp-102 
(2.7) with BZC and Kp-8 (2.7), Kp-19 (4.0), Kp-107 (4.0), Kp-126 (3.3) with CS. 
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Figure 2-4. Repartition of MICs and MBCs for four biocides among K. pneumoniae 
isolates. 
The intervals of concentrations (in μg/mL) are indicated on the x axis as [A; B[, 
corresponding to concentrations higher or equal to A but strictly lower than B. MIC and 
MBC repartitions among the 160 K. pneumoniae isolates are indicated for BZC, CHX, CS 
and SN. 
The impact of the carbapenemase produced by the isolates on the MIC repartitions 
was investigated (Figure 2-5). When considering each biocide separately, NDM-, VIM-, 
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OXA-48-like- and KPC-producing isolates presented similar MIC distributions (Dunn’s test; 
p>0.05). The outlier Kp-94 with an elevated SN MIC possessed both blaNDM-1 and blaOXA-232. 
 
Figure 2-5. Repartition of MICs among K. pneumoniae isolates according to their 
produced carbapenemases. 
The intervals of concentrations (in μg/mL) are indicated on the x axis as [A; B[, 
corresponding to concentrations higher or equal to A but strictly lower than B. MIC 
repartitions among the NDM- (n=41), VIM- (n=15), OXA-48-like- (n=54) and 
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KPC-producing (n=53) K. pneumoniae isolates are indicated for BZC, CHX, CS and SN. 
Isolates producing a combination of two different carbapenemases were represented in both 
categories. 
2.3.4.2 Escherichia coli isolates 
The MICs and MBCs obtained for E. coli ATCC 25922 are grouped in Table 2-8. 
The data obtained for the clinical isolates are summarised in Table 2-9 and detailed values 
are included in appendix V. MICs and MBCs obtained for the reference strain were in 
accordance with the 50% most susceptible fraction of the clinical isolates investigated, 
except with BZC where the reference strain MIC was higher than the MIC50 obtained for the 
overall population. BZC susceptibility data seemed higher than CHX in E. coli while, despite 
a narrow range of values, SN MIC and MBC were comparable to those of CHX. CS showed 
higher values for both MIC and MBC when compared to the other biocides. Data were not 
normally distributed (p<0.05) for any of the biocides according to D’Agostino and Pearson 
normality test. 
Table 2-8. Mean biocide MICs and MBCs for the reference strain E. coli ATCC 25922. 
MICs and MBCs were determined at least in triplicate for each biocide (n≥3). SD: standard 
deviation. 
    Mean SD 
BZC MIC 5.7 1.7 
µg/mL MBC 5.8 0.8 
CHX MIC 1.7 0.3 
µg/mL MBC 1.7 0.3 
CS MIC 31.2 0.0 
µg/mL MBC 38.1 12.0 
SN MIC 1.1 0.3 
µg/mL MBC 1.2 0.2 
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Table 2-9. Summary of the MICs and MBCs obtained for the four investigated biocides 
on the overall E. coli population. 
For each isolate, MICs and MBCs were determined at least in triplicate for each biocide 
(n≥3). 
 BZC CHX CS SN 
 µg/mL µg/mL µg/mL µg/mL 
 MIC MBC MIC MBC MIC MBC MIC MBC 
Mean 5.2 6.6 2.0 2.8 61.8 72.8 2.6 2.8 
Minimum 2.7 2.7 0.5 1.7 7.8 15.6 1.7 1.7 
Maximum 8.0 16.0 4.0 5.3 249.7 249.7 4.0 5.4 
MIC50/MBC50 4.0 6.7 2.0 2.7 31.2 31.2 2.0 2.7 
MIC90/MBC90 8.0 10.7 3.9 4.0 124.8 203.2 4.0 4.0 
 
The overall repartitions of MICs and MBCs for BZC, CHX, CS and SN obtained for 
the E. coli isolates are presented in Figure 2-6. Uni-modal distributions of MICs and MBCs 
were observed for BZC, CHX and SN, while a double-bell shape with a wider range of 
concentrations was obtained for CS. MIC and MBC distributions of both BZC and CS were 
significantly different than the ones obtained for the other investigated biocides (Dunn’s test; 
p<0.05). No significant difference between the distributions obtained for CHX and SN was 
detected (Dunn’s test; p>0.05). No statistically significant differences were observed 
between MIC and MBC distributions when considering each biocide separately (Dunn’s test; 
p>0.05), with MBC being usually double or equivalent to the MIC. MBC/MIC ratios higher 
than two were however obtained for Ec-187 (MBC/MIC ratio: 3.3) and Ec-210 (2.4) with 
BZC, Ec-161 (2.7) and Ec-206 (4.0) with CHX, and Ec-158 (2.7), Ec-162 (3.2), Ec-187 
(2.7), Ec-199 (2.7) and Ec-206 (16.0) with CS. With regards to Ec-206, however, MICs were 
difficult to evaluate due to the low turbidity obtained after incubation when growth was 
obtained, which could influence the ratio value. 
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Figure 2-6. Repartition of MICs and MBCs for four biocides among E. coli isolates. 
The intervals of concentrations (in μg/mL) are indicated on the x axis as [A; B[, 
corresponding to concentrations higher or equal to A but strictly lower than B. MIC and 
MBC repartitions among the 50 E. coli isolates are indicated for BZC, CHX, CS and SN. 
The repartitions of MIC and MBC according to the carbapenemase-encoding genes 
possessed by the different isolates are shown in Figure 2-7. The type of carbapenemase 
produced (NDM, VIM, OXA-48-like and KPC) did not have an impact on the MIC and 
MBC distribution when considering each biocide separately (Dunn’s test; p>0.05). 
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Figure 2-7. Repartition of MICs for four biocides among E. coli isolates according to 
their produced carbapenemases. 
The intervals of concentrations (in μg/mL) are indicated on the x axis as [A; B[, 
corresponding to concentrations higher or equal to A but strictly lower than B. MIC 
repartitions among the NDM- (n=21), VIM- (n=3), OXA-48-like- (n=13) and KPC-
producing (n=15) E. coli isolates are indicated for BZC, CHX, CS and SN. The isolates 
producing a combination of different carbapenemases were represented in both categories. 
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When comparing both species, MIC and MBC distributions for each biocide were 
similar (Dunn’s test; p>0.05), except for CHX where statistically significant higher values 
were obtained for the K. pneumoniae population (Dunn’s test; p<0.05). 
2.4 Discussion 
Regarding antibiotic susceptibility profiles, all isolates in this study were categorised 
as multi-drug resistant according to a harmonised definition established by international 
experts: ‘multi-drug resistance is defined as non-susceptibility to at least one agent in three 
or more antimicrobial categories’ (Magiorakos et al., 2012; Mathers et al., 2015). Extensive 
drug resistance corresponds to ‘non-susceptibility to at least one agent in all but two or fewer 
antimicrobial categories’ (corresponding to the list of recommended antibiotics and 
antibiotic categories to test for resistance by Magiorakos and colleagues). As not every 
recommended category of antibiotics was tested for this work, it was not possible to define 
any isolate as extensively-drug resistant. No pan-drug resistant isolate was identified, as no 
‘non-susceptibility to all agents in all antimicrobial categories’ was detected; isolates were 
susceptible to at least one of the tested antibiotics (Magiorakos et al., 2012). It is important 
to note however that MICs were determined by agar-dilution method, including for colistin, 
for which testing is now recommended to be performed by broth dilution methods; this could 
lead to false estimates of MICs and, thus, incorrect susceptibility profiles to colistin (Giske 
& Kahlmeter, 2018; Matuschek et al., 2018). 
As opposed to antibiotics, MIC determination for biocides is not a standardised 
procedure, preventing from being able to compare data with the existing literature; 
moreover, a similar lack of standard protocol is also observed when considering biocide 
susceptibility testing in general, mostly due to the differences in regulations between 
countries and/or agencies (some more stringent than others) and factors inherent to the test 
protocol itself such as the biocide concentration and formulation or the contact time for 
example (SCENIHR, 2009; Knapp et al., 2015). When focusing on MIC determination, the 
method (agar-diffusion, macrodilution and microdilution methods), the media and its 
composition, the nature and coating of the microtitre plates (for microdilution method), 
among other parameters, can have a major impact on the MICs obtained (Maillard et al., 
2013; Wessels & Ingmer, 2013; Bock et al., 2018). This can be illustrated in Table 2-10 
(K. pneumoniae) and Table 2-11 (E. coli), regrouping MIC values collected from different 
studies using various methods and media combinations. Even when the same protocol was 
followed, e.g. the broth microdilution method detailed in the ISO 20776-1:2006, any 
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modification would impact the results. Indeed, in this study, the recommended CAMHB had 
to be replaced by R2A broth due to precipitation outcomes with CHX. The cation content, 
especially Mg2+ and Ca2+, is lower in R2A than in CAMHB. Divalent cations are known to 
increase the susceptibility towards QACs, including BZC, and to impact some antibiotic 
MICs (Chow et al., 1989). When comparing MIC data obtained in this study for E. coli 
ATCC 25922, values similar to the ones found in the literature were obtained for CHX (Grare 
et al., 2010; Naparstek et al., 2012; Tetz & Tetz, 2015), but they were very different for CS 
and SN (Sutterlin et al., 2018). K. pneumoniae ATCC 13883 was used in only two of the 
studies grouped in Table 2-10 below, and a 2- to 8-fold difference in MIC was obtained for 
CHX (Naparstek et al., 2012; Hashemi et al., 2019). Due to this variability, the MIC values 
found in the literature were used as indicators of general trends rather than strictly being 
compared to the results generated in this study. 
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Table 2-10. MICs reported in the literature and from this study determined by 
different protocols for K. pneumoniae. 
*Individual MICs were not reported; the indicated values correspond to the MIC90. **Data 
were available only on graphics and not mentioned in the text and are therefore an estimation 
in this table. CAMHA: cation-adjusted Mueller-Hinton agar; ISB: Iso-Sensitest broth; 
MHA: Mueller-Hinton agar; MHB: Mueller-Hinton broth; TYE: tryptone yeast extract 
broth. 
Reference Design of the assay Biocide MIC (μg/mL) Isolates tested 
This study Microdilution with 
R2A 
BZC 2-4 K. pneumoniae 
ATCC 13883 
This study Microdilution with 
R2A 
BZC 2-16 Clinical isolates 
Pastrana-
Carrasco et al., 
2012 
Agar-dilution 
(media?) 
BZC 32-128 Clinical isolates 
Abuzaid et al., 
2012 
Agar-dilution with 
ISA 
BZC 16-64 Clinical isolates 
Hammond et 
al., 1987 
Agar-dilution with 
ISA 
BZC 15 K. pneumoniae 
ATCC 10273 
Curiao et al., 
2015 
Microdilution 
(broth?) 
BZC 16 Clinical isolate 
Guo et al., 
2015 
Microdilution 
(broth?) 
BZC 8-32 Clinical isolates 
Morrissey et 
al., 2014 
Microdilution 
(broth?) 
BZC 16* Not specified 
Wand et al., 
2015 
Microdilution 
(broth?) 
BZC 1-32 Pre-antibiotic era 
and modern isolates 
Vijayakumar et 
al., 2018 
Microdilution with 
MHB 
BZC 8-32 Clinical isolates 
Houari & Di 
Martino, 2007 
Microdilution with 
TSB 
BZC 125 Clinical strain 
Knapp et al., 
2015 
Microdilution with 
TSB 
BZC ≈ 20** Unilever collection 
isolate 
This study Microdilution with 
R2A 
CHX 1-2 K. pneumoniae 
ATCC 13883 
This study Microdilution with 
R2A 
CHX 2-16 Clinical isolates 
Pastrana-
Carrasco et al., 
2012 
Agar-dilution 
(media?) 
CHX 16-64 Clinical isolates 
Naparstek et 
al., 2012 
Agar-dilution with 
CAMHA 
CHX 8-256 Clinical isolates 
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Table 2-10 – Continued. 
Reference Design of the assay Biocide MIC (μg/mL) Isolates tested 
Naparstek et 
al., 2012 
Agar-dilution with 
CAMHA 
CHX 16 K. pneumoniae 
ATCC 13883 
Abuzaid et al., 
2012 
Agar-dilution with 
ISA 
CHX 4-128 Clinical isolates 
Hammond et 
al., 1987 
Agar-dilution with 
ISA 
CHX 40 K. pneumoniae 
ATCC 10273 
Block & 
Furman, 2002 
Agar-dilution with 
MHA 
CHX 2-128 Clinical isolates 
Tetz & Tetz, 
2015 
Macrodilution 
(broth?) 
CHX 32 Private collection 
isolate 
Koljalg et al., 
2002 
Macrodilution with 
CAMHB 
CHX 16 Clinical isolates 
Bock et al., 
2016 
Microdilution 
(broth?) 
CHX 128-512 Pre-chlorhexidine / 
modern era isolates 
Curiao et al., 
2015 
Microdilution 
(broth?) 
CHX 32 Clinical isolate 
Guo et al., 
2015 
Microdilution 
(broth?) 
CHX 32 Clinical isolates 
Morrissey et 
al., 2014 
Microdilution 
(broth?) 
CHX 32* Not specified 
Wand et al., 
2015 
Microdilution 
(broth?) 
CHX 0.25-32 Pre-antibiotic era 
and modern isolates 
Wand et al., 
2017 
Microdilution 
(broth?) 
CHX 32-512 Clinical isolates 
Grare et al., 
2010 
Microdilution with 
CAMHB 
CHX 2-4 Clinical isolates 
Suwantarat et 
al., 2014 
Microdilution with 
CAMHB 
CHX 2->32 Clinical isolates 
Zhou et al., 
2015 
Microdilution with 
CAMHB 
CHX 16-32 Clinical isolates 
Hashemi et al., 
2019 
Microdilution with 
MHB 
CHX 4 K. pneumoniae 
ATCC 13883 
Vijayakumar et 
al., 2018 
Microdilution with 
MHB 
CHX 16-64 Clinical isolates 
Darouiche et 
al., 2008 
Microdilution with 
TSB 
CHX 6.25 Clinical isolate 
Houari & Di 
Martino, 2007 
Microdilution with 
TSB 
CHX 625 Clinical isolate 
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Table 2-10 – Continued. 
Reference Design of the assay Biocide MIC (μg/mL) Isolates tested 
Knapp et al., 
2015 
Microdilution with 
TSB 
CHX ≈ 4** Unilever collection 
isolate 
This study Microdilution with 
R2A 
SN 1-2 K. pneumoniae 
ATCC 13883 
This study Microdilution with 
R2A 
SN 2-256 Clinical isolates 
Elkrewi et al., 
2017 
Agar-dilution 
(media?) 
SN 1-8 Clinical isolates 
Kapoor et al., 
1989 
Macrodilution with 
TYE 
SN 5-20 Clinical isolates 
Cavassin et al., 
2015 
Microdilution with 
both CAMHB and 
TSB 
SN 3.4-13.5 Enterobacteriaceae 
(no species 
indication) 
Table 2-11. MICs reported in the literature and from this study determined by 
different protocols for E. coli. 
*Individual MIC were not reported; the indicated values correspond to the MIC90. ISA: Iso-
Sensitest agar; LB: Luria-Bertani broth; MHA: Mueller-Hinton agar; MHB: Mueller-Hinton 
broth. 
Reference Design of the assay Biocide MIC (μg/mL) Isolates tested 
This study Microdilution with 
R2A 
BZC 4-8 E. coli ATCC 
25922 
This study Microdilution with 
R2A 
BZC 2.7-8 Clinical isolates 
Hammond et 
al., 1987 
Agar-dilution with 
ISA 
BZC 20-50 E. coli ATCC 
10536 and ATCC 
11776 
Hammond et 
al., 1987 
Agar-dilution with 
ISA 
BZC 25-100 Clinical isolates 
Soumet et al., 
2012 
Macrodilution with 
MHB 
BZC 16-32 Avian and porcine 
isolates 
Curiao et al., 
2015 
Microdilution 
(broth?) 
BZC 16 Clinical isolate 
Morrissey et 
al., 2014 
Microdilution 
(broth?) 
BZC 32* Not specified 
Aarestrup & 
Hasman, 2004 
Microdilution with 
CAMHB 
BZC 16-128 Isolates from 
livestock animals 
Beier et al., 
2016 
Microdilution with 
CAMHB 
BZC 4-32 Food animals and 
clinical isolates 
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Table 2-11 – Continued. 
Reference Design of the assay Biocide MIC (μg/mL) Isolates tested 
Bock et al., 
2018 
Microdilution with 
different broth/plates 
BZC 8-16 E. coli ATCC 
10536 
Deus et al., 
2017 
Microdilution with 
MHB 
BZC 4-32 Isolates from 
patients and broiler 
chickens 
Henly et al., 
2019 
Microdilution with 
MHB 
BZC 15.6 Clinical isolate 
Bore et al., 
2007 
Microdilution with 
TSB 
BZC 13 E. coli ATCC 
47076 
Houari & Di 
Martino, 2007 
Microdilution with 
TSB 
BZC 62.5 Clinical isolate 
This study Microdilution with 
R2A 
CHX 1.3-2 E. coli ATCC 
25922 
This study Microdilution with 
R2A 
CHX 0.5-4 Clinical isolates 
Naparstek et 
al., 2012 
Agar-dilution with 
CAMHA 
CHX 2 E. coli ATCC 
25922 
Hammond et 
al., 1987 
Agar-dilution with 
ISA 
CHX 1.5 E. coli ATCC 
10536 and ATCC 
11776 
Hammond et 
al., 1987 
Agar-dilution with 
ISA 
CHX 1-5 Clinical isolates 
do Amorim et 
al., 2004 
Agar-dilution with 
MHA 
CHX 2.67 Clinical isolate 
Tetz & Tetz, 
2015 
Macrodilution 
(broth?) 
CHX 2 E. coli ATCC 
25922 
Tetz & Tetz, 
2015 
Macrodilution 
(broth?) 
CHX 16 Private collection 
isolate 
Koljalg et al., 
2002 
Macrodilution with 
CAMHB 
CHX 2 Clinical isolates 
Braoudaki & 
Hilton, 2004 
Macrodilution with 
nutrient broth 
CHX 4 E. coli ATCC 
700728 
O'Driscoll et 
al., 2014 
Macrodilution with 
nutrient broth 
CHX 0.6 E. coli NCTC 4174 
Thomas et al., 
2000 
Macrodilution with 
nutrient broth 
CHX 0.2 E. coli ATCC 
10536 
Curiao et al., 
2015 
Microdilution 
(broth?) 
CHX 8 Clinical isolate 
Morrissey et 
al., 2014 
Microdilution 
(broth?) 
CHX 16* Not specified 
Wesgate et al., 
2016 
Microdilution 
(broth?) 
CHX 7 E. coli ATCC 8739 
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Table 2-11 – Continued. 
Reference Design of the assay Biocide MIC (μg/mL) Isolates tested 
Aarestrup & 
Hasman, 2004 
Microdilution with 
CAMHB 
CHX 1-2 Isolates from 
livestock animals 
Beier et al., 
2016 
Microdilution with 
CAMHB 
CHX 0.25-4 Food animals and 
clinical isolates 
Grare et al., 
2010 
Microdilution with 
CAMHB 
CHX < 1-2 E. coli ATCC 
25922 and clinical 
isolates 
Suwantarat et 
al., 2014 
Microdilution with 
CAMHB 
CHX 2-4 Clinical isolates 
Bock et al., 
2018 
Microdilution with 
different broth/plates 
CHX 0.125-2 E. coli ATCC 
10536 
Deus et al., 
2017 
Microdilution with 
MHB 
CHX 0.5-4 Isolates from 
patients and broiler 
chickens 
Koburger et al., 
2010 
Microdilution with 
MHB 
CHX 8 E. coli ATCC 
35218 
McBain et al., 
2004 
Microdilution with 
nutrient broth 
CHX 13 E. coli ATCC 8729 
Darouiche et 
al., 2008 
Microdilution with 
TSB 
CHX 0.39 Clinical isolate 
Houari & Di 
Martino, 2007 
Microdilution with 
TSB 
CHX 80 Clinical isolate 
This study Microdilution with 
R2A 
CS 31.2-52.0 E. coli ATCC 
25922 
This study Microdilution with 
R2A 
CS 7.8-249.7 Clinical isolates 
Aarestrup & 
Hasman, 2004 
Microdilution with 
CAMHB 
CS 1,997.4-
5,992.3 
Isolates from 
livestock animals 
Biagi et al., 
2014 
Microdilution with 
CAMHB 
CS 12,500 E. coli CCUG 
50175 and clinical 
isolates 
Sutterlin et al., 
2018 
Microdilution with 
ISB 
CS 512-2,048 Clinical isolates 
Sutterlin et al., 
2018 
Microdilution with 
ISB 
CS 1,024-2,048 E. coli ATCC 
25922 
Harrison et al., 
2005 
Microdilution with 
LB broth 
CS 1,124 Not specified 
Deus et al., 
2017 
Microdilution with 
MHB 
CS 512-4,096 Isolates from 
patients and broiler 
chickens 
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Table 2-11 – Continued. 
Reference Design of the assay Biocide MIC (μg/mL) Isolates tested 
This study Microdilution with 
R2A 
SN 0.8-1.3 E. coli ATCC 
25922 
This study Microdilution with 
R2A 
SN 1.7-4 Clinical isolates 
Elkrewi et al., 
2017 
Agar-dilution 
(media?) 
SN 1-8 Clinical isolates 
Sutterlin et al., 
2014 
Macro- or 
microdilution(?) with 
ISB 
SN 8-32 Isolates from human 
and wild birds’ 
faecal samples 
Cavassin et al., 
2015 
Microdilution with 
both CAMHB and 
TSB 
SN 3.4-13.5 Enterobacteriaceae 
(no species 
indication) 
Sutterlin et al., 
2018 
Microdilution with 
ISB 
SN 8-512 Clinical isolates 
Sutterlin et al., 
2018 
Microdilution with 
ISB 
SN 16-32 E. coli ATCC 
25922 
Harrison et al., 
2005 
Microdilution with 
LB broth 
SN 10.2 Not specified 
Deus et al., 
2017 
Microdilution with 
MHB 
SN 2-4 Isolates from 
patients and broiler 
chickens 
Henly et al., 
2019 
Microdilution with 
MHB 
SN 31.3 Clinical isolate 
 
Uni-modal distributions were obtained for BZC, CHX and SN in both species, being 
in accordance with previous work (Kumari et al., 2011; Deus et al., 2017), while CS MICs 
and MBCs followed a bi-modal distribution. This could indicate the presence of different 
subpopulations harbouring a wide range of tolerance thresholds within the collection of 
strains used for this study (Morrissey et al., 2014). MBCs were usually found to be 
equivalent or two-fold higher than MICs for both species and for all the biocides 
investigated, apart from the few exceptions mentioned previously. This seemed to be in 
accordance with the literature, especially for cationic compounds like BZC and CHX (Biagi 
et al., 2014; Morrissey et al., 2014; Bock et al., 2016). 
Regarding CS susceptibility profiles, it is important to notice that the ranges of MICs 
and MBCs obtained might have been affected by the acidity of the solution containing the 
highest concentrations of CS. Growth curves in R2A broth adjusted to similar pH values 
than the ones presented in Table 2-4 (page 31) were performed for both E. coli and 
K. pneumoniae reference strains. It appeared that, at pH equivalent to a CS solution of 
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approximately 249.6 μg/mL, growth was not observed. As a consequence, for strains 
harbouring MICs and/or MBCs corresponding to this value, it was not possible to determine 
if the inhibitory/killing effect was due to the low pH, the concentration of CS, or a 
combination of both phenomena. 
Despite available cut-off values to decipher between ‘susceptible’ and ‘resistant’ 
isolates to certain biocides (Morrissey et al., 2014), the variability inherent to the design of 
the assay does not enable the use of such established thresholds. Moreover, the literature 
does not seem to agree on the notion of ‘resistant’ isolates to biocides. Isolates can be 
labelled as resistant when their MIC and MBC are higher than the ones obtained for a 
standard strain (Guo et al., 2015), when they are not inactivated by an in-use concentration 
of a biocide or a concentration that inactivates other strains of that organism (Kampf, 2018), 
or when a change in susceptibility renders a biocide ineffective against a given organism to 
which it was previously susceptible (Maillard et al., 2013). However, isolates showing a 
reduced susceptibility to a biocide, hence whose MIC would be higher than a reference strain 
or most of the population, could still be killed by the in-use concentration of the biocide, as 
highlighted previously (Table 2-3 page 25) (do Amorim et al., 2004; Maillard et al., 2013; 
Harbarth et al., 2014; Wales & Davies, 2015), and with the example of this study where 
CHX MICs ranged from 0.5 to 16 μg/mL (when considering both species), while a skin 
disinfection solution, HiBiScrub®, contains 40,000 μg/mL CHX. As a consequence, the 
term ‘resistance’ was not used here for biocides, preferring ‘reduced susceptibility’ for 
isolates harbouring high MICs. In addition, MIC values do not necessarily correspond to an 
indicator of success or failure of disinfection procedures, as testing conditions for MIC 
determination do not reflect ‘real-life’, in-use conditions for biocides. Indeed, biocidal 
solutions usually consist in a mixture of one or more active compounds at high 
concentrations, formulated with excipients and applied for a specific amount of time (i.e. 
contact time) on different surface types, under different conditions (e.g. temperature, 
humidity, nutrient availability for microorganisms), among other parameters; when 
determining MICs, some important differences are that only one biocidal compound is 
investigated at a time, and put in contact with a specific bacterial density, incubated over 24 
hours at 37ºC in rich media (SCENIHR, 2009; Maillard et al., 2013; Morrissey et al., 2014; 
Knapp et al., 2015; Pelling et al., 2019). 
Regarding SN data, one strain, Kp-94, showed an important reduction in 
susceptibility, with an MIC and MBC of 256 μg/mL, while the other clinical isolates were 
inhibited and/or killed by concentrations between 2 and 4 μg/mL. It appears that Kp-94 was 
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isolated from a wound drain. Although no additional information regarding the potential 
treatments received by the patient was provided, it is known that silver can be used as an 
antimicrobial agent in wound treatments, including wound dressings (Gaisford et al., 2009; 
Kumari et al., 2011; Deus et al., 2017). A hypothesis explaining this particularly high MIC 
for SN could be that Kp-94 was in contact with sub-lethal concentrations of silver ions, 
consequently reducing its susceptibility to this antimicrobial (McHugh et al., 1975; Ip et al., 
2006). 
When comparing both species, K. pneumoniae isolates seemed to be less susceptible 
to three out of four biocides than E. coli, while similar MIC and MBC values were observed 
for SN. This fact was consistent with previous studies where K. pneumoniae was found to 
harbour higher MICs for CHX than E. coli (Koljalg et al., 2002; Guet-Revillet et al., 2012). 
Isolates did not seem to be segregated according to their carbapenemase-encoding genes 
regarding their MIC and MBC distributions. This did not agree with the findings by Deus 
and colleagues, where differences in MICs were observed based on the produced ESBLs in 
E. coli (Deus et al., 2017). 
2.5 Conclusion 
This work enabled the establishment of baseline data regarding the susceptibility 
profiles to four commonly used biocides of a wide collection of clinical isolates. 
Nonetheless, they could not be categorized as ‘susceptible’ or ‘resistant’ due to a lack of 
standardisation of the method leading to important variability within the results obtained, the 
absence of widely-accepted thresholds and the significance of ‘resistance’ when biocide 
concentrations within commercial products are found to be well above the MICs determined 
in vitro.
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Chapter 3. Links between susceptibility to biocides and antibiotics 
3.1 Introduction 
3.1.1 Current status and associated risks 
Several sectors rely heavily on the use of antibiotics, biocides and heavy metals, 
including healthcare but also farming and aquaculture, among others (SCENIHR, 2009; 
Ortega Morente et al., 2013; Romero et al., 2017). Low, sub-inhibitory concentrations of 
these antimicrobials can reach and persist in the environment, through inappropriate use, 
excretion after treatment, dilution or degradation in the environment among others 
(Andersson & Hughes, 2014; Wales & Davies, 2015; Martinez-Suarez et al., 2016; Gadea 
et al., 2017a). 
A major concern is, with the importance of infection prevention and control measures 
relying especially on biocides to limit the spread of MDROs, that biocides may instead 
contribute to this (Maillard et al., 2013; Harbarth et al., 2014). Indeed, exposure to sub-
inhibitory concentrations of antibiotics or biocides can trigger several mechanisms within 
bacteria for them to counteract the adverse effects of these compounds (Andersson & 
Hughes, 2014) and can result in reduced susceptibility to other unrelated antimicrobials; this 
is referred to as co-selection. Co-selection between different antimicrobials can occur 
through different mechanisms: co-resistance, cross-resistance and co-regulation (Baker-
Austin et al., 2006; Buffet-Bataillon et al., 2012a). Co-resistance can happen when the genes 
responsible for resistance to each compound are located on the same mobile genetic element, 
e.g. qacΔE, involved in QACs efflux, and sulI, conferring resistance to sulphonamides, both 
present in class 1 integrons and widespread among Gram-negative bacteria (Fluit & Schmitz, 
1999; Domingues et al., 2012). The selective pressure exerted by one compound would 
select for both genetic determinants to be expressed or transferred. Cross-resistance results 
from the ability of a common resistance mechanism to counteract several unrelated 
antimicrobials; a development of resistance as a response to the selective pressure exerted 
by one compound would result in resistance to the other antimicrobial as well (Buffet-
Bataillon et al., 2012a). An example of cross-resistance would be the involvement of efflux 
pumps, such as AcrAB-TolC in E. coli, able to expel a wide range of substrates (Poole, 2007; 
Sun et al., 2014). Exposure to antimicrobials could engender a cascade of regulatory 
responses impacting bacterial susceptibility to several compounds, e.g. copper provoking the 
dissociation of the transcriptional repressor MarR from its promoter region, resulting in the 
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expression of the mar operon involved in antibiotic resistance and virulence (with, among 
other consequences, an alteration of the outer membrane permeability; Hao et al., 2014). 
This phenomenon can be referred to as co-regulation (Baker-Austin et al., 2006). 
Conflicting reports can be found in the literature regarding co-selection between 
biocides and antibiotics (Gnanadhas et al., 2013; Harbarth et al., 2014; Kampf, 2016; Kampf, 
2018), and the clinical significance of such links between these antimicrobials is questioned 
(Wales & Davies, 2015). The impact of the use of biocides on the maintenance and spread 
of resistance genes among bacteria is controversial within the scientific community; 
nonetheless, the precaution principle, i.e. using biocides when appropriate and according to 
the manufacturers’ recommendations, has to be kept in mind to ensure their efficacy 
(Oggioni et al., 2013; Harbarth et al., 2014; Wilson et al., 2016). 
3.1.2 Investigating potential links between biocide and antibiotic susceptibility 
No international organisation (including the Food and Drug Administration in the 
United States or the European Chemicals Agency) indicates what tests to conduct when 
investigating bacterial resistance to biocide and, therefore, co-resistance mechanisms with 
antibiotics, to ensure the safety of these products (Maillard, 2018). A first step to investigate 
the presence of links between susceptibility to biocides and antibiotics is to perform 
correlation studies. Based on statistical analysis, correlation studies can indicate the presence 
of hypothetical relationships between two factors and give an insight about the next 
experimental work to perform (Chow et al., 1989; Lavilla Lerma et al., 2015). 
The involvement of co-selection mechanism(s) is often associated with a fitness cost 
for the bacteria, especially cross-resistance such as efflux (Andersson & Hughes, 2010; 
Andersson & Hughes, 2012). Exposure to sub-inhibitory concentrations of biocides while 
monitoring bacterial growth can enable the evaluation of the associated fitness cost, through 
measurements of the lag phase duration or the growth rate, i.e. an extended lag phase could 
be linked to adaptation from the bacteria in order to respond to the selective pressure before 
resuming normal growth (Maillard et al., 2013; Andersson & Hughes, 2014). Analyses of 
the outer membrane composition (proteins, fatty acids) and properties (hydrophobicity, 
permeability) is also important when considering cross-resistance mechanisms (Gnanadhas 
et al., 2013). Re-evaluating antimicrobial susceptibility in the presence of additional 
compounds, such as ethylenediaminetetraacetic acid (EDTA) known to disturb the 
membrane structure by chelating the divalent cations within (Pelletier et al., 1994; Sawer et 
al., 1997; Denyer & Maillard, 2002), or in the presence of efflux pump inhibitors, e.g. 
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carbonyl cyanide 3-chorophenylhydrazone (CCCP) or reserpine (Marquez, 2005; Opperman 
& Nguyen, 2015; Alav et al., 2018), could also provide insights regarding the involvement 
of an alteration of the membrane permeability or an increase in efflux, respectively. 
Expression analyses through transcriptomics studies (quantitative real-time polymerase 
chain reaction [PCR], RNA-sequencing) can help unveil the underlying mechanisms 
following exposure to sub-inhibitory concentrations of biocides (Gnanadhas et al., 2013; 
Kim et al., 2018a). 
3.1.3 Aim 
The aim of this chapter was to determine if correlations between biocide and 
antibiotic MIC were present for the 210 strains comprised within this study. Fifty 
representative isolates were then selected to pursue further work and investigate the presence 
and nature of potential links between susceptibility to biocides and antibiotics. 
3.2 Methods 
3.2.1 Investigation of links between susceptibility to biocides and antibiotics 
3.2.1.1 Choice of test and interpretation criteria 
The MIC and MBC values obtained for BZC, CHX, CS and SN did not follow a 
normal distribution (see section 2.3.4 page 41). Using Prism GraphPad 5 for Windows, 
correlation studies were therefore performed using Spearman’s nonparametric test described 
to be more robust when extreme values are involved (Ferguson, 2009; Mukaka, 2012). 
Correlations were considered significant when p-values were lower than 0.05. 
Positive r scores indicated positive correlations, i.e. when one variable increases, the other 
one increases too. Negative values highlighted inverted correlations, i.e. when one variable 
increases, the other one decreases. The strength of the correlations was measured based on 
criteria established within similar studies, including one performed on S. aureus using 
Spearman’s test (Oggioni et al., 2015), and two others where Pearson’s test, the equivalent 
test used for normally distributed data, was used (Lavilla Lerma et al., 2015; Romero et al., 
2017). Correlations were then categorized as weak when 0 < r < 0.4, moderate when 
0.4 ≤ r < 0.7, and strong when 0.7 ≤ r ≤ 1 (considering the absolute value of r). The stronger 
the correlation, the more the variation of one variable is explained by the variation of the 
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other one, i.e. if A and B are strongly correlated, a variation in A will be mainly explained 
by a variation in B and vice-versa (Goodwin & Leech, 2006). 
3.2.1.2 Data pre-treatment 
Correlations studies were performed using MIC and MBC values obtained during the 
establishment of the susceptibility profiles to biocides (see section 2.3.4 page 41) and, when 
data were available, MICs determined for a wide-range of antibiotics prior to this study by 
Public Health England (see section 2.3.3 page 39). Regarding antibiotic MICs, when values 
were indicated as ‘> x’ (x being the highest concentration tested for the MIC determination 
of a given antibiotic), they were changed into ‘2x’, i.e. twice the concentration x. When 
values were indicated as ‘≤ y’ (y being the lowest concentration tested for the MIC 
determination of a specific antibiotic), they were changed to ‘y’. As Spearman’s test is based 
on the rank of the values and not the values themselves, these changes were necessary to 
include all the available data in the correlation studies without having an impact on the scores 
obtained (Lambert, 2004). 
3.2.2 Selection of representative strains for further studies 
3.2.2.1 Rationale for the selection of strains 
In order to proceed with further experiments, a more manageable amount of strains 
was needed. A target number of 50 strains was considered, instead of the initial 210 isolates. 
K. pneumoniae isolates represented 76.2 % (160/210) of the initial population, while E. coli 
represented 23.8 % (50/210 isolates). In order to keep the same ratio between both species, 
the target was to select 38 K. pneumoniae (76.0 %) and 12 E. coli (24.0 %) isolates. The aim 
was to choose isolates harbouring different categories of MIC values for BZC, CHX, CS and 
SN to represent the initial population. 
The first step was to allocate a sub-group number to each strain and for each biocide 
according to their MIC. The sub-groups were designed as indicated in Table 3-1 
(K. pneumoniae) and Table 3-2 (E. coli). The summary of the different allocated sub-groups 
for each strain is indicated in appendix VI for K. pneumoniae isolates and in appendix VII 
for E. coli isolates. 
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Table 3-1. Design of the different sub-groups for each biocide for K. pneumoniae 
isolates. 
Sub-group MIC range (µg/mL) Number of strains within the sub-group 
BZC1 [2; 4[ 7 
BZC2 [4; 8[ 65 
BZC3 [8; 16[ 80 
BZC4 [16; 32[ 8 
CHX1 [2; 4[ 10 
CHX2 [4; 8[ 75 
CHX3 [8; 16[ 74 
CHX4 [16; 32[ 1 
CS1 [7.8; 15.6[ 1 
CS2 [15.6; 31.2[ 8 
CS3 [31.2; 62.4[ 24 
CS4 [62.4; 124.8[ 19 
CS5 [124.8; 249.7[ 54 
CS6 [249.7; 499.4[ 54 
SN1 [2; 4[ 79 
SN2 [4; 8[ 80 
SN3 [256; 512[ 1 
 
Table 3-2. Design of the different sub-groups for each biocide for E. coli isolates. 
Sub-group MIC range (µg/mL) Number of strains within the sub-group 
BZC1 [2; 4[ 4 
BZC2 [4; 8[ 39 
BZC3 [8; 16[ 7 
CHX1 [0.5; 1[ 1 
CHX2 [1; 2[ 18 
CHX3 [2; 4[ 26 
CHX4 [4; 8[ 5 
CS1 [7.8; 15.6[ 3 
CS2 [15.6; 31.2[ 18 
CS3 [31.2; 62.4[ 13 
CS4 [62.4; 124.8[ 3 
CS5 [124.8; 249.7[ 10 
CS6 [249.7; 499.4[ 3 
SN1 [1; 2[ 1 
SN2 [2; 4[ 39 
SN3 [4; 8[ 10 
 
CS was the biocide harbouring the widest range of MICs for both species, therefore 
it was the biocide with the highest number of sub-groups. The second step consisted in 
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picking an equivalent number of strains within each CS sub-group. For example, regarding 
E. coli, the target was to select 12 isolates. As there were 6 CS sub-groups, 2 isolates from 
each sub-group had to be picked. The same rationale was then applied to the other biocides 
to have approximately the same number of strains within each sub-group of each biocide. 
The last step consisted in choosing a limited number of isolates when several 
candidates were available within the same sub-group. In this case, the availability of WGS 
data (performed prior to this study by Public Health England), the availability of antibiotic 
susceptibility profiles, the sequence type and the carbapenemase-encoding genes harboured 
by the different isolates were considered. These criteria were decided in order to facilitate 
further experiments by avoiding completing pre-existing data (WGS, antibiotic 
susceptibility profiles) and to ensure representative and different isolates (in terms of 
molecular characterisation, provenance, susceptibility profiles) would be investigated. 
3.2.2.2 Selected strains and characteristics 
The 38 selected K. pneumoniae and the 12 chosen E. coli isolates, and the different 
sub-groups they belong to (indicated with a X), are listed in Table 3-3 and Table 3-4, 
respectively. The total number of strains within each sub-group is indicated at the bottom of 
the table. More detailed information about these strains (provenance, carbapenemase-
encoding genes, susceptibility profiles to biocides) are available in appendix I (highlighted 
in blue). 
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Table 3-3. Selected K. pneumoniae isolates and their sub-group for each biocide. 
The different sub-groups each of the selected isolates belong to (as determined previously, 
see Table 3-1 page 63), i.e. BZC1-4, CHX1-4, CS1-6 and SN1-3, are indicated with a X. 
Strain 
BZC CHX CS SN 
1 2 3 4 1 2 3 4 1 2 3 4 5 6 1 2 3 
Kp-1       X     X             X   X   
Kp-7       X     X           X   X     
Kp-13       X   X               X   X   
Kp-16     X     X       X         X     
Kp-18 X         X         X       X     
Kp-19 X       X       X           X     
Kp-20     X     X       X           X   
Kp-22   X     X             X       X   
Kp-26 X         X           X       X   
Kp-27   X         X     X         X     
Kp-28     X       X     X           X   
Kp-30     X   X             X       X   
Kp-45 X         X         X         X   
Kp-51 X         X               X   X   
Kp-58   X         X         X       X   
Kp-61     X   X                 X   X   
Kp-63 X         X             X   X     
Kp-69       X   X         X       X     
Kp-79     X   X           X       X     
Kp-85   X     X                 X X     
Kp-88       X X               X   X     
Kp-94   X       X             X       X 
Kp-96     X       X     X         X     
Kp-99     X       X     X         X     
Kp-101   X       X           X     X     
Kp-106       X     X           X     X   
Kp-107     X       X     X         X     
Kp-109   X     X               X   X     
Kp-112 X         X           X       X   
Kp-114   X       X           X     X     
Kp-115   X       X           X     X     
Kp-118   X     X           X       X     
Kp-125       X     X           X     X   
Kp-126     X       X       X         X   
Kp-136     X     X         X       X     
Kp-147     X       X     X           X   
Kp-149       X     X             X   X   
Kp-155     X       X             X   X   
Total 7 10 13 8 9 15 14 0 1 8 7 8 7 7 19 18 1 
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Table 3-4. Selected E. coli isolates and their sub-group for each biocide. 
The different sub-groups each of the selected isolates belong to (as determined previously, 
see Table 3-2 page 63), i.e. BZC1-3, CHX1-4, CS1-6 and SN1-3, are indicated with a X. 
Strain 
BZC CHX CS SN 
1 2 3 1 2 3 4 1 2 3 4 5 6 1 2 3 
Ec-158     X     X   X             X   
Ec-161   X     X           X       X   
Ec-165   X         X           X     X 
Ec-172   X       X       X           X 
Ec-180     X       X     X           X 
Ec-187   X       X       X           X 
Ec-188     X       X   X           X   
Ec-191   X     X             X   X     
Ec-198 X       X           X       X   
Ec-199 X         X   X             X   
Ec-206 X     X         X           X   
Ec-207   X         X         X     X   
Total 3 6 3 1 3 4 4 2 2 3 2 2 1 1 7 4 
 
3.2.3 Growth curves analysis 
The protocol detailed is this section is adapted from a pioneer study in the exposure 
of bacteria to low concentrations of antimicrobials (Gullberg et al., 2011). To ensure 
continuity with the MIC determinations performed in the previous chapter, considering the 
different factors able to impact MICs (inoculum size, temperature, volumes), the previously 
described adapted version of the ISO 20776-1:2006 was followed (International 
Organization for Standardization, 2006). Growth curves were performed on the 50 selected 
isolates and were exposed to CHX only. CHX was chosen for further experiments with 
regards to the correlations found and its important use as a biocide in healthcare settings. 
Experiments were carried at least in triplicate (n≥3). 
3.2.3.1 Bioscreen plates inoculation and incubation 
The bacterial suspensions were prepared, and bacterial counts were checked as 
described in sections 2.2.4.1 and 2.2.4.2 (page 31). The assay was performed using 
Honeycomb Bioscreen plates (Fisher Scientific, Loughborough, UK), whose layout is 
presented in Figure 3-1. 
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Figure 3-1. Bioscreen plates layout. 
Testing for six strains with three technical replicates was performed using two Bioscreen 
plates simultaneously. 
The CHX concentrations to test depended on the MBCs previously determined (see 
appendix IV and appendix V for CHX MBC values measured for K. pneumoniae and E. coli 
isolates, respectively) for the different isolates. Indeed, the highest concentration tested for 
each strain corresponded to twice its MBC in case variability was to be observed between 
both methods. 
Two-fold serial dilutions of CHX were prepared in R2A, in centrifuge tubes. Each 
solution corresponded to twice the final tested concentration, i.e. if the concentration to test 
was 0.5 μg/mL CHX, the solution was prepared at 1 μg/mL CHX in the centrifuge tube. 
Fifty μL of the different CHX solutions in R2A was distributed to the corresponding wells. 
R2A broth only was used for the bottom row, as a CHX-free control. Fifty μL of the 
inoculum suspension (approximately 1.0 x106 CFU/mL) was then added to each well over 
three columns; R2A broth was used for the last column as a control without bacteria. 
K. pneumoniae ATCC 13883 and E. coli ATCC 25922 were used as quality controls. Plates 
were incubated at 37ºC for 24 hours in a Bioscreen C Analyzer (Oy Growth Curves Ab Ltd, 
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Helsinki, Finland) with continuous agitation (medium amplitude, rotation speed not 
specified). The OD was measured every 4 min at 600 nm. 
3.2.3.2 Data acquisition and pre-treatment 
Bioscreen C was used in combination with the software EZExperiment for Windows 
(Oy Growth Curves Ab Ltd, Helsinki, Finland). The OD600nm measured every 4 min for each 
well were automatically grouped into a spreadsheet. 
The OD600nm measured for R2A broth and the different solutions containing CHX 
was found to decrease over time and to vary between experiments, as illustrated in Figure 
3-2. The OD600nm measured for the first 40 to 50 min were especially high when compared 
to the following time points, and these values were higher than the OD600nm measured in 
wells containing bacteria as well, leading to negative values when blanking against the 
bacteria-free well OD values. To avoid this, for each well, the OD600nm value was blanked 
against its own value measured 4 min after the beginning on the incubation, corresponding 
to the first time point after the start of the agitation mechanism. After blanking, the OD600nm 
values were converted into logarithms and plotted against time. 
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Figure 3-2. Variations in OD600nm values over time for R2A only, R2A containing 
1 μg/mL and 32 μg/mL CHX. 
The OD600nm was measured every 4 min over a 24-hour period. Data were obtained for 14 
replicates for 32 μg/mL CHX, 24 replicates for 1 μg/mL CHX and 25 replicates for R2A 
broth only. 
3.2.3.3 Determination of lag phase duration and growth rate 
Due to very low blanked OD600nm values at the early stages of growth, the lag phase 
duration and growth rate determinations were carried manually for each technical replicate 
after plotting the blanked OD600nm and their logarithm values against time using Prism 
GraphPad 5 for Windows, respectively. The means obtained for the different parameters 
from the technical replicates constituted one biological replicate. Each parameter was 
determined over a minimum of three biological replicates. 
The lag phase duration corresponded to the elapsed time until the point where an 
increase in the blanked OD600nm values leading to the exponential growth phase was 
observed. Its determination is illustrated in Figure 3-3. The lag phase delay was obtained by 
subtracting the lag phase duration measured when the strain was grown in R2A only 
(0 μg/mL CHX) to the lag phase duration measured at a set concentration (x μg/mL CHX): 
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𝐷𝑒𝑙𝑎𝑦(𝑥 𝜇𝑔/𝑚𝐿 𝐶𝐻𝑋) = 𝐷𝑢𝑟𝑎𝑡𝑖𝑜𝑛(𝑥 𝜇𝑔/𝑚𝐿 𝐶𝐻𝑋)  − 𝐷𝑢𝑟𝑎𝑡𝑖𝑜𝑛(0 𝜇𝑔/𝑚𝐿 𝐶𝐻𝑋) 
 
Figure 3-3. Lag phase duration and growth rate determinations. 
Blanked OD600nm and corresponding ln(OD600nm) values were obtained from one technical 
replicate where Kp-115 was exposed to 2 μg/mL CHX. The data point corresponding to the 
end of the lag phase is indicated in red. The lag phase duration corresponded to 130.5 min. 
A linear regression (orange line) was fitted on the exponential growth phase on the 
ln(OD600nm) against time graph. Its slope corresponded to the growth rate μ (0.01388 min-1). 
The r2 value showed that the regression fitted the curve (the closer to 1.0 the better the fit). 
The growth rate was calculated based on the ln(OD600nm) versus time graph, as 
illustrated in Figure 3-3. A linear regression was fitted on the linear part of the curve 
corresponding to the exponential growth phase, so to obtain a coefficient correlation r2 value 
the closest to 1 possible (representing a perfect correlation between the model and the curve). 
The slope of the linear regression corresponded to the growth rate μ. 
The doubling time t1/2, corresponding to the time needed for the bacterial population 
to double, was determined as follow (Hall et al., 2014): 
𝑡1/2 =
ln (2)
𝜇
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3.2.3.4 Statistical analysis 
Statistical analyses were carried using Prism GraphPad 8 for Windows. CHX MICs 
obtained with the Bioscreen assay were compared to the ones previously obtained in 96-well 
plates using two-way analysis of variance (ANOVA) followed by Sidak’s multiple-
comparison post-test. Differences were considered significant when p<0.05. For each strain, 
the different parameters measured at each CHX concentration tested were compared to the 
control condition, i.e. bacteria growing in CHX-free R2A broth (i.e. 0 μg/mL CHX) using 
the one-way ANOVA followed by Dunnett’s post-test (significant differences when p<0.05). 
For the growth rate only, when CHX concentrations were tested for both a clinical isolate 
and the reference strain belonging to the same species, the difference between them was 
assessed using two-way ANOVA followed by Sidak’s post-test (significant when p<0.05). 
3.2.4 Investigation of possible cross-resistance mechanisms between biocides and 
antibiotics 
3.2.4.1 Determination of minimum inhibitory concentrations of chlorhexidine in 
the presence of a chelator of cations 
CHX MICs were determined in the presence of the ion chelator 
ethylenediaminetetraacetic acid (EDTA; Sigma-Aldrich, Gillingham, UK). A stock solution 
containing 1,200 μg/mL EDTA (pH 8.0-8.5) was prepared in distilled water, filtered onto 
0.20 μm cellulose acetate membrane filter and stored at 4ºC for up to a month. The solution 
was diluted in R2A when needed for testing. 
MICs for CHX were determined in the presence of 60 μg/mL EDTA. The CHX 
concentrations tested ranged from 32 μg/mL to 0.03125 μg/mL for K. pneumoniae isolates, 
and from 4 μg/mL to 0.00781 μg/mL for E. coli isolates. This concentration of EDTA was 
chosen to ensure the growth of all the tested isolates after testing several concentrations 
(EDTA MIC for both reference strains corresponding to 125 μg/mL). 
The inoculum was prepared as previously described (see section 2.2.4.1 page 31). 
The microtitre plates were first filled with 50 μL R2A containing twice the final appropriate 
concentration of EDTA (120 μg/mL EDTA, for a final concentration of 60 μg/mL). The 
serial dilution was performed by mixing 50 μL of a four-times concentrated solution of CHX 
(128 μg/mL CHX for K. pneumoniae, 32 μg/mL CHX for E. coli) in R2A containing 
120 μg/mL EDTA across the microtitre plate, except in the final column (control without 
biocide). Fifty μL of the inoculum suspension (approximately 1.0 x 106 CFU/mL) was 
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finally added to the wells, except in the control wells without bacteria where R2A broth was 
used instead. Plates were incubated for 24 hours at 37ºC ± 1ºC. MICs were read as the lowest 
concentrations of CHX without growth as perceived by an un-aided eye. 
3.2.4.2 Determination of minimum inhibitory concentrations of chlorhexidine in 
the presence of a proton-motive force inhibitor 
The proton-motive force inhibitor carbonyl cyanide 3-chlorophenylhydrazone 
(CCCP) was prepared at 2,000 μg/mL in 100 % dimethylsulfoxide (DMSO; both from Acros 
Organics, Geel, Belgium), sterilised by filtration on 0.20 μm nylon membrane filter and 
stored at 4ºC for up to a month. This concentration allowed to reach a final concentration of 
DMSO below toxic levels (DMSO MIC was 5 % v/v for both K. pneumoniae ATCC 13883 
and E. coli ATCC 25922 when tested as previously described). When needed, the solution 
was diluted in R2A. 
MICs for CHX were determined in the presence of 20 μg/mL CCCP (1 % v/v 
DMSO) for K. pneumoniae isolates (except for Kp-63, which needed the concentration to be 
reduced to 5 μg/mL to be able to grow) and 10 μg/mL CCCP (0.5 % v/v DMSO) for E. coli 
isolates (as they were not able to grow at higher concentrations of CCCP). The CHX 
concentrations tested ranged from 32 μg/mL to 0.03125 μg/mL for K. pneumoniae isolates, 
and from 4 μg/mL to 0.00781 μg/mL for E. coli isolates. These concentrations were below 
the CCCP MIC obtained for both K. pneumoniae and E. coli ATCC strains (40 μg/mL). 
The inoculum was prepared as previously detailed (see section 2.2.4.1 page 31). The 
microtitre plates were first filled with 50 μL R2A containing twice the final desired 
concentration of CCCP (40 μg/mL CCCP for K. pneumoniae, 20 μg/mL CCCP for E. coli). 
The serial dilution was performed by mixing 50 μL of a four-times concentrated solution of 
CHX (128 μg/mL CHX for K. pneumoniae, 32 μg/mL CHX for E. coli) in R2A containing 
either 40 μg/mL or 20 μg/mL CCCP depending on the species across the microtitre plate, 
except in the final column (control without biocide). Finally, 50 μL of the inoculum 
suspension (approximately 1.0 x 106 CFU/mL) was added to the wells (R2A broth was used 
instead as a control without bacteria). Plates were incubated for 24 hours at 37ºC ± 1ºC. 
MICs were determined as the lowest concentrations of CHX without growth as seen by a 
naked eye as previously described. 
Chapter 3 – Links between susceptibility between biocides and antibiotics 
Page 73 
3.2.4.3 Statistical analysis 
CHX MICs measured in the presence of either EDTA or CCCP were compared to 
the MICs previously obtained (see appendix IV and appendix V for detailed values) using 
two-way ANOVA followed by Dunnett’s post-test. Differences were considered significant 
when p<0.05. The test was performed with GraphPad Prism 8 for Windows. 
3.3 Results 
3.3.1 Correlation study 
3.3.1.1 Klebsiella pneumoniae isolates 
3.3.1.1.1 Correlations between biocides 
The Spearman’s r scores obtained after performing the correlations studies on MICs 
and MBCs between biocides are shown in Table 3-5. For each biocide, strong positive 
correlations were observed between MICs and MBCs, and weak to moderate positive 
correlations were obtained between BZC and CHX, for the overall K. pneumoniae 
population and the different carbapenemase-producing categories with the exception of the 
KPC-producers where no correlation between BZC and CHX was detected. A moderate to 
strong positive correlation was determined between CHX and SN for VIM-producers, while 
the relationship between these biocides corresponded to a weak inverted correlation for 
NDM-producers. Weak to moderate correlations between both heavy metals were obtained 
when considering the overall population and the KPC-producers. 
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Table 3-5. Spearman's r scores between biocide MICs and MBCs for K. pneumoniae 
isolates. 
Correlations were considered as weak when r ranged from 0 to 0.4, moderate when r ranged 
from 0.4 to 0.7 and strong for values above 0.7 (when considering the absolute value of r). 
Only significant correlations (Spearman’s test; p<0.05) are displayed in this table. 
Correlations were calculated for the whole K. pneumoniae population (n=160) and according 
to the carbapenemases produced (NDM-, VIM-, OXA-48-like- and KPC-producing 
K. pneumoniae isolates). When an isolate possessed a combination of carbapenemases, it 
was represented in both categories. 
   CHX BZC CS SN 
      MIC MBC MIC MBC MIC MBC MIC MBC 
A
ll
 (
n
=
1
6
0
) 
C
H
X
 
MIC                 
MBC 0.850               
B
Z
C
 
MIC 0.407 0.454             
MBC 0.323 0.359 0.823           
C
S
 MIC                 
MBC         0.936       
S
N
 MIC         0.158       
MBC             0.935   
N
D
M
 (
n
=
4
1
) 
C
H
X
 
MIC                 
MBC 0.718               
B
Z
C
 
MIC 0.371 0.461             
MBC 0.389 0.393 0.847           
C
S
 MIC                 
MBC         0.959       
S
N
 MIC                 
MBC -0.317           0.927   
V
IM
 (
n
=
1
5
) 
C
H
X
 
MIC                 
MBC 0.908               
B
Z
C
 
MIC 0.593 0.620             
MBC     0.744           
C
S
 MIC                 
MBC         0.971       
S
N
 MIC 0.721 0.655             
MBC 0.630 0.521         0.875   
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Table 3-5 – Continued. 
   CHX BZC CS SN 
      MIC MBC MIC MBC MIC MBC MIC MBC 
O
X
A
 (
n
=
5
4
) 
C
H
X
 
MIC                 
MBC 0.869               
B
Z
C
 
MIC 0.542 0.535             
MBC 0.394 0.473 0.863           
C
S
 MIC                 
MBC         0.984       
S
N
 MIC                 
MBC             0.973   
K
P
C
 (
n
=
5
3
) 
C
H
X
 
MIC                 
MBC 0.794               
B
Z
C
 
MIC                 
MBC     0.794           
C
S
 MIC                 
MBC         0.828       
S
N
 MIC         0.561 0.414     
MBC         0.436   0.910   
3.3.1.1.2 Correlations between biocides and antibiotics 
The different correlations calculated between biocide and antibiotic MICs are 
summarised in Table 3-6. Regarding the overall K. pneumoniae population, weak to 
moderate positive correlations were obtained between CHX and carbapenems, 
cephalosporins, AK, ATM, CIP and TIG. Weak positive correlations were also calculated 
between BZC and AK, TIG and MIN. Weak inverted correlations were obtained between 
CS and MEM, cephalosporins and TEMO. 
When considering the NDM-producers, moderate positive correlations were 
determined between CHX and TIG and MIN, and weak positive correlations between BZC 
and MIN. Weak to moderate inverted correlations were obtained between CS and 
carbapenems, CTX, CPM and CIP. Regarding the VIM-producers, moderate to strong 
positive correlations were determined between either one or both of the cationic biocides 
and carbapenems, FOX, CTX, aminoglycosides and TIG. OXA-48-like-producers 
harboured weak to moderate positive correlations between CHX and carbapenems, FOX, 
TIG, MIN and COL. Similarly, weak to moderate positive correlations were obtained 
between BZC and aminoglycosides, TIG and MIN. Weak to moderate inverted correlations 
were determined between CS and carbapenems. For KPC-producers, weak to moderate 
Hélène Hérault Cardiff University 2019 
Page 76 
positive correlations were calculated between CHX and FOX, CAZ and ATM, and weak 
inverted correlations were found between BZC and TOB. 
Table 3-6. Spearman's r scores between biocide and antibiotic MICs for K. pneumoniae 
isolates. 
A), correlations between biocide MICs and carbapenem and cephalosporin MICs. B), 
correlations between biocide MICs and aminoglycoside and other antibiotic MICs. 
Correlations were considered as weak when r ranged from 0 to 0.4, moderate when r ranged 
from 0.4 to 0.7 and strong for values above 0.7 (when considering the absolute value of r). 
Only significant correlations (Spearman’s test; p<0.05) are displayed in this table. 
Correlations were calculated for the whole K. pneumoniae population (n=160) and according 
to the carbapenemases produced (NDM-, VIM-, OXA-48-like- and KPC-producing 
K. pneumoniae isolates). When an isolate possessed a combination of carbapenemases, it 
was represented in both categories. The pair number indicates on how many isolates the 
correlation was determined according to their antibiotic MIC availabilities. 
A 
Carbapenems Cephalosporins 
IPM MEM ETP FOX CTX CAZ CPM 
A
ll
 (
n
=
1
6
0
) Pairs 148 148 147 147 147 148 139 
CHX 0.218 0.297 0.245 0.363   0.225 0.191 
BZC               
CS   -0.193   -0.185 -0.178   -0.232 
SN               
N
D
M
 (
n
=
4
1
) Pairs 41 41 41 41 41 41 37 
CHX               
BZC               
CS -0.344 -0.331 -0.310   -0.317   -0.435 
SN               
V
IM
 (
n
=
1
5
) Pairs 14 14 14 14 14 14 12 
CHX   0.683 0.613         
BZC 0.582 0.810 0.839 0.746 0.570     
CS               
SN               
O
X
A
 (
n
=
5
4
) Pairs 48 48 47 47 47 48 45 
CHX 0.378 0.451 0.444 0.496       
BZC               
CS -0.362 -0.424 -0.295         
SN               
K
P
C
 (
n
=
5
3
) Pairs 48 48 48 48 48 48 48 
CHX       0.469   0.412   
BZC               
CS               
SN               
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Table 3-6 – Continued. 
B 
Aminoglycosides Other antibiotics 
TOB AK CN TEMO ATM CIP TIG MIN COL 
A
ll
 (
n
=
1
6
0
) Pairs 148 148 148 135 143 148 147 138 148 
CHX   0.209     0.165 0.163 0.370 0.434   
BZC   0.166         0.285 0.263   
CS       -0.233           
SN                   
N
D
M
 (
n
=
4
1
) Pairs 41 41 41 36 40 41 41 39 41 
CHX             0.426 0.588   
BZC               0.366   
CS           -0.343       
SN                   
V
IM
 (
n
=
1
5
) Pairs 14 14 14 14 14 14 14 13 14 
CHX 0.591 0.534 0.585       0.650 0.740   
BZC 0.768 0.783 0.652         0.638   
CS                   
SN                   
O
X
A
 (
n
=
5
4
) Pairs 48 48 48 48 44 48 47 44 48 
CHX             0.406 0.363 0.290 
BZC 0.356 0.357 0.317       0.422 0.324   
CS                   
SN                   
K
P
C
 (
n
=
5
3
) Pairs 48 48 48 40 48 48 48 45 48 
CHX         0.342         
BZC -0.293                 
CS                   
SN                   
 
3.3.1.2 Escherichia coli isolates 
3.3.1.2.1 Correlations between biocides 
The results of the Spearman’s correlation test between biocide MICs performed on 
the overall population of E. coli and after segregation according to the produced 
carbapenemases are presented in Table 3-7. Strong positive correlations between MICs and 
MBCs for each biocide were observed in all cases, except for NDM-producers (moderate 
correlation between CHX MICs and MBCs) and VIM-producers (no significant correlation). 
Weak to moderate positive correlations were obtained between both cationic compounds, 
with the exception of VIM- and KPC-producers (no significant correlation). Moderate to 
strong positive correlations were observed between BZC and SN for the overall population 
and for NDM- and OXA-48-like-producers. Weak positive correlations were calculated 
between heavy metals when considering the overall E. coli population only. 
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Table 3-7. Spearman's r scores between biocide MICs and MBCs for E. coli isolates. 
Correlations were considered as weak when r ranged from 0 to 0.4, moderate when r ranged 
from 0.4 to 0.7 and strong for values above 0.7 (when considering the absolute value of r). 
Only significant correlations (Spearman’s test; p<0.05) are displayed in this table. 
Correlations were calculated for the whole E. coli population (n=50) and according to the 
carbapenemases produced (NDM-, VIM-, OXA-48-like- and KPC-producing E. coli 
isolates). When an isolate possessed a combination of carbapenemases, it was represented 
in both categories. N/A: not available as isolates possessed the same MIC for at least one of 
the agents investigated. 
   CHX BZC CS SN 
      MIC MBC MIC MBC MIC MBC MIC MBC 
A
ll
 (
n
=
5
0
) 
C
H
X
 
MIC                 
MBC 0.715               
B
Z
C
 
MIC 0.370 0.422             
MBC 0.418 0.464 0.790           
C
S
 MIC                 
MBC         0.843       
S
N
 MIC     0.345 0.500   0.283     
MBC       0.411   0.295 0.873   
N
D
M
 (
n
=
2
1
) 
C
H
X
 
MIC                 
MBC 0.567               
B
Z
C
 
MIC 0.608 0.590             
MBC 0.549 0.648 0.750           
C
S
 MIC                 
MBC         0.724       
S
N
 MIC       0.485         
MBC             0.907   
V
IM
 (
n
=
3
) 
C
H
X
 
MIC                 
MBC                 
B
Z
C
 
MIC                 
MBC                 
C
S
 MIC                 
MBC       N/A         
S
N
 MIC N/A N/A N/A N/A N/A N/A     
MBC N/A N/A N/A N/A N/A N/A N/A   
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Table 3-7 – Continued. 
   CHX BZC CS SN 
      MIC MBC MIC MBC MIC MBC MIC MBC 
O
X
A
 (
n
=
1
3
) 
C
H
X
 
MIC                 
MBC 0.769               
B
Z
C
 
MIC   0.740             
MBC 0.562 0.635 0.844           
C
S
 MIC 0.598               
MBC 0.701       0.926       
S
N
 MIC     0.608 0.800         
MBC     0.615 0.815     0.995   
K
P
C
 (
n
=
1
5
) 
C
H
X
 
MIC                 
MBC 0.779               
B
Z
C
 
MIC                 
MBC     0.837           
C
S
 MIC                 
MBC         0.992       
S
N
 MIC                 
MBC             0.731   
 
3.3.1.2.2 Correlations between biocides and antibiotics 
The different Spearman’s r scores calculated between biocide and antibiotic MICs 
are presented in Table 3-8. Regarding the overall E. coli population, a weak positive 
correlation was obtained between SN and TEMO. NDM-producers harboured moderate 
positive correlations between TEMO and both BZC and CS. No significant correlation was 
calculated for VIM-producers. Moderate positive correlations were obtained between CHX 
and ETP and AK, and between CS and IPM, ETP and CPM for OXA-48-like-producers. A 
strong positive correlation was also observed between SN and COL for this group. 
Regarding KPC-producers, a moderate positive correlation was determined between BZC 
and CTX, and moderate inverted correlations were obtained between CS and FOX and CPM. 
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Table 3-8. Spearman's r scores between biocide and antibiotic MICs for E. coli isolates. 
A), correlations between biocide MICs and carbapenem and cephalosporin MICs. B), 
correlations between biocide MICs and aminoglycoside and other antibiotic MICs. 
Correlations were considered as weak when r ranged from 0 to 0.4, moderate when r ranged 
from 0.4 to 0.7 and strong for values above 0.7 (when considering the absolute value of r). 
Only significant correlations (Spearman’s test; p<0.05) are displayed in this table. 
Correlations were calculated for the whole E. coli population (n=50) and according to the 
carbapenemases produced (NDM-, VIM-, OXA-48-like- and KPC-producing E. coli 
isolates). When an isolate possessed a combination of carbapenemases, it was represented 
in both categories. The pair number indicates on how many isolates the correlation was 
determined according to their antibiotic MIC availabilities. N/A: not available as isolates 
possessed the same MIC for at least one of the agents investigated. 
A 
Carbapenems Cephalosporins 
IPM MEM ETP FOX CTX CAZ CPM 
A
ll
 (
n
=
5
0
) 
Pairs 44 44 44 44 44 44 43 
CHX               
BZC               
CS               
SN               
N
D
M
 (
n
=
2
1
) Pairs 21 21 21 N/A 21 N/A 20 
CHX       N/A   N/A   
BZC       N/A   N/A   
CS       N/A   N/A   
SN       N/A   N/A   
V
IM
 (
n
=
3
) 
Pairs 3 3 3 N/A 3 3 3 
CHX       N/A       
BZC       N/A       
CS       N/A N/A     
SN N/A N/A N/A N/A N/A N/A N/A 
O
X
A
 (
n
=
1
3
) Pairs 11 11 11 11 11 11 11 
CHX     0.641         
BZC               
CS 0.630   0.678       0.656 
SN               
K
P
C
 (
n
=
1
5
) Pairs 11 11 11 11 11 11 11 
CHX               
BZC         0.660     
CS       -0.696     -0.637 
SN               
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Table 3-8 – Continued. 
B 
Aminoglycosides Other antibiotics 
TOB AK CN TEMO ATM CIP TIG COL 
A
ll
 (
n
=
5
0
) 
Pairs 44 44 44 38 43 44 44 44 
CHX                 
BZC                 
CS                 
SN       0.322         
N
D
M
 (
n
=
2
1
) Pairs 21 21 21 16 20 21 21 21 
CHX                 
BZC       0.510         
CS       0.573         
SN                 
V
IM
 (
n
=
3
) 
Pairs 3 3 3 N/A 3 3 3 3 
CHX       N/A       N/A 
BZC N/A   N/A N/A         
CS       N/A         
SN N/A N/A N/A N/A N/A N/A N/A N/A 
O
X
A
 (
n
=
1
3
) Pairs 11 11 11 11 11 11 11 11 
CHX   0.603             
BZC                 
CS                 
SN               0.857 
K
P
C
 (
n
=
1
5
) Pairs 11 11 11 10 11 11 11 11 
CHX                 
BZC                 
CS                 
SN                 
 
3.3.2 Growth curves analysis 
3.3.2.1 Unusual growth patterns 
When performing the Bioscreen assay, it was decided not to pursue with Ec-206. 
Despite viable counts corresponding to expected bacterial concentration, very low and 
variable OD600nm were measured for this isolate, rendering the data unreliable and difficult 
to analyse. As a consequence, Ec-206 was removed from any further experiment. 
Several isolates showed variability in growth at some concentrations, i.e. growth was 
not observed for all the replicates under set conditions (Kp-7, Kp-45, Kp-51, Kp-94, Kp-99, 
Kp-106 and Ec-207). As this impacted the different analysis, and to facilitate the following 
explanations, this group of strains will further be referred to as the “variable-growth strains”. 
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One isolate in particular, Kp-125, harboured an exponential growth phase separated 
in two distinct parts as illustrated in Figure 3-4. As a consequence, analysis, when needed, 
were performed on each part, labelled as “first phase” and “second phase” as per indicated 
on the figure below. 
 
Figure 3-4. Growth pattern of Kp-125 when exposed to different concentrations of 
CHX. 
The blanked OD600nm is indicated on the y axis. Each curve corresponds to the growth of 
Kp-125 in R2A containing the indicated CHX concentration. The dark blue dashed box 
indicates the data points corresponding to the first growth phase of Kp-125, and the brown 
dashed box corresponds to its second growth phase. This figure corresponds to one replicate 
only. 
3.3.2.2 Klebsiella pneumoniae isolates 
The detailed results obtained for the K. pneumoniae reference strain and clinical 
isolates are presented in appendix VIII. Isolates for which statistically significant differences 
were observed when compared to the control condition are detailed in Table 3-9. 
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Table 3-9. Results obtained from the growth curves study for the K. pneumoniae 
isolates. 
Experiments were carried at least in triplicate for each condition (n≥3). Values in bold and 
red corresponded to significant differences (one-way ANOVA followed by Dunnett’s post-
test; p<0.05) observed when compared to the CHX-free R2A growth condition (0 μg/mL 
CHX). Only isolates and concentrations at which significant differences for at least one of 
the investigated parameters are displayed, alongside with the control condition. For 
“variable-growth strains”, the concentration at which variability in growth was observed was 
highlighted in orange. Statistical analyses were not performed on doubling times as they 
were inferred from the mean growth rate values. 
S
tr
a
in
 
CHX 
(µg/mL) 
Lag phase 
duration 
(min) 
Lag phase 
delay (min) 
Growth rate µ 
(min-1) 
Doubling 
time t1/2 
(min) 
OD600nm max 
Mean SD Mean SD Mean SD Mean SD 
K
. 
p
n
eu
m
o
n
ia
e 
A
T
C
C
 1
3
8
8
3
 4 1,436.1 0.0 1,218.0 42.8 0.0000 0.0000  0.002 0.003 
2 329.9 134.6 117.7 124.3 0.0119 0.0018 58.3 0.216 0.010 
1 218.5 41.5 0.4 8.4 0.0122 0.0012 57.0 0.230 0.008 
0.5 213.0 36.9 -5.0 11.3 0.0124 0.0012 56.1 0.235 0.008 
0.25 209.3 38.2 -4.2 7.8 0.0123 0.0013 56.5 0.238 0.009 
0.125 210.0 36.6 -8.1 14.9 0.0124 0.0011 55.8 0.240 0.007 
0.0625 210.4 36.6 -7.7 14.1 0.0124 0.0012 56.1 0.240 0.008 
0.03125 211.5 37.4 -6.6 12.8 0.0121 0.0014 57.2 0.239 0.009 
0.01563 213.3 38.7 -4.8 9.7 0.0120 0.0014 57.7 0.233 0.009 
0 218.1 42.8 0.0 0.0 0.0124 0.0019 55.9 0.210 0.012 
K
p
-1
 
16 1,436.1 0.0 1,316.4 10.1 0.0000 0.0000  0.005 0.006 
8 1,436.1 0.0 1,316.4 10.1 0.0000 0.0000  0.005 0.004 
4 535.9 115.9 414.9 120.4 0.0204 0.0030 34.0 0.236 0.009 
0 119.7 10.1 0.0 0.0 0.0184 0.0022 37.7 0.263 0.018 
K
p
-7
 
32 1,436.1 0.0 1,299.3 16.8 0.0000 0.0000  0.005 0.005 
16 1,436.1 0.0 1,299.3 16.8 0.0000 0.0000  0.004 0.005 
8 1,168.6 337.8 1,031.7 333.4 0.0061 0.0074 114.0 0.074 0.081 
4 314.1 144.1 177.7 136.6 0.0121 0.0018 57.1 0.195 0.017 
0 136.8 16.8 0.0 0.0 0.0089 0.0011 78.3 0.245 0.014 
K
p
-1
3
 
16 1,436.1 0.0 1,316.8 6.3 0.0000 0.0000  0.005 0.005 
8 1,436.1 0.0 1,316.8 6.3 0.0000 0.0000  0.002 0.002 
4 1,436.1 0.0 1,316.8 6.3 0.0000 0.0000  0.002 0.002 
2 171.8 64.3 52.5 65.0 0.0174 0.0019 39.8 0.288 0.023 
0 119.3 6.3 0.0 0.0 0.0167 0.0011 41.4 0.308 0.024 
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Table 3-9 – Continued. 
S
tr
a
in
 
CHX 
(µg/mL) 
Lag phase 
duration 
(min) 
Lag phase 
delay (min) 
Growth rate µ 
(min-1) 
Doubling 
time t1/2 
(min) 
OD600nm max 
Mean SD Mean SD Mean SD Mean SD 
K
p
-1
6
 
8 1,436.1 0.0 1,311.3 6.6 0.0000 0.0000  0.002 0.002 
4 1,436.1 0.0 1,308.7 4.5 0.0000 0.0000  0.001 0.001 
0.0625 125.0 6.8 0.2 0.5 0.0172 0.0030 40.3 0.300 0.014 
0.03125 125.2 7.0 0.4 1.1 0.0173 0.0028 40.1 0.296 0.008 
0 124.8 6.6 0.0 0.0 0.0175 0.0028 39.5 0.279 0.004 
K
p
-1
8
 
8 1,436.1 0.0 1,329.2 5.6 0.0000 0.0000  0.001 0.002 
4 1,436.1 0.0 1,328.9 5.2 0.0000 0.0000  0.002 0.003 
2 139.3 36.9 32.3 34.5 0.0137 0.0018 50.7 0.260 0.013 
0.03125 106.9 5.6 0.0 0.0 0.0131 0.0011 52.9 0.288 0.009 
0 106.9 5.6 0.0 0.0 0.0137 0.0010 50.7 0.274 0.012 
K
p
-1
9
 8 1,436.1 0.0 1,329.6 9.5 0.0000 0.0000  0.002 0.003 
4 1,436.1 0.0 1,329.6 9.5 0.0000 0.0000  0.003 0.002 
2 162.7 76.3 56.2 70.4 0.0122 0.0022 57.0 0.246 0.016 
0 106.5 9.5 0.0 0.0 0.0114 0.0017 60.7 0.247 0.012 
K
p
-2
6
 16 1,436.1 0.0 1,329.9 4.7 0.0000 0.0000  0.005 0.009 
8 1,436.1 0.0 1,329.9 4.7 0.0000 0.0000  0.001 0.002 
4 585.0 64.5 477.7 61.9 0.0155 0.0011 44.9 0.244 0.013 
0 106.2 4.7 0.0 0.0 0.0152 0.0012 45.5 0.297 0.012 
K
p
-2
7
 16 1,436.1 0.0 1,306.4 10.2 0.0000 0.0000  0.003 0.005 
8 1,436.1 0.0 1,306.4 10.2 0.0000 0.0000  0.002 0.003 
4 459.5 224.6 330.2 227.1 0.0163 0.0017 42.5 0.245 0.008 
0 129.7 10.2 0.0 0.0 0.0158 0.0011 43.8 0.281 0.007 
K
p
-2
8
 
16 1,436.1 0.0 1,296.0 32.6 0.0000 0.0000  0.004 0.005 
8 1,436.1 0.0 1,296.0 32.6 0.0000 0.0000  0.001 0.001 
4 492.5 299.6 352.4 267.0 0.0206 0.0014 33.6 0.228 0.010 
2 140.1 32.6 0.0 0.0 0.0171 0.0009 40.6 0.280 0.005 
0.0625 140.1 32.6 0.0 0.0 0.0158 0.0001 43.9 0.303 0.002 
0 140.1 32.6 0.0 0.0 0.0163 0.0004 42.5 0.291 0.001 
K
p
-3
0
 
16 1,436.1 0.0 1,311.1 10.8 0.0000 0.0000  0.002 0.002 
8 1,436.1 0.0 1,311.1 10.8 0.0000 0.0000  0.003 0.003 
4 1,436.1 0.0 1,311.0 11.0 0.0000 0.0000  0.003 0.001 
2 181.0 54.0 56.0 56.1 0.0123 0.0006 56.4 0.273 0.016 
1 125.3 10.7 0.3 0.6 0.0108 0.0006 64.2 0.280 0.012 
0.5 125.0 10.8 0.0 0.0 0.0105 0.0006 65.8 0.285 0.011 
0.25 125.0 10.8 0.0 0.0 0.0105 0.0007 66.2 0.286 0.011 
0.125 125.0 10.8 0.0 0.0 0.0106 0.0007 65.2 0.284 0.011 
0.0625 125.0 10.8 0.0 0.0 0.0112 0.0011 61.9 0.277 0.011 
0 125.0 10.8 0.0 0.0 0.0129 0.0016 53.9 0.261 0.007 
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Table 3-9 – Continued. 
S
tr
a
in
 
CHX 
(µg/mL) 
Lag phase 
duration 
(min) 
Lag phase 
delay (min) 
Growth rate µ 
(min-1) 
Doubling 
time t1/2 
(min) 
OD600nm max 
Mean SD Mean SD Mean SD Mean SD 
K
p
-4
5
 16 1,436.1 0.0 1,334.3 15.8 0.0000 0.0000  0.001 0.002 
8 1,436.1 0.0 1,334.3 15.8 0.0000 0.0000  0.001 0.002 
4 1,137.2 409.4 1,035.4 418.3 0.0064 0.0090 107.7 0.097 0.132 
0 101.8 15.8 0.0 0.0 0.0181 0.0014 38.4 0.300 0.010 
K
p
-5
1
 16 1,436.1 0.0 1,326.4 13.9 0.0000 0.0000  0.003 0.004 
8 1,436.1 0.0 1,326.4 13.9 0.0000 0.0000  0.002 0.002 
4 891.4 499.6 781.6 503.0 0.0121 0.0096 57.2 0.142 0.115 
0 109.7 13.9 0.0 0.0 0.0209 0.0008 33.2 0.288 0.008 
K
p
-5
8
 16 1,436.1 0.0 1,311.0 12.6 0.0000 0.0000  0.002 0.001 
8 1,436.1 0.0 1,311.0 12.6 0.0000 0.0000  0.001 0.002 
4 388.7 63.5 263.7 71.5 0.0127 0.0015 54.8 0.165 0.004 
0 125.1 12.6 0.0 0.0 0.0122 0.0012 56.9 0.237 0.008 
K
p
-6
1
 8 1,436.1 0.0 1,311.3 20.4 0.0000 0.0000  0.000 0.000 
4 1,436.1 0.0 1,313.3 24.4 0.0000 0.0000  0.003 0.001 
2 166.4 30.3 41.7 19.4 0.0133 0.0009 52.1 0.259 0.017 
0 124.8 20.4 0.0 0.0 0.0140 0.0011 49.7 0.279 0.018 
K
p
-6
3
 16 1,436.1 0.0 1,265.0 27.9 0.0000 0.0000  0.001 0.001 
8 1,436.1 0.0 1,265.0 27.9 0.0000 0.0000  0.003 0.004 
4 632.0 101.7 445.3 111.2 0.0118 0.0010 58.5 0.185 0.008 
0 171.1 27.9 0.0 0.0 0.0101 0.0016 68.4 0.210 0.014 
K
p
-6
9
 16 1,436.1 0.0 1,308.6 18.7 0.0000 0.0000  0.003 0.003 
8 1,436.1 0.0 1,308.6 18.7 0.0000 0.0000  0.003 0.002 
4 825.4 247.2 694.7 257.4 0.0178 0.0021 38.9 0.220 0.011 
0 127.5 18.7 0.0 0.0 0.0162 0.0013 42.8 0.270 0.005 
K
p
-7
9
 
8 1,436.1 0.0 1,312.9 10.8 0.0000 0.0000  0.002 0.001 
4 1,436.1 0.0 1,312.0 11.6 0.0000 0.0000  0.001 0.000 
2 127.6 4.3 4.4 6.6 0.0151 0.0002 45.9 0.251 0.006 
0.03125 123.2 10.8 0.0 0.0 0.0142 0.0009 49.0 0.283 0.006 
0 123.2 10.8 0.0 0.0 0.0153 0.0006 45.4 0.271 0.007 
K
p
-8
8
 
8 1,436.1 0.0 1,319.3 19.6 0.0000 0.0000  0.001 0.001 
4 1,436.1 0.0 1,319.3 19.6 0.0000 0.0000  0.003 0.005 
0.125 116.8 19.6 0.0 0.0 0.0182 0.0019 38.0 0.279 0.005 
0.0625 116.8 19.6 0.0 0.0 0.0181 0.0014 38.3 0.281 0.004 
0.03125 116.8 19.6 0.0 0.0 0.0183 0.0010 37.9 0.280 0.005 
0 116.8 19.6 0.0 0.0 0.0182 0.0018 38.0 0.269 0.004 
K
p
-9
4
 16 1,436.1 0.0 1,321.9 9.0 0.0000 0.0000  0.004 0.005 
8 1,436.1 0.0 1,321.9 9.0 0.0000 0.0000  0.003 0.002 
4 917.4 479.0 802.4 483.6 0.0074 0.0068 93.6 0.180 0.157 
0 114.2 9.0 0.0 0.0 0.0115 0.0011 60.3 0.323 0.017 
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Table 3-9 – Continued. 
S
tr
a
in
 
CHX 
(µg/mL) 
Lag phase 
duration 
(min) 
Lag phase 
delay (min) 
Growth rate µ 
(min-1) 
Doubling 
time t1/2 
(min) 
OD600nm max 
Mean SD Mean SD Mean SD Mean SD 
K
p
-9
6
 16 1,436.1 0.0 1,309.1 10.7 0.0000 0.0000  0.003 0.003 
8 1,436.1 0.0 1,307.1 11.0 0.0000 0.0000  0.006 0.007 
4 373.3 99.7 246.2 101.8 0.0139 0.0022 49.9 0.193 0.011 
0 127.0 10.7 0.0 0.0 0.0102 0.0015 68.0 0.240 0.015 
K
p
-9
9
 16 1,436.1 0.0 1,308.8 10.3 0.0000 0.0000  0.006 0.005 
8 1,129.3 184.0 1,001.7 189.4 0.0100 0.0060 69.4 0.098 0.060 
0 127.3 10.3 0.0 0.0 0.0113 0.0012 61.6 0.225 0.017 
K
p
-1
0
1
 
8 1,436.1 0.0 1,305.3 2.3 0.0000 0.0000  0.002 0.003 
4 437.4 28.8 306.7 31.1 0.0157 0.0027 44.1 0.196 0.009 
0 130.8 2.3 0.0 0.0 0.0126 0.0017 54.9 0.240 0.007 
K
p
-1
0
6
 
32 1,436.1 0.0 1,319.8 6.1 0.0000 0.0000  0.016 0.006 
16 1,436.1 0.0 1,319.8 6.1 0.0000 0.0000  0.009 0.006 
8 1,220.3 256.5 1,104.0 259.8 0.0045 0.0049 154.5 0.102 0.106 
4 303.0 7.4 186.7 9.4 0.0143 0.0009 48.3 0.251 0.005 
0 116.3 6.1 0.0 0.0 0.0118 0.0004 58.6 0.299 0.005 
K
p
-1
0
7
 16 1,436.1 0.0 1,322.4 0.8 0.0000 0.0000  0.008 0.009 
8 1,436.1 0.0 1,320.6 3.9 0.0000 0.0000  0.006 0.002 
4 333.7 62.9 220.0 63.3 0.0148 0.0028 46.7 0.165 0.019 
0 113.7 0.8 0.0 0.0 0.0087 0.0011 79.4 0.103 0.014 
K
p
-1
0
9
 8 1,436.1 0.0 1,336.1 5.1 0.0000 0.0000  0.022 0.032 
4 1,436.1 0.0 1,335.0 5.7 0.0000 0.0000  0.020 0.029 
2 120.0 24.1 20.0 21.5 0.0119 0.0024 58.2 0.284 0.010 
0 100.0 5.1 0.0 0.0 0.0119 0.0011 58.1 0.291 0.008 
K
p
-1
1
2
 16 1,436.1 0.0 1,324.6 6.2 0.0000 0.0000  0.006 0.006 
8 1,436.1 0.0 1,324.6 6.2 0.0000 0.0000  0.005 0.001 
4 458.6 52.3 347.1 50.3 0.0172 0.0009 40.3 0.226 0.005 
0 111.5 6.2 0.0 0.0 0.0124 0.0018 55.8 0.271 0.003 
K
p
-1
1
4
 16 1,436.1 0.0 1,316.7 16.1 0.0000 0.0000  0.007 0.006 
8 1,436.1 0.0 1,316.7 16.1 0.0000 0.0000  0.006 0.003 
4 490.2 18.7 370.7 18.2 0.0192 0.0009 36.1 0.234 0.009 
0 119.4 16.1 0.0 0.0 0.0122 0.0010 56.6 0.264 0.004 
K
p
-1
1
5
 
16 1,436.1 0.0 1,336.4 6.3 0.0000 0.0000  0.003 0.003 
8 1,436.1 0.0 1,336.4 6.3 0.0000 0.0000  0.004 0.001 
4 1,436.1 0.0 1,336.4 6.3 0.0000 0.0000  0.008 0.002 
2 122.8 14.1 23.1 20.2 0.0141 0.0019 49.2 0.269 0.012 
0 99.7 6.3 0.0 0.0 0.0127 0.0006 54.6 0.275 0.002 
  
Chapter 3 – Links between susceptibility between biocides and antibiotics 
Page 87 
Table 3-9 – Continued. 
S
tr
a
in
 
CHX 
(µg/mL) 
Lag phase 
duration 
(min) 
Lag phase 
delay (min) 
Growth rate µ 
(min-1) 
Doubling 
time t1/2 
(min) 
OD600nm max 
Mean SD Mean SD Mean SD Mean SD 
K
p
-1
2
5
 (
1
st
 p
h
as
e)
 
16 1,436.1 0.0 1,283.9 18.6 0.0000 0.0000  0.006 0.008 
8 1,436.1 0.0 1,283.9 18.6 0.0000 0.0000  0.001 0.002 
4 322.3 20.6 170.0 35.5 0.0055   127.1 0.030 0.009 
2 160.2 32.9 8.0 19.6 0.0136 0.0015 51.0 0.071 0.006 
1 152.2 18.6 0.0 0.0 0.0139 0.0015 49.9 0.080 0.005 
0 152.2 18.6 0.0 0.0 0.0127 0.0020 54.6 0.094 0.008 
K
p
-1
2
5
 (
2
n
d
 p
h
as
e)
 
16 1,436.1 0.0 1,103.8 6.3 0.0000 0.0000  0.007 0.009 
8 1,436.1 0.0 1,103.8 6.3 0.0000 0.0000  0.001 0.002 
4 624.3 88.5 292.0 92.4 0.0145 0.0020 47.8 0.146 0.012 
2 396.3 12.1 64.0 7.2 0.0102 0.0014 67.8 0.166 0.012 
1 337.6 3.2 5.3 6.5 0.0107 0.0013 64.5 0.182 0.007 
0 332.3 6.3 0.0 0.0 0.0102 0.0004 68.1 0.201 0.008 
K
p
-1
2
6
 16 1,436.1 0.0 1,289.5 20.5 0.0000 0.0000  0.002 0.003 
8 1,436.1 0.0 1,294.0 19.5 0.0000 0.0000  0.004 0.004 
4 404.6 35.0 258.0 23.7 0.0153 0.0017 45.4 0.220 0.005 
0 146.6 20.5 0.0 0.0 0.0123 0.0003 56.5 0.278 0.012 
K
p
-1
3
6
 8 1,436.1 0.0 1,334.3 4.0 0.0000 0.0000  0.030 0.030 
4 1,436.1 0.0 1,334.3 4.0 0.0000 0.0000  0.025 0.022 
2 113.8 17.3 12.0 13.9 0.0188 0.0046 36.9 0.269 0.025 
0 101.8 4.0 0.0 0.0 0.0201 0.0019 34.5 0.278 0.008 
K
p
-1
4
7
 16 1,436.1 0.0 1,326.5 3.0 0.0000 0.0000  0.004 0.003 
8 1,436.1 0.0 1,326.5 3.0 0.0000 0.0000  0.003 0.002 
4 335.4 14.7 225.8 12.0 0.0155 0.0022 44.9 0.246 0.002 
0 109.6 3.0 0.0 0.0 0.0127 0.0015 54.8 0.327 0.003 
K
p
-1
4
9
 
32 1,436.1 0.0 1,331.8 6.0 0.0000 0.0000  0.005 0.008 
16 1,436.1 0.0 1,331.8 6.0 0.0000 0.0000  0.005 0.008 
8 1,436.1 0.0 1,331.0 6.3 0.0000 0.0000  0.001 0.001 
4 219.0 23.5 114.7 22.7 0.0192 0.0035 36.0 0.226 0.013 
2 104.3 6.0 0.0 0.0 0.0170 0.0011 40.8 0.261 0.006 
1 104.3 6.0 0.0 0.0 0.0170 0.0011 40.8 0.268 0.008 
0 104.3 6.0 0.0 0.0 0.0160 0.0010 43.3 0.287 0.005 
K
p
-1
5
5
 
16 1,436.1 0.0 1,296.2 12.7 0.0000 0.0000  0.000 0.000 
8 1,436.1 0.0 1,296.2 12.7 0.0000 0.0000  0.003 0.002 
4 397.2 85.3 257.3 86.1 0.0153 0.0020 45.4 0.167 0.007 
2 147.9 20.6 8.0 9.8 0.0125 0.0011 55.5 0.197 0.006 
0.0625 139.9 12.7 0.0 0.0 0.0110 0.0008 63.1 0.219 0.005 
0 139.9 12.7 0.0 0.0 0.0111 0.0005 62.7 0.210 0.003 
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3.3.2.2.1 Differences in MICs between assays 
The CHX MICs obtained with the Bioscreen assay are summarised in Table 3-10, 
alongside the values previously determined in 96-well plates. Significant differences 
between both methods (Sidak’s post-test; p<0.05) were observed for K. pneumoniae ATCC 
13883 (fold-change: 2.8), Kp-7 (1.5), Kp-26 (2.0), Kp-63 (2.0), Kp-69 (2.0), Kp-99 (1.8) 
and Kp-101 (2.0), with higher MICs obtained with the Bioscreen assay. 
Table 3-10. Differences between CHX MICs obtained with the 96-well plate and the 
Bioscreen assays for the K. pneumoniae reference strain and clinical isolates. 
MICs were determined at least in triplicates (n≥3). Significant differences (two-way 
ANOVA followed by Sidak’s post-test; p<0.05) are indicated in bold and red. 
Strain 
96-well plate assay 
CHX MIC 
Bioscreen assay 
CHX MIC 
µg/mL µg/mL 
Mean SD Mean SD 
K. pneumoniae 
ATCC 13883 1.42 0.41 4.00 0.00 
Kp-1 8.00 0.00 8.00 0.00 
Kp-7 8.00 0.00 12.36 4.18 
Kp-13 6.67 2.31 4.00 0.00 
Kp-16 4.00 0.00 4.00 0.00 
Kp-18 4.00 0.00 4.00 0.00 
Kp-19 2.67 1.15 4.00 0.00 
Kp-20 4.00 0.00 4.00 0.00 
Kp-22 3.33 1.15 4.00 0.00 
Kp-26 4.00 0.00 8.00 0.00 
Kp-27 8.00 0.00 8.00 0.00 
Kp-28 8.00 0.00 8.00 0.00 
Kp-30 3.33 1.15 4.00 0.00 
Kp-45 6.67 2.31 5.60 2.19 
Kp-51 5.33 2.31 6.67 2.07 
Kp-58 8.00 0.00 8.00 0.00 
Kp-61 2.00 0.00 4.00 0.00 
Kp-63 4.00 0.00 8.00 0.00 
Kp-69 4.00 0.00 8.00 0.00 
Kp-79 2.00 0.00 4.00 0.00 
Kp-85 2.00 0.00 4.00 0.00 
Kp-88 2.67 1.15 4.00 0.00 
Kp-94 4.00 0.00 6.40 2.19 
Kp-96 8.00 0.00 8.00 0.00 
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Table 3-10 – Continued. 
Strain 
96-well plate assay 
CHX MIC 
Bioscreen assay 
CHX MIC 
µg/mL µg/mL 
Mean SD Mean SD 
Kp-99 8.00 0.00 14.40 3.58 
Kp-101 4.00 0.00 8.00 0.00 
Kp-106 10.67 4.62 12.00 4.38 
Kp-107 8.00 0.00 8.00 0.00 
Kp-109 3.33 1.15 4.00 0.00 
Kp-112 6.67 2.31 8.00 0.00 
Kp-114 6.67 2.31 8.00 0.00 
Kp-115 4.00 0.00 4.00 0.00 
Kp-118 2.00 0.00 2.00 0.00 
Kp-125 8.00 0.00 8.00 0.00 
Kp-126 8.00 0.00 8.00 0.00 
Kp-136 4.00 0.00 4.00 0.00 
Kp-147 8.00 0.00 8.00 0.00 
Kp-149 8.00 0.00 8.00 0.00 
Kp-155 8.00 0.00 8.00 0.00 
 
3.3.2.2.2 Impact on the maximum OD600nm 
The detailed results obtained for each isolate are grouped in appendix VIII, and 
statistically significant results presented in Table 3-9 (page 83). The highest OD600nm 
measured during the growth was recorded and reported as OD600nm max for the 38 selected 
clinical isolates and the reference strain. For all the strains, the OD600nm max was obtained 
at the beginning of the plateau phase. Within each strain, the OD600nm max values obtained 
when exposed to each tested concentration were compared to the control condition, i.e. the 
strain growing in R2A only (0 μg/mL CHX). All K. pneumoniae isolates reached OD600nm 
max ranging from 0.200 to 0.340 approximately, except Kp-107 and Kp-125 (first growth 
phase only) for which the OD600nm max was lower (approximately 0.100). 
For 12/39 isolates (Kp-1, Kp-13, Kp-19, Kp-20, Kp-22, Kp-61, Kp-63, Kp-85, Kp-
109, Kp-115, Kp-118 and Kp-136), the OD600nm max was not impacted by the CHX 
concentrations they were exposed to (one-way ANOVA followed by Dunnett’s test; p>0.05), 
except for concentrations corresponding to their MIC or above. 
Regarding the “variable-growth strains”, a significant decrease in OD600nm max was 
observed at the concentration to which variability in growth was observed (Dunnett’s test; 
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p<0.05). For Kp-26, Kp-27, Kp-58, Kp-69, Kp-79, Kp-96, Kp-101, Kp-112, Kp-114, Kp-
126, Kp-147 and Kp-7, exposure to CHX concentrations corresponding to half their MIC 
significantly decreased their OD600nm max. This observation was extended to 1/4 and 1/8 of 
their MICs as well for Kp-125 (for both phases) and Kp-149. On the contrary, the OD600nm 
max observed when exposed to half its MIC significantly increased for Kp-107. 
Regarding the other isolates, there seemed to be a tendency where the OD600nm max 
measured in CHX-free media was significantly lower than when the bacteria were growing 
in CHX-containing R2A. The reference strain, K. pneumoniae ATCC 13883, harboured a 
significantly higher OD600nm max when growing in R2A containing CHX at concentrations 
below half its MIC (2 μg/mL) when compared to CHX-free media. A similar phenomenon 
was observed for Kp-30, and, to a lesser extent, for Kp-16, Kp-18, Kp-28, Kp-79, Kp-88 and 
Kp-155. 
3.3.2.2.3 Impact on the lag phase duration 
The detailed results obtained for each strain are grouped in appendix VIII, and 
statistically significant differences in lag phase duration are highlighted in Table 3-9 (page 
83). The lag phase durations measured for each K. pneumoniae isolate tested under different 
CHX exposure conditions (CHX concentrations expressed as a fraction of their CHX MIC) 
are presented in Figure 3-5. When no growth was observed, the lag phase duration was 
considered as equal to 1,436.1 min, corresponding to the last time point where the OD600nm 
was measured. For each strain, the lag phase duration measured for each CHX concentration 
was compared to growth in the CHX-free R2A (0 μg/mL CHX). 
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Figure 3-5. Changes in lag phase duration in K. pneumoniae isolates depending on CHX 
concentrations expressed as fractions of the organism’s MIC. 
Experiments were carried at least in triplicate (n≥3) and reported results correspond to mean 
values and standard deviations. K. pneumoniae isolates segregated into three different 
clusters: the “variable-growth strains” (red), for which variability in growth was observed at 
concentrations corresponding to approximately half of their MIC values; the strains for 
which significant changes in lag phase duration were obtained, mostly when exposed to 
concentrations corresponding to half their MICs (black); the strains for which no significant 
difference in lag phase duration was measured across the different CHX concentrations 
investigated (blue). 
In the cases of Kp-16, Kp-20, Kp-22, Kp-79, Kp-85, Kp-88, Kp-109 and Kp-118 
(blue isolates in Figure 3-5), the exposure to CHX did not have any impact on the lag phase 
duration (one-way ANOVA followed by Dunnett’s post-test; p>0.05), except for 
concentrations corresponding to their MICs or above. 
Regarding the “variable-growth strains” (red isolates in Figure 3-5), the lag phase 
duration was significantly extended (Dunnett’s post-test; p<0.05) when exposed to the 
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concentration at which the variability in growth was observed (phenomenon observed as 
well at the following dilution for Kp-7 and Kp-106). For most strains (25/39; black isolates 
in Figure 3-5), including the reference strain K. pneumoniae ATCC 13883, the duration of 
the lag phase was significantly increased when exposed to concentrations corresponding to 
half their MICs, up to approximately 700 min delay when compared to CHX-free R2A for 
Kp-69. Regarding Kp-125, the lag phase was also significantly longer when exposed to a 
quarter of its MIC when considering the second growth phase only. 
3.3.2.2.4 Impact on the growth rate 
Growth rates measured for all the investigated K. pneumoniae isolates are presented 
in appendix VIII. For a majority of isolates (23/39), including the reference strain 
K. pneumoniae ATCC 13883, exposure to CHX concentrations lower than their MICs did 
not have any significant impact on their growth rate when compared to the CHX-free control 
(0 μg/mL CHX). Without CHX, the growth rates measured ranged from 0.0087 min-1 for 
Kp-7 (corresponding t1/2: 79.4 min) to 0.0209 min
-1 for Kp-51 (t1/2: 33.2 min). 
Regarding the “variable-growth strains”, the growth rate when exposed to the CHX 
concentration at which variability was observed was significantly lower than in CHX-free 
R2A, with the exception of Kp-99 where no difference was observed. The results obtained 
for the following statistically significant differences observed are grouped in Table 3-9 (page 
83). When exposed to half their MICs, Kp-7, Kp-28, Kp-96, Kp-107, Kp-112, Kp-114, Kp-
125 (second growth phase), Kp-126, Kp-147, Kp-149 and Kp-155 harboured a significantly 
higher growth rate than in R2A only. However, it was significantly decreased when 
considering the first growth phase of Kp-125 (for which only one replicate was obtained). 
Kp-30 had a significantly higher growth rate when growing in CHX-free R2A than when 
exposed to CHX, except when exposed to half its MIC where there was no significant 
difference. 
The comparisons between the growth rates measured for the clinical isolates and the 
reference strain K. pneumoniae ATCC 13883 are grouped in appendix IX; statistically 
significant differences observed are presented in Figure 3-6. When both a clinical strain and 
the reference strain were able to grow, there was no or almost no significant difference 
(Sidak’s post-test; p>0.05) between their growth rates for 21/38 clinical strains. Regarding 
Kp-1, Kp-13, Kp-16, Kp-20, Kp-26, Kp-28, Kp-45, Kp-51, Kp-69, Kp-79, Kp-88, Kp-136 
and Kp-149, these isolates harboured significantly higher growth rates than the reference 
strain when growing in CHX-containing R2A (Sidak’s post-test; p<0.05). Few isolates 
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(Kp-7, Kp-63, Kp-96, Kp-107 and Kp-125 for its second growth phase only) displayed 
significantly lower growth rates than K. pneumoniae ATCC 13883 when growing in R2A 
containing different CHX concentrations (Sidak’s post-test; p<0.05). 
 
Figure 3-6. Comparison between the growth rates measured for the clinical isolates and 
the reference strain K. pneumoniae ATCC 13883 when exposed to different sub-
inhibitory concentrations of CHX. 
Experiments were carried at least in triplicates (n≥3). Data points represent the mean of the 
different replicates and bars represent the corresponding SD. Only isolates presenting 
significant differences when compared to the reference strain (two-way ANOVA followed 
by Sidak’s post-test) are displayed in this figure. *: p<0.05, **: p<0.01, ***: p<0.001, ****: 
p<0.0001. 
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Figure 3-6 – Continued. 
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Figure 3-6 – Continued. 
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Figure 3-6 – Continued. 
3.3.2.3 Escherichia coli isolates 
The detailed results obtained for the E. coli reference strain and clinical isolates are 
presented in appendix X. Results obtained for strains harbouring statistically significant 
differences for any of the parameters investigated are highlighted in Table 3-11. 
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Table 3-11. Results obtained from the growth curves study for the E. coli isolates. 
Experiments were carried at least in triplicate for each condition (n≥3). Values in bold and 
red corresponded to significant differences (one-way ANOVA followed by Dunnett’s post-
test; p<0.05) observed when compared to the CHX-free R2A growth condition (0 μg/mL 
CHX). Only isolates and concentrations at which significant differences for at least one of 
the investigated parameters are displayed, alongside with the control condition. For 
“variable-growth strains”, the concentration at which variability in growth was observed was 
highlighted in orange. Statistical analyses were not performed on doubling times as they 
were inferred from the mean growth rate values. SD: standard deviation. 
S
tr
a
in
 
CHX 
(µg/mL) 
Lag phase 
duration 
(min) 
Lag phase 
delay (min) 
Growth rate µ 
(min-1) 
Doubling 
time t1/2 
(min) 
OD600nm max 
Mean SD Mean SD Mean SD Mean SD 
E
c-
1
5
8
 8 1,436.1 0.0 1,321.7 15.5 0.0000 0.0000  0.030 0.027 
4 1,436.1 0.0 1,321.7 15.5 0.0000 0.0000  0.027 0.025 
2 147.8 51.7 33.3 38.3 0.0133 0.0028 52.1 0.222 0.022 
0 114.4 15.5 0.0 0.0 0.0140 0.0027 49.4 0.221 0.004 
E
c-
1
6
5
 8 1,436.1 0.0 1,321.7 9.0 0.0000 0.0000  0.019 0.021 
4 1,436.1 0.0 1,321.7 9.0 0.0000 0.0000  0.027 0.030 
2 133.8 28.3 19.3 21.5 0.0144 0.0047 48.3 0.229 0.018 
0 114.4 9.0 0.0 0.0 0.0147 0.0025 47.0 0.238 0.011 
E
c-
1
8
0
 8 1,436.1 0.0 1,321.7 11.4 0.0000 0.0000  0.020 0.021 
4 1,436.1 0.0 1,321.7 11.4 0.0000 0.0000  0.028 0.028 
2 301.1 166.9 186.7 159.5 0.0143 0.0017 48.4 0.211 0.015 
0 114.4 11.4 0.0 0.0 0.0134 0.0026 51.7 0.229 0.008 
E
c-
1
8
7
 
8 1,436.1 0.0 1,326.3 4.0 0.0000 0.0000  0.002 0.002 
4 1,436.1 0.0 1,326.3 4.0 0.0000 0.0000  0.002 0.002 
2 1,436.1 0.0 1,326.3 4.0 0.0000 0.0000  0.006 0.003 
1 109.8 4.0 0.0 0.0 0.0145 0.0005 48.0 0.219 0.004 
0 109.8 4.0 0.0 0.0 0.0129 0.0003 53.5 0.221 0.005 
E
c-
1
8
8
 
8 1,436.1 0.0 1,306.3 4.0 0.0000 0.0000  0.004 0.002 
4 1,436.1 0.0 1,306.3 4.0 0.0000 0.0000  0.006 0.004 
2 143.1 2.3 13.3 2.3 0.0130 0.0017 53.2 0.212 0.006 
0.25 129.8 4.0 0.0 0.0 0.0118 0.0017 58.8 0.236 0.003 
0.125 129.8 4.0 0.0 0.0 0.0115 0.0014 60.5 0.237 0.003 
0.0625 129.8 4.0 0.0 0.0 0.0116 0.0018 59.5 0.234 0.005 
0.03125 129.8 4.0 0.0 0.0 0.0121 0.0019 57.3 0.232 0.006 
0 129.8 4.0 0.0 0.0 0.0124 0.0014 55.9 0.218 0.010 
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Table 3-11 – Continued. 
S
tr
a
in
 
CHX 
(µg/mL) 
Lag phase 
duration 
(min) 
Lag phase 
delay (min) 
Growth rate µ 
(min-1) 
Doubling 
time t1/2 
(min) 
OD600nm max 
Mean SD Mean SD Mean SD Mean SD 
E
c-
1
9
1
 
8 1,436.1 0.0 1,315.7 6.1 0.0000 0.0000  0.005 0.006 
4 1,436.1 0.0 1,315.7 6.1 0.0000 0.0000  0.002 0.004 
2 1,436.1 0.0 1,315.7 6.1 0.0000 0.0000  0.011 0.002 
0.5 120.4 6.1 0.0 0.0 0.0130 0.0016 53.1 0.240 0.004 
0.25 120.4 6.1 0.0 0.0 0.0129 0.0017 53.9 0.245 0.002 
0.125 120.4 6.1 0.0 0.0 0.0124 0.0017 56.1 0.244 0.001 
0.0625 120.4 6.1 0.0 0.0 0.0119 0.0017 58.2 0.246 0.002 
0.03125 120.4 6.1 0.0 0.0 0.0124 0.0017 56.1 0.247 0.003 
0 120.4 6.1 0.0 0.0 0.0143 0.0019 48.5 0.228 0.003 
E
c-
1
9
8
 
4 1,436.1 0.0 1,330.6 10.3 0.0000 0.0000  0.004 0.003 
2 1,436.1 0.0 1,331.1 10.2 0.0000 0.0000  0.016 0.007 
1 112.5 10.9 7.0 14.0 0.0123 0.0003 56.2 0.201 0.007 
0.125 105.5 10.3 0.0 0.0 0.0113 0.0014 61.3 0.200 0.010 
0 105.5 10.3 0.0 0.0 0.0111 0.0014 62.6 0.184 0.009 
E
c-
1
9
9
 
4 1,436.1 0.0 1,327.3 5.5 0.0000 0.0000  0.006 0.003 
2 1,436.1 0.0 1,328.1 4.8 0.0000 0.0000  0.016 0.006 
0.125 108.8 5.5 0.0 0.0 0.0113 0.0008 61.5 0.149 0.011 
0.0625 108.8 5.5 0.0 0.0 0.0114 0.0011 61.0 0.148 0.008 
0 108.8 5.5 0.0 0.0 0.0133 0.0014 52.0 0.157 0.012 
E
c-
2
0
7
 16 1,436.1 0.0 1,309.9 8.7 0.0000 0.0000  0.002 0.003 
8 1,436.1 0.0 1,309.9 8.7 0.0000 0.0000  0.001 0.002 
4 797.6 699.5 671.4 703.4 0.0077 0.0088 89.8 0.108 0.116 
0 126.2 8.7 0.0 0.0 0.0140 0.0012 49.5 0.231 0.005 
 
3.3.2.3.1 Differences in MICs between assays 
CHX MICs determined with the Bioscreen assay and the previous 96-well plate 
determination are grouped in Table 3-12. Despite a tendency towards higher values with the 
Bioscreen assay, no significant differences between the MICs obtained with both methods 
were detected by Sidak’s post-test (p>0.05). 
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Table 3-12. Differences between CHX MICs obtained with the 96-well plate and the 
Bioscreen assays for the E. coli reference strain and clinical isolates. 
MICs were determined at least in triplicates (n≥3). No significant differences (two-way 
ANOVA followed by Sidak’s post-test; p>0.05) were observed between both methods. SD: 
standard deviation. 
Strain 
96-well plate assay 
CHX MIC 
Bioscreen assay 
CHX MIC 
µg/mL µg/mL 
Mean SD Mean SD 
E. coli ATCC 
25922 1.67 0.33 2.00 0.00 
Ec-158 2.00 0.00 4.00 0.00 
Ec-161 1.00 0.00 2.00 0.00 
Ec-165 4.00 0.00 4.00 0.00 
Ec-172 2.00 0.00 2.00 0.00 
Ec-180 4.00 0.00 4.00 0.00 
Ec-187 2.00 0.00 2.00 0.00 
Ec-188 4.00 0.00 4.00 0.00 
Ec-191 1.67 0.58 2.00 0.00 
Ec-198 1.67 0.58 2.00 0.00 
Ec-199 2.00 0.00 2.00 0.00 
Ec-207 4.00 0.00 6.00 2.19 
 
3.3.2.3.2 Impact on the maximum OD600nm 
The OD600nm max values obtained for each strain and each concentration tested was 
compared to the control (0 μg/mL CHX) to see if exposure to CHX had any significant 
impact on this parameter. The detailed results obtained for each strain are grouped in 
appendix X; Table 3-11 (page 97) highlights strains for which statistically significant 
differences were determined. In CHX-free R2A, OD600nm max measured for the E. coli 
isolates ranged from 0.157 (Ec-199) to 0.238 (Ec-165). 
Exposure to sub-MIC concentrations of CHX did not have any significant impact 
(one-way ANOVA followed by Dunnett’s post-test; p>0.05) on the OD600nm max for 8/12 
E. coli strains, including the reference strain E. coli ATCC 25922. A significant difference 
was observed for Ec-207, a “variable-growth strain”, when exposed to the concentration at 
which variability in growth was observed (4 μg/mL). Ec-188, Ec-191 and Ec-198 harboured 
significantly higher OD600nm max values when compared to the CHX-free control for some 
of the CHX concentrations tested, but never when exposed to half their MICs. 
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3.3.2.3.3 Impact on the lag phase duration and delay 
The detailed results measured for each isolate are grouped in appendix X; an 
overview is presented in Figure 3-7. No significant impact on the lag phase duration when 
isolates were exposed to sub-MIC concentrations of CHX was detected for a majority of 
isolates (8/12; blue isolates). Regarding Ec-207 (red isolate), a significant increase in the lag 
phase duration when exposed to the concentration at which variable growth was observed 
was detected (see Table 3-11 page 97). When exposed to half their MICs, Ec-165, Ec-180 
and Ec-188 (black isolates) harboured a significantly extended lag phase duration 
(respectively 19 min, 187 min and 13 min; Dunnett’s test with p<0.05). 
 
Figure 3-7. Changes in lag phase duration in E. coli isolates depending on CHX 
concentrations expressed as fractions of the organism’s MIC. 
Experiments were carried at least in triplicate (n≥3) and reported results correspond to mean 
values and standard deviations. E. coli isolates segregated into three different clusters: the 
“variable-growth strain” (Ec-207, in red), for which variability in growth was observed at 
concentration corresponding to approximately half of its MIC; the strains for which 
significant changes in lag phase duration were obtained, mostly when exposed to 
concentrations corresponding to half their MICs (black); the strains for which no significant 
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difference in lag phase duration was measured across the different CHX concentrations 
investigated (blue). 
3.3.2.3.4 Impact on the growth rate 
The growth rates measured for each strain are presented in appendix X, and 
significant results highlighted in Table 3-11 (page 97). In biocide-free environment, the 
growth rates measured for the E. coli isolates ranged from 0.0113 min-1 (Ec-161; t1/2: 
61.2 min) to 0.0147 min-1 (Ec-165; t1/2: 47 min). The growth rates of E. coli ATCC 25922, 
Ec-158, Ec-161, Ec-165, Ec-172, Ec-180, Ec-188, Ec-191 and Ec-198 were not significantly 
impacted by CHX exposure at any of the tested concentrations, except when exposed to their 
MICs or above. At 4 μg/mL CHX (concentration at which variability in growth was 
observed), the growth rate of Ec-207 was significantly decreased when compared to growth 
in CHX-free R2A. Ec-187’s growth rate was significantly increased when exposed to half 
its MIC. Ec-199 harboured significantly lower growth rates than in R2A only when exposed 
to 0.0625 and 0.125 μg/mL CHX. 
The growth rates of each isolate were compared to the ones obtained with the 
reference strain E. coli ATCC 25922 (appendix XI). When both the tested clinical isolate 
and the reference strain were able to grow, there was no or almost no significant difference 
between their growth rates at the different CHX concentrations tested (Sidak’s post-test; 
p>0.05). 
3.3.3 Cross-resistance mechanisms between biocides and antibiotics  
3.3.3.1 Investigation of a hypothetical reduced membrane permeability 
The CHX MICs for the 49 selected isolates were determined in the presence of 
60 μg/mL EDTA. The results are presented in Table 3-13 for the K. pneumoniae isolates and 
in Table 3-14 for the E. coli strains. A significant decrease (Dunnett’s post-test; p<0.05) in 
CHX MIC was observed for 22/38 K. pneumoniae and for 7/11 E. coli isolates in the 
presence of EDTA; no fold-change ≥ 8.0 was measured (maximum fold-change: 4.8 for 
Kp-58). 
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Table 3-13. Comparison between CHX MICs with or without addition of EDTA for 
K. pneumoniae clinical isolates. 
CHX MICs were determined at least in triplicates (n≥3). CHX MICs in R2A only were 
previously measured in chapter 2. CHX MICs with addition of EDTA were measured in the 
presence of 60 μg/mL EDTA. Statistical significance was determined by two-way ANOVA 
followed by Dunnett’s post-test (significant when p<0.05, shown in bold and red). No fold-
change higher or equal to 8.0 was detected. SD: standard deviation. 
Strain 
CHX only CHX+EDTA 
CHX MIC (µg/mL) 
CHX MIC 
(µg/mL) 
Fold change Mean SD Mean SD 
Kp-1 8.00 0.00 3.78 0.39 2.1 
Kp-7 8.00 0.00 4.00 0.00 2.0 
Kp-13 6.67 2.31 3.33 0.00 2.0 
Kp-16 4.00 0.00 3.56 0.77 1.1 
Kp-18 4.00 0.00 2.67 0.67 1.5 
Kp-19 2.67 1.15 2.00 0.00 1.3 
Kp-20 4.00 0.00 2.25 0.50 1.8 
Kp-22 3.33 1.15 3.11 1.02 1.1 
Kp-26 4.00 0.00 3.83 0.34 1.0 
Kp-27 8.00 0.00 3.00 0.67 2.7 
Kp-28 8.00 0.00 3.67 0.39 2.2 
Kp-30 3.33 1.15 1.56 0.20 2.1 
Kp-45 6.67 2.31 3.33 1.15 2.0 
Kp-51 5.33 2.31 2.22 0.39 2.4 
Kp-58 8.00 0.00 1.67 0.58 4.8 
Kp-61 2.00 0.00 3.33 0.67 0.6 
Kp-63 4.00 0.00 4.00 0.00 1.0 
Kp-69 4.00 0.00 3.78 0.39 1.1 
Kp-79 2.00 0.00 4.00 0.00 0.5 
Kp-85 2.00 0.00 2.89 1.02 0.7 
Kp-88 2.67 1.15 3.55 0.39 0.8 
Kp-94 4.00 0.00 3.78 0.39 1.1 
Kp-96 8.00 0.00 3.11 1.02 2.6 
Kp-99 8.00 0.00 2.22 0.39 3.6 
Kp-101 4.00 0.00 2.22 0.39 1.8 
Kp-106 10.67 4.62 2.89 0.38 3.7 
Kp-107 8.00 0.00 3.56 0.77 2.2 
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Table 3-13 – Continued. 
Strain 
CHX only CHX+EDTA 
CHX MIC (µg/mL) 
CHX MIC 
(µg/mL) 
Fold change Mean SD Mean SD 
Kp-109 3.33 1.15 3.33 0.00 1.0 
Kp-112 6.67 2.31 3.33 0.00 2.0 
Kp-114 6.67 2.31 3.55 0.39 1.9 
Kp-115 4.00 0.00 3.78 0.39 1.1 
Kp-118 2.00 0.00 0.89 0.19 2.2 
Kp-125 8.00 0.00 4.00 0.00 2.0 
Kp-126 8.00 0.00 3.55 0.39 2.3 
Kp-136 4.00 0.00 3.33 1.15 1.2 
Kp-147 8.00 0.00 3.78 0.39 2.1 
Kp-149 8.00 0.00 7.11 1.54 1.1 
Kp-155 8.00 0.00 2.44 0.77 3.3 
 
Table 3-14. Comparison between CHX MICs with or without addition of EDTA for 
E. coli clinical isolates. 
CHX MICs were determined at least in triplicates (n≥3). CHX MICs in R2A only were 
previously measured in chapter 2. CHX MICs with addition of EDTA were measured in the 
presence of 60 μg/mL EDTA. Statistical significance was determined by two-way ANOVA 
followed by Dunnett’s post-test (significant when p<0.05, shown in bold and red). No fold-
change higher or equal to 8.0 was detected. SD: standard deviation. 
Strain 
CHX only CHX+EDTA 
CHX MIC (µg/mL) 
CHX MIC 
(µg/mL) 
Fold change Mean SD Mean SD 
Ec-158 2.00 0.00 1.50 0.58 1.3 
Ec-161 1.00 0.00 0.67 0.24 1.5 
Ec-165 4.00 0.00 2.00 0.00 2.0 
Ec-172 2.00 0.00 0.88 0.25 2.3 
Ec-180 4.00 0.00 0.92 0.17 4.4 
Ec-187 2.00 0.00 1.50 0.58 1.3 
Ec-188 4.00 0.00 1.61 0.68 2.5 
Ec-191 1.67 0.58 0.89 0.10 1.9 
Ec-198 1.67 0.58 0.58 0.38 2.9 
Ec-199 2.00 0.00 1.56 0.51 1.3 
Ec-207 4.00 0.00 1.75 0.50 2.3 
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3.3.3.2 Investigation of a possible enhanced efflux 
CHX MICs were determined in the presence of CCCP. These results are summarised 
in Table 3-15 for K. pneumoniae isolates and in Table 3-16 for E. coli strains. CHX MICs 
were found to be significantly decreased (Dunnett’s post-test; p<0.05) in the presence of 
CCCP for most strains regardless of the species (37/38 for K. pneumoniae, 10/11 for E. coli). 
The fold-change observed was equal to or greater than 8.0 for 21/38 K. pneumoniae (up to a 
33.8-fold decrease in CHX MIC for Kp-125 in the presence of CCCP) and 1/11 E. coli 
isolates. 
Table 3-15. Comparison between CHX MICs with or without addition of CCCP for 
K. pneumoniae clinical isolates. 
CHX MICs were determined at least in triplicates (n≥3). CHX MICs in R2A only were 
previously measured in chapter 2. CHX MICs with addition of CCCP were measured in the 
presence of 20 μg/mL CCCP, except for Kp-63 where this concentration was decreased to 
5 μg/mL. Statistical significance was determined by two-way ANOVA followed by 
Dunnett’s post-test (significant when p<0.05, shown in bold and red). Fold-changes equal to 
or higher than 8.0 were highlighted in green. SD: standard deviation. 
Strain 
CHX only CHX+CCCP 
CHX MIC (µg/mL) 
CHX MIC 
(µg/mL) 
Fold change Mean SD Mean SD 
Kp-1 8.00 0.00 0.83 0.17 9.6 
Kp-7 8.00 0.00 0.42 0.14 19.2 
Kp-13 6.67 2.31 0.42 0.09 16.0 
Kp-16 4.00 0.00 0.50 0.00 8.0 
Kp-18 4.00 0.00 0.78 0.25 5.2 
Kp-19 2.67 1.15 0.39 0.24 6.8 
Kp-20 4.00 0.00 0.78 0.25 5.2 
Kp-22 3.33 1.15 0.61 0.33 5.4 
Kp-26 4.00 0.00 0.42 0.21 9.6 
Kp-27 8.00 0.00 1.00 0.59 8.0 
Kp-28 8.00 0.00 0.92 0.17 8.7 
Kp-30 3.33 1.15 0.61 0.10 5.4 
Kp-45 6.67 2.31 0.39 0.05 17.1 
Kp-51 5.33 2.31 0.33 0.09 16.0 
Kp-58 8.00 0.00 1.16 0.29 6.9 
Kp-61 2.00 0.00 0.42 0.14 4.8 
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Table 3-15 – Continued. 
Strain 
CHX only CHX+CCCP 
CHX MIC (µg/mL) 
CHX MIC 
(µg/mL) 
Fold change Mean SD Mean SD 
Kp-63 4.00 0.00 1.00 0.00 4.0 
Kp-69 4.00 0.00 0.67 0.29 6.0 
Kp-79 2.00 0.00 0.79 0.25 2.5 
Kp-85 2.00 0.00 0.50 0.00 4.0 
Kp-88 2.67 1.15 0.56 0.23 4.7 
Kp-94 4.00 0.00 0.61 0.19 6.6 
Kp-96 8.00 0.00 0.28 0.05 28.9 
Kp-99 8.00 0.00 0.94 0.10 8.5 
Kp-101 4.00 0.00 0.83 0.00 4.8 
Kp-106 10.67 4.62 0.72 0.25 14.7 
Kp-107 8.00 0.00 1.00 0.00 8.0 
Kp-109 3.33 1.15 0.39 0.13 8.5 
Kp-112 6.67 2.31 0.42 0.14 16.0 
Kp-114 6.67 2.31 1.33 0.34 5.0 
Kp-115 4.00 0.00 0.72 0.25 5.5 
Kp-118 2.00 0.00 0.67 0.30 3.0 
Kp-125 8.00 0.00 0.24 0.02 33.8 
Kp-126 8.00 0.00 0.72 0.25 11.1 
Kp-136 4.00 0.00 0.47 0.05 8.5 
Kp-147 8.00 0.00 0.83 0.17 9.6 
Kp-149 8.00 0.00 0.94 0.10 8.5 
Kp-155 8.00 0.00 0.94 0.10 8.5 
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Table 3-16. Comparison between CHX MICs with or without addition of CCCP for 
E. coli clinical isolates. 
CHX MICs were determined at least in triplicates (n≥3). CHX MICs in R2A only were 
previously measured in chapter 2. CHX MICs with addition of CCCP were measured in the 
presence of 10 μg/mL CCCP. Statistical significance was determined by two-way ANOVA 
followed by Dunnett’s post-test (significant when p<0.05, shown in bold and red). Fold-
changes equal to or higher than 8.0 were highlighted in green. SD: standard deviation. 
Strain 
CHX only CHX+CCCP 
CHX MIC (µg/mL) 
CHX MIC 
(µg/mL) 
Fold change Mean SD Mean SD 
Ec-158 2.00 0.00 0.56 0.10 3.6 
Ec-161 1.00 0.00 0.48 0.17 2.1 
Ec-165 4.00 0.00 0.67 0.29 6.0 
Ec-172 2.00 0.00 0.50 0.00 4.0 
Ec-180 4.00 0.00 0.56 0.10 7.2 
Ec-187 2.00 0.00 0.67 0.17 3.0 
Ec-188 4.00 0.00 0.50 0.00 8.0 
Ec-191 1.67 0.58 0.78 0.25 2.1 
Ec-198 1.67 0.58 0.48 0.04 3.5 
Ec-199 2.00 0.00 0.72 0.25 2.8 
Ec-207 4.00 0.00 1.78 0.39 2.3 
 
3.4 Discussion 
Data for antibiotic MICs (performed prior to this work) were not available for all 
isolates and were, sometimes, expressed in a way not suitable for correlation studies (‘> x’ 
or ‘≤ y’). Discarding these extreme values was not considered, as it would have resulted in 
the loss of too many data points. Converting the MICs into resistant, intermediate or 
susceptible status according to the breakpoints provided for Enterobacteriaceae was a 
possibility but would have had too big an impact on the accuracy and sensitivity of the test. 
Therefore, as Spearman’s test is based on the rank of the values and not the values 
themselves, MICs expressed as ‘> x’ and ‘≤ y’ were converted into ‘2x’ and ‘y’, respectively. 
There are no established criteria to measure the strength of Spearman’s correlations, 
making difficult the interpretation of results (Kraemer, 2006). When interpretation criteria 
were detailed in the literature, studies did not seem to agree on thresholds discriminating 
weak, moderate and strong correlations, e.g. strong correlations corresponding to r scores 
higher than either 0.3, 0.5, or 0.7 in absolute values (Green, 1978; Chow et al., 1989; Koljalg 
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et al., 2002; Lambert, 2004; Condell et al., 2012; Mukaka, 2012; Lavilla Lerma et al., 2015; 
Oggioni et al., 2015; Romero et al., 2017). For this work, the interpretation criteria used was 
adapted from similar studies where Spearman’s and Pearson’s (the parametric counterpart 
of the Spearman’s test) tests were used to detect potential links between susceptibility to 
antibiotics and biocides (Lavilla Lerma et al., 2015; Oggioni et al., 2015; Romero et al., 
2017). It is however important to bear in mind that correlations do not involve causality, and 
do not constitute a proof of cross-resistance for example, only an indication of a potential 
link (Chow et al., 1989). Regarding the current study, a bias in the establishment of 
correlations could be that all the investigated microorganisms were multi-drug resistant and 
carbapenemase producers, therefore harbouring elevated antibiotic MICs for a wide range 
of compounds. Moreover, for some of the sub-populations investigated (based on the 
carbapenemase produced), the number of isolates taken into account for the calculation of 
the Spearman’s r scores were low or even insufficient, with the example of the E. coli VIM-
producer sub-group containing only three isolates, where a minimum of five was necessary 
for the calculation with Prism GraphPad 5.0 for Windows. 
For both species, independently of the carbapenemase produced, positive 
correlations were found between some biocides, especially between cationic compounds, 
and to some extent between heavy metals, which could be expected considering their similar 
chemical properties. However, conflicting reports have been published, some indicating a 
correlation between similar compounds, e.g. BZC and CHX (Braoudaki & Hilton, 2004; 
Gadea et al., 2017a; Gadea et al., 2017b; Kampf, 2018; Wand et al., 2019), and others 
showing no link between them (Romero et al., 2017; Wand et al., 2017; Shepherd et al., 
2018). Cross-resistance mechanisms can arise when antimicrobials share a target, an entry 
route or a mechanism of action (Fernández-Fuentes et al., 2012). For example, BZC and 
CHX, despite having different mechanisms of action, interact both with the bacterial outer 
membrane (which harbours a net negative charge) and displace the divalent cations within 
(Gilbert & Moore, 2005; Ortega Morente et al., 2013). Several mechanisms, including efflux 
for BZC, CHX (e.g. AcrAB-TolC, Qac proteins, CepA; Poole, 2005; Jaglic & Cervinkova, 
2012; Ortega Morente et al., 2013; Anes et al., 2015), CS and SN (e.g. CusCFBA, CopA, 
Sil proteins; Nies, 2003; Poole, 2005; Ortega Morente et al., 2013; Anes et al., 2015) and 
permeability alterations (e.g. changes in hydrophobicity, outer membrane protein and fatty 
acid compositions (Ortega Morente et al., 2013; Wales & Davies, 2015) have been 
previously reported in E. coli and K. pneumoniae. 
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Only few significant correlations between antibiotic and biocide MICs were detected 
for the overall E. coli isolates. When considering sub-groups based on the carbapenemase 
produced, our data are in accordance with a previous study showing no cross-resistance 
between CHX and antibiotics when an E. coli reference strain was exposed to increasing 
concentrations of CHX (Thomas et al., 2000). Links between QACs and antibiotics 
including CIP, (Buffet-Bataillon et al., 2016; Soumet et al., 2016; Henly et al., 2019), IPM, 
tetracycline, (Braoudaki & Hilton, 2004; Soumet et al., 2012), and cephalosporins, (Soumet 
et al., 2016; Kampf, 2018) have been reported in the literature. One study claimed no 
significant differences in antibiotic resistance were observed between households using 
QACs and the ones who did not (Gerba, 2015). Many potential links were unveiled for the 
K. pneumoniae isolates. This could be surprising as both species belong to the 
Enterobacteriaceae family. Regarding K. pneumoniae isolates, the different correlations 
observed for the overall population were found in not all but at least 2/4 sub-groups based 
on the carbapenemase produced. Surprisingly, VIM-producers and NDM-producers did not 
harbour similar correlation patterns, despite the common features between these 
carbapenemases; both belong to the Ambler class B (metallo-β-lactamases). Positive 
correlations were detected between BZC and TIG, MIN and aminoglycosides, except for 
KPC-producers where the association was inverted. Previous reports showed different 
correlations between exposure to BZC and changes in MIC for ciprofloxacin and tetracycline 
(but not for aminoglycosides) in P. aeruginosa (Mc Cay et al., 2010; Kim et al., 2018b). 
CHX was found to be positively associated with carbapenems, cephalosporins, TIG, MIN 
and to some extent, aminoglycosides; previous studies showed similar associations (Koljalg 
et al., 2002; Romero et al., 2017). A weak positive correlation was found between CHX and 
CIP when considering the global population (as previously reported for Gram-negative 
bacteria; Koljalg et al., 2002), and between CHX and COL only for OXA-48-like-producers. 
These associations between cationic biocides and antibiotics, especially tetracyclines and 
derivatives (Ball et al., 1980; McMurry et al., 1980; Srinivasan et al., 2014), and 
ciprofloxacin (Nikaido & Pages, 2012; Soumet et al., 2012; Slipski et al., 2018), tend to 
pinpoint towards the expression of efflux-pumps as a potential cross-resistance mechanism. 
Correlations between CHX and COL were previously shown in K. pneumoniae and thought 
to be linked to efflux or changes in the outer membrane or the LPS (Wand et al., 2017; 
Hashemi et al., 2019; Zhang et al., 2019). After being left aside for years due to 
nephrotoxicity side-effects (Gupta, 2016), COL represents now one of the last resort 
treatments for severe infections. It is therefore paramount to protect this molecule from 
emerging resistance and possible cross-resistance mechanisms (WHO, 2014; Gu et al., 2016; 
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Liu et al., 2016). In most cases, CS was found to be negatively correlated with carbapenems 
and cephalosporins. This was surprising, as copper has been previously reported to be 
involved in the de-repression of the antibiotic resistance response in E. coli (Hao et al., 
2014). In the literature, heavy metals and antibiotics could be found to lead to co- or counter-
selective consequences, although the latter were seen with mercury and not copper (Wales 
& Davies, 2015). 
CHX was one of the biocides with which most of the correlations with antibiotics 
were observed. Its use is especially relevant in healthcare settings for a wide range of 
applications (e.g. dentistry, skin decolonization; Russell, 1986). However, the presence of 
links between CHX reduced susceptibility and antibiotic resistance, i.e. whether or not cross-
resistance mechanisms between these antimicrobials might be involved, remains unclear due 
to conflicting reports (Oggioni et al., 2013; Kampf, 2016). Here, we chose to focus the scope 
of this study on CHX, using a limited number of isolates representative of the original 
population, to pursue further experimental work. 
The Bioscreen assay was able to confirm the CHX MICs previously measured in 96-
well plates for the investigated isolates. Firstly, determinations for lag phase duration and 
growth rate were performed by hand, which can be less powerful and accurate than software 
specifically designed for this task, such as GrowthRate (Hall et al., 2014; Jung et al., 2015). 
However, due to the very low OD values obtained (due to a combination of both the initial 
inoculum and the blanking system linked to the decreasing R2A broth OD values previously 
mentioned), such software could not be used. For some isolates, at specific concentrations 
of CHX (around their MICs), both growth and no growth were observed across the different 
replicates for each strain. These isolates were referred to as the “variable growth strains”. 
When exposed to these specific CHX concentrations, statistically significant changes in 
OD600nm max, lag phase duration and growth rate were sometimes measured, although high 
standard deviation values were obtained for these parameters. This phenomenon seemed 
however to be linked to the variability in growth observed under these specific conditions. 
A minority of isolates (14/39 K. pneumoniae, none of the investigated E. coli) was not able 
to grow at the same maximum density (based on OD600nm max values) when exposed to CHX 
concentrations corresponding to half their MICs, compared to the control conditions. A 
decrease in the maximum OD was reported in E. coli ATCC 10536 when exposed to CHX 
concentrations corresponding to approximately 2/3 x MIC, but not 1/3 x MIC (Cheung et 
al., 2012), or to sub-inhibitory concentrations of QACs (Walsh et al., 2003); prolonged 
exposure to very low concentrations of BZC (0.0002-0.002% the MIC) also resulted in 
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maximum bacterial density in E. coli (Forbes et al., 2019). Exposure to 1/2 x MIC had 
however a significant impact on the lag phase duration for a majority of isolates (27/39 
K. pneumoniae and 3/12 E. coli), delaying the regrowth of the bacteria for up to 700 min. 
Extended lag phase duration was previously reported for both E. coli and K. pneumoniae 
following exposure to low concentrations of triclosan, and associated with a high fitness cost 
(Curiao et al., 2015). 
When considering the growth rate, no variation was observed for most 
K. pneumoniae (27/39) and E. coli (9/12) isolates when exposed to CHX. A similar trend 
was observed in a previous study where no significant change in growth rate was measured 
after long-term exposure to CHX in K. pneumoniae (Zhang et al., 2019). Several isolates 
from both species harboured increased growth rate values when exposed to half their MICs, 
and to some extent to lower concentrations. This observation could be linked to a 
phenomenon previously observed in P. aeruginosa and S. aureus, referred to as hormesis, 
where exposure to a low concentration of biocide could result in a stimulating effect rather 
than a neutral or deleterious one (Morales-Fernández et al., 2014). Another explanation for 
these elevated growth rates could be linked to the design of the assay itself. The initial 
inoculum used (5 x 105 CFU/mL) resulted in low turbidity during the lag phase, which in 
turn corresponded to very low logarithm values. It has been previously reported that low OD 
values could lead to abnormal growth rates (Jung et al., 2015), which could be the case here. 
Regarding Kp-125 (first growth phase only), a significant decrease in growth rate was 
observed when exposed to half its MIC. It is however of importance to keep in mind that 
only one replicate was obtained for this condition. Nevertheless, exposure to QACs was 
shown to negatively impact the growth rates in P. aeruginosa and E. coli (Walsh et al., 
2003). Effects of QACs were thought to be linked to interactions with non-vital targets in 
this previous study. Long-term exposure to sub-inhibitory concentrations of BZC or 
octenidine (a biguanide like CHX) also resulted in a decreased growth rate when compared 
to the original strain in P. aeruginosa (Mc Cay et al., 2010; Shepherd et al., 2018). The 
growth rates of the clinical isolates and the reference strains were compared for both species. 
No significant differences were observed between clinical and reference strain for E. coli 
(except at concentrations at which E. coli ATCC 25922 was not able to grow). Similar 
observations were made for most K. pneumoniae isolates (21/38 clinical isolates). A group 
of K. pneumoniae outgrew the reference strain (13/38), while K. pneumoniae ATCC 13883 
was able to outcompete five clinical isolates at lower CHX concentrations. For these isolates, 
the minimum selective concentration (MSC) i.e. the minimal concentration of antimicrobial 
able to select for resistance, could be estimated (2 μg/mL). The rationale behind the MSC 
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determination is illustrated in Figure 3-8. The ‘traditional’ selective window is based on the 
theory that enrichment for resistant bacteria can only occur within a range of concentrations 
comprised between the MICs of the susceptible (corresponding to the reference strain in this 
study) and of the resistant strain. However, Gullberg and colleagues demonstrated that 
enrichment in resistant bacteria can also happen at lower concentrations, in the ‘sub-MIC’ 
selective window. This range of concentrations corresponds to values between the MIC of 
the susceptible strain and the concentration at which the susceptible strain is able to 
outcompete the growth of the resistant strain, corresponding to the MSC (Gullberg et al., 
2011). 
 
Figure 3-8. Minimum selective concentration determination rationale. 
Figure from Gullberg et al., 2011. The ‘traditional’ selective window (red background) 
corresponds to the concentrations between the MIC measured for the resistant strain (MICres) 
and the one for the susceptible strain (MICsusc). The ‘sub-MIC’ selective window (orange 
background) corresponds to concentrations lower than the MICsusc while the growth rate 
measured for the resistant strain is still higher than the one for the susceptible strain. The 
concentration corresponding to the point where the reference strain is able to outcompete the 
resistant strain corresponds to the minimum selective concentration (MSC). 
When investigating cross-resistance mechanisms with the addition of CCCP or 
EDTA for CHX MIC determinations, only differences in MICs equal to or higher than 8-fold 
between CHX alone and CHX+compound were considered relevant. Indeed, for a given 
condition, a 2-fold variation in MIC values is common when determining MICs (Osei 
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Sekyere & Amoako, 2017). As a consequence, if between two distinct conditions MICs 
differ by 4-folds or less, the value ranges could overlap, and the difference in MICs would 
not be significant. Therefore, a minimum of 8-fold variation in MIC values enabled the 
discrimination between significant and non-significant differences. 
No potentiation (changes in MICs ≥ 8.0-folds) of the effects of CHX was observed 
when EDTA was added for E. coli or K. pneumoniae isolates at the concentration tested, 
which seemed consistent with previous observations (Russell, 1986). Similar findings were 
published with QACs in E. coli (Walsh et al., 2003). EDTA increases membrane 
permeability by chelating the divalent cations required for its stability (Pelletier et al., 1994; 
Sawer et al., 1997; Denyer & Maillard, 2002). This could indicate that changes in the 
membrane permeability were not involved as a mechanism to counteract the effects of CHX 
in this study. 
In the presence of CCCP, almost all isolates, regardless of the species, harboured a 
statistically significant decrease in CHX MIC. A fold-change equal to or higher than 8.0 was 
observed for approximately half of the studied K. pneumoniae isolates and only one E. coli. 
CCCP had been previously shown to potentiate CHX (Abuzaid et al., 2012; Wand et al., 
2017) but also colistin (Ni et al., 2016; Osei Sekyere & Amoako, 2017) and ciprofloxacin 
(in Acinetobacter baumannii; Ardebili et al., 2014). CCCP disrupts the proton-motive force, 
which is necessary for efflux pumps belonging to the SMR, MFS, RND and to some extent, 
the MATE superfamilies, to extrude their substrates (Marquez, 2005; Alav et al., 2018). 
However, CCCP can interfere with other bacterial functions, including cell division and 
metabolism, and impact membrane permeability (Anes et al., 2015; Alav et al., 2018). In 
that regard, potentiation of colistin using CCCP could be linked to the restoration of negative 
charges on the membrane surface rather than efflux; indeed, colistin, as well as CHX, is a 
cationic compound, therefore a reduction of the net negative charge (e.g. following a change 
in the LPS composition) on the membrane would decrease the affinity of these compounds 
for the structure (Ni et al., 2016; Wand et al., 2017). A cooperation between both increased 
efflux (through SmvA, a member of the MFS superfamily) and changes in LPS structure has 
been previously reported to decrease CHX susceptibility in Proteus mirabilis as well 
(Pelling et al., 2019). 
When investigating common resistance mechanisms between antibiotics and 
biocides, the scientific community does not seem to reach a consensus, especially about their 
clinical relevance (Maillard et al., 2013; Oggioni et al., 2013; Kampf, 2016). When cross-
resistance mechanisms between biocides and antibiotics are investigated, one of the most 
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encountered hypotheses is the role of efflux pumps (Braoudaki & Hilton, 2004; Baker-
Austin et al., 2006; Gnanadhas et al., 2013), although this does not exclude the possibility 
that several distinct mechanisms may be involved at once, such as alterations in the 
membrane structure as well (Wand et al., 2017; Pelling et al., 2019). Conflicting 
observations are reported about links between the presence of these efflux pump genes and 
elevated MICs for biocides. For instance, qacΔE, reported to encode an efflux pump widely 
distributed among Gram-negative bacteria (Jaglic & Cervinkova, 2012), or cepA and smvA 
present in K. pneumoniae, among others, are thought to be involved in reduced susceptibility 
to CHX or QACs (Wand et al., 2017; Slipski et al., 2018; Wand et al., 2019). Some studies 
reported a correlation between the presence of one or more of these genes and reduced 
susceptibility to biocides (Abuzaid et al., 2012; Guo et al., 2015; Wu et al., 2015; Zhang et 
al., 2019), while others did not find any link between them (Naparstek et al., 2012; Azadpour 
et al., 2015; Vijayakumar et al., 2018). Efflux pumps are associated with an important fitness 
cost and might be unlikely to be selected at very low concentrations (Andersson & Hughes, 
2012). In addition, additional information is still required to elucidate the complete 
mechanism of extrusion linked to several efflux systems, including the MFS superfamily. 
Indeed, these efflux pumps, like SmvA, are located within the inner membrane and expel 
their substrates into the periplasmic space, where CHX is likely to cause damage; other 
transporters, such as outer membrane proteins, would be needed to release CHX in the 
outside environment (Slipski et al., 2018; Pelling et al., 2019). Another explanation could 
be that these proteins might not be single components but part of tripartite systems, similarly 
to the RND superfamily, e.g. the AcrA-AcrB-TolC system (Pasqua et al., 2019; Pelling et 
al., 2019). 
3.5 Conclusion 
Overall, the findings in this study (correlations between antibiotic and biocide MICs, 
extended lag phase when exposure to sub-inhibitory concentrations, impact of CCCP on 
MIC values) indicate the expression of efflux pumps may account as a resistance mechanism 
between CHX and some antibiotics, mainly in the K. pneumoniae isolates studied. The next 
chapter will explore the phenotypic and transcriptomic consequences following exposure to 
sub-inhibitory concentrations of CHX.
Impact of commonly used antimicrobial biocides on resistance and cross-resistance in 
carbapenemase-producing Enterobacteriaceae 
Page 115 
Chapter 4. Effects of exposure to sub-inhibitory concentrations of 
chlorhexidine 
4.1 Introduction 
4.1.1 Conditions leading to exposure to sub-inhibitory concentrations of 
antimicrobials 
Sub-inhibitory concentrations of antibiotics can be found in various environments, 
generating gradients of antibiotic concentrations and applying selective pressure on the 
bacterial communities within, as highlighted in Figure 4-1 (Andersson & Hughes, 2014). 
In human medicine, sub-inhibitory concentrations of antibiotics can be found within 
the body, linked to poor pharmacokinetic properties (poor distribution and/or penetration in 
the targeted tissues) and poor patient compliance, among other factors (Andersson & 
Hughes, 2014). In animal production, antibiotics are also used as feed additives to promote 
growth, and consequently administered at low doses over longer periods of time, exposing 
the animals’ microbiota to sub-inhibitory concentrations (Chattopadhyay, 2014). Residual 
concentrations of antibiotics were reported in animal-derived products destined for human 
consumption, including meat and milk (Aalipour et al., 2013; Ramatla et al., 2017). 
After antibiotic therapy, up to 80 % of the administered antibiotics can be excreted 
without undergoing any change, mainly through urine but also faeces and reach wastewater 
and the global environment without being fully degraded by wastewater treatment plants for 
example (Diwan et al., 2010; Andersson & Hughes, 2014; Van Epps & Blaney, 2016). 
Antibiotic can persist over long periods of time in the environment, including soil and water, 
and enrich their ecosystems in antibiotic resistance determinants and, therefore, antibiotic 
resistant bacteria (Van Epps & Blaney, 2016; Cycon et al., 2019). 
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Figure 4-1. Residual antibiotic concentrations and associated resistance are transferred 
between interconnected environments. 
Figure from Andersson & Hughes, 2014. Residual, sub-inhibitory concentrations of 
antibiotics are found in the environment, from the surroundings of their production to their 
utilization in human and veterinary medicine or in other agricultural-related settings, 
resulting in elevated selective pressure enabling the rise and transfer of antibiotic resistance. 
Biocides, especially in formulations designed for surface and/or skin 
decontamination, usually involve a mixture of several active compounds (SCENIHR, 2009). 
Different parameters have been reported to impact the efficacy of biocides. Some are linked 
to the biocidal product itself: its chemical properties, its formulation (e.g. possible 
incompatibility due to interaction with excipients), its stability (especially towards changes 
in pH and temperature) and its concentration and the subsequent effects of dilution upon 
activity (Maillard, 2018). Other parameters are related to the surface treated and the use of 
the biocidal product: extended contact time are correlated with enhanced efficacy, and high 
organic loads on the surface could quench the activity of the biocide (Maillard, 2005). 
Finally, some factors are related to the micro-organisms themselves: the type of micro-
organisms (bacterial spores being the least susceptible and viruses the most susceptible), the 
number of micro-organisms (higher number will be more difficult to eradicate), and their 
physiological state (e.g. presence of biofilm with protecting matrix and reduced metabolism 
harder to disinfect than planktonic bacteria) (Maillard, 2005; Maillard, 2018). As a 
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consequence, an improper use, e.g. incorrect dilution, short contact time, dirty surface, 
and/or a degradation of the biocide (e.g. bacterial degradation of QACs in aerobic conditions; 
Tezel & Pavlostathis, 2015) could lead to microbial exposure to sub-inhibitory 
concentrations of biocides. 
4.1.2 Impact of exposure to sub-inhibitory concentrations of biocides 
As highlighted in the previous section, contact time is an important parameter in 
biocide efficacy. Indeed, short or prolonged exposure to biocides can have various 
detrimental effects on bacteria, as illustrated in Table 4-1. Exposition to sub-inhibitory 
concentrations of biocides could trigger different mechanisms (see below) leading to a 
further decrease of intracellular concentration of biocides; this decrease could enable 
bacteria to survive rather than suffering irreversible damage if the exposure was prolonged 
and/or at higher concentrations of biocides (Maillard, 2018). 
Table 4-1. Global impact of short-term or prolonged exposure to biocides on bacterial 
functions. 
Table adapted from Maillard, 2018. A short-term or prolonged exposure to biocides can lead 
to various cellular effects engendering reversible (highlighted in blue) or irreversible 
(highlighted in red) consequences on bacterial growth and survival. 
 Degree of damage   Consequences 
S
h
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t 
e
x
p
o
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r
e
 Disruption of the transmembrane proton-
motive force, leading to an uncoupling of 
oxidative phosphorylation and inhibition 
of active transport across the membrane 
    
R
ev
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b
le
 
Inhibition of respiratory or 
catabolic/anabolic reactions 
    
P
r
o
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n
g
e
d
 e
x
p
o
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r
e 
Disruption of metabolic processes     
Disruption of replication     
Loss of membrane integrity, resulting in 
leakage of essential cellular constituents 
(potassium ions, inorganic phosphate, 
pentoses, nucleotides and nucleosides, 
proteins) 
  Imbalance of pH 
Ir
re
v
er
si
b
le
 
Coagulation of intracellular materials   Commitment to 
cell death 
(autocidal 
pathway) 
Lysis   Cell death 
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Exposure to sub-inhibitory concentrations of biocides have been reported to trigger 
two major mechanisms in bacteria: the induction of the SOS response, and the promotion of 
mutations, as illustrated in Figure 4-2 (Tezel & Pavlostathis, 2015). The SOS response 
corresponds to a generalised regulatory response triggered by DNA damage or oxidative 
stress for example, in order for the bacteria to ensure its survival (Simmons et al., 2008; 
Baharoglu & Mazel, 2014). The expression of a wide range of genes can subsequently be 
altered (e.g. involved in efflux, virulence, global metabolism; Kreuzer, 2013), especially in 
order to promote the uptake of mobile genetic elements (including transposons, integrons, 
plasmids, via horizontal gene transfer [HGT] and homologous recombination (Tezel & 
Pavlostathis, 2015). The SOS response has been shown to be induced following exposure 
and/or adaptation to BZC or CHX in E. coli (Bore et al., 2007; Moen et al., 2012; Curiao et 
al., 2015). Moreover, exposure to sub-inhibitory concentrations of CHX resulted in an 
increase HGT rate in the same bacterium (Jutkina et al., 2018). On the other hand, increase 
in mutation rates has also been reported following exposure to sub-inhibitory concentrations 
of biocides; for example a mutation in mutS, involved in mismatch repair, was observed 
following adaptation to CHX in K. pneumoniae (Wand et al., 2017). 
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Figure 4-2. Global bacterial response following exposure to sub-inhibitory 
concentrations of biocides. 
Figure from Tezel & Pavlostathis, 2015. Exposure to sub-inhibitory concentrations of 
biocides (QACs in this example) can induce the SOS response, impacting the global 
regulation of the expression of a wide range of genes and promoting acquisition of genetic 
determinants through horizontal gene transfer (HGT). The apparition of mutations can also 
be promoted, potentially leading to reduced susceptibility or resistance mechanisms. 
4.1.3 Aim 
In this chapter, the aim is to assess the phenotypical and molecular responses of two 
selected K. pneumoniae isolates following exposure to sub-inhibitory concentrations of 
CHX. 
4.2 Methods 
4.2.1 Rationale for the selection of strains and concentrations 
Two K. pneumoniae isolates were selected to investigate the effects of exposure to 
sub-inhibitory concentrations of CHX. E. coli isolates demonstrated few differences in 
growth pattern when exposed to CHX, or in their CHX MICs with the addition of either 
CCCP or EDTA (see chapter 3). K. pneumoniae isolates were chosen according to the 
observed fold-change in CHX MIC when CCCP was added, and to the availability of results 
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generated by the growth pattern analysis assay at the time of the selection; isolates for which 
changes in lag phase duration and/or changes in growth rate when exposed to CHX were 
preferred. 
The two selected K. pneumoniae were Kp-1 and Kp-125. Kp-125 showed the most 
important fold-change in CHX MIC when CCCP was added (33.8), and Kp-1 CHX MIC 
was reduced by 9.6-fold in the same condition. Both isolates presented an extended lag phase 
when exposed to half their MICs (corresponding to 4 μg/mL CHX) and the growth rate of 
Kp-125 during its first growth phase was significantly decreased when exposed to the same 
concentration of CHX and 1/4 x MIC (2 μg/mL CHX). Moreover, Kp-125 belongs to ST258, 
a clone especially significant in the clinic (Mathers et al., 2015). 
4.2.2 Exposure to sub-inhibitory concentrations of chlorhexidine 
A schematic view of the CHX sub-inhibitory concentration exposure and following 
assays is presented in Figure 4-3. 
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Figure 4-3. Outline of the exposure to sub-inhibitory concentrations of CHX and 
subsequent assays. 
Kp-1 and Kp-125 were firstly exposed to either 0, 2 or 4 μg/mL CHX until they reached 
mid-exponential phase or for 30 hours depending on the assay. For Kp-125 exposed to 0 and 
4 μg/mL only (see dashed blue box), a second exposure to the same concentrations of CHX 
was performed for 48 hours. Antimicrobial susceptibility testing and virulence assays were 
performed directly after this second exposure (PRE; post re-exposure). For RNA sequencing, 
as bacteria needed to be harvested during mid-exponential growth phase, OD625nm-adjusted 
bacterial suspensions obtained after re exposure were used to inoculate fresh R2A containing 
CHX concentrations (0 or 4 μg/mL) corresponding to prior exposure. These suspensions 
were incubated until they reached their mid-exponential growth phase for RNA sequencing. 
Isolates were grown overnight in 25 mL TSB at 37 ± 1ºC and suspensions were 
washed with R2A, OD625nm-adjusted (values ranged from 0.150 to 0.175) and diluted in R2A 
to reach bacterial density of approximately 1.0 x106 CFU/mL as detailed in section 2.2.4.1 
(page 31). Ten mL from these suspensions was then added to 10 mL of either R2A (0 μg/mL 
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CHX, control condition) or twice concentrated CHX solutions in R2A corresponding to final 
CHX concentrations of either 2 (1/4 xMIC) or 4 μg/mL (1/2 xMIC), e.g. 10 mL of bacterial 
suspension added to 10 mL of a solution containing 4 μg/mL CHX for a final concentration 
of 2 μg/mL CHX. Suspensions were incubated at 37 ± 1ºC with shaking (150 rpm) until 
reaching either mid-exponential phase (RNA sequencing) or after 30 hours of culture, 
enabling bacteria for all tested conditions to reach the plateau phase (antimicrobial 
susceptibility testing, virulence assay). Based on growth curve studies using the Bioscreen 
(see chapter 3), both isolates reached mid-exponential phase at OD625nm values of 
approximately 0.070-0.100. Several studies proposed exposure over 24 hours before 
performing antimicrobial susceptibility testing (Bore et al., 2007; Henly et al., 2019). It was 
however not possible in this work as, when growing in 4 μg/mL CHX, both strains could 
take up to 28 hours to reach the plateau phase. 
An additional CHX sub-inhibitory concentration exposure was performed for 
Kp-125 only at 0 and 4 μg/mL CHX to investigate if an extended exposure could lead to 
additional or more important responses; several multi-step exposures are described in the 
literature (Forbes et al., 2019; Henly et al., 2019). After a first 30-hour exposure to either 
0 or 4 μg/mL CHX, bacterial suspensions were washed and OD625nm-adjusted as described 
in the previous paragraph (values ranged from 0.150 to 0.175), before inoculating fresh R2A 
containing 0 μg/mL CHX if the first exposure was performed in the presence of 0 μg/mL 
CHX, or 4 μg/mL CHX if the first exposure was performed in the presence of 4 μg/mL CHX. 
Suspensions were incubated for 48 hours at 37 ºC ± 1ºC. Suspensions were subsequently 
processed for antimicrobial susceptibility testing and virulence assay (see sections below). 
As sampling for RNA sequencing had to be performed during mid-exponential growth 
phase, these suspensions were in parallel used to inoculate CHX-containing R2A, i.e. 
containing 0 μg/mL CHX if previous exposure was performed in the presence of 0 μg/mL 
CHX, or containing 4 μg/mL CHX if previous exposure was performed in the presence of 
4 μg/mL CHX. These suspensions were incubated at 37 ºC ± 1ºC until mid-exponential 
growth phase was reached. The control (0 μg/mL) and the highest tested CHX concentration 
(4 μg/mL) were investigated for the effects post re-exposure (PRE), as most of the observed 
effects were obtained with 4 μg/mL CHX (see section 3.3.2.2 page 82). 
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4.2.3 Phenotypic impact of exposure to sub-inhibitory concentrations of 
chlorhexidine 
4.2.3.1 Determination of susceptibility profiles to antimicrobials 
After 30 hours of exposure to either 0 (control condition), 2, or 4 μg/mL CHX, the 
bacterial suspensions were centrifuged at 5,000 g for 10 min at 20ºC. The pellets were 
resuspended in 10 mL of the corresponding broth (see below) and suspensions were adjusted 
to OD625nm ranging between 0.150 to 0.175, corresponding to approximately 
1.0 x108 CFU/mL bacteria. Subsequent steps depended on the protocol followed, as detailed 
below. Experiments were performed at least in triplicate (n≥3). 
4.2.3.1.1 MIC determinations using broth microdilution protocol 
Susceptibility testing for BZC and CHX was performed as previously described in 
section 2.2.4 (page 30) using R2A broth. The OD625nm-adjusted suspensions (range: 0.150-
0.175) were diluted 1/100 in R2A (corresponding to approximately 1.0 x106 CFU/mL) 
before inoculation of the microtitre plates. Viable counts were performed as previously 
detailed (see section 2.2.4.2 page 32). BZC or CHX tested concentrations ranged from 128 
to 0.125 μg/mL. The final bacterial concentration corresponded to approximately 
5.0 x105 CFU/mL. K. pneumoniae ATCC 13883 was included as a quality control. Plates 
were incubated at 37 ± 1ºC and MICs were read after 24 hours and corresponded to the 
lowest concentrations able to inhibit growth as seen by a naked eye. 
MIC determinations for TIG and COL were performed in a similar way, with the use 
of CAMHB instead of R2A and polystyrene, non-treated, round bottom microtitre plates 
(Corning, Ewloe, UK) instead of the tissue-culture treated ones following the standard ISO 
20776-1:2006 protocol (International Organization for Standardization, 2006). CAMHB was 
prepared by adding sterile magnesium chloride and calcium chloride solutions to sterile 
Mueller-Hinton broth (MHB; Oxoid, Basingstoke, UK) in order for it to reach final 
concentrations of Ca2+ and Mg2+ of 25 mg/L and 12.5 mg/L, respectively. Stock solutions of 
10 mg/mL magnesium chloride (Acros Organics, Geel, Belgium) and 10 mg/mL calcium 
chloride (Fisher Scientific, Loughborough, UK) were prepared in distilled water and 
sterilised by filtration through a 0.20 μm cellulose acetate membrane filter. Cation stock 
solutions and CAMHB were kept at 4 ºC. TIG and COL (both from Sigma-Aldrich, 
Gillingham, UK) stock solutions were prepared at 640 and 1280 μg/mL, respectively, in 
distilled water and filtered through a 0.20 μm cellulose acetate membrane filter. The COL 
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solution was kept at 4 ºC up to 60 days following manufacturer’s recommendations. TIG 
solutions had to be prepared on the day of the testing due to stability issues. 
The OD625nm-adjusted suspensions (OD range: 0.150-0.175) were diluted 1/100 in 
CAMHB (corresponding to approximately 1.0 x106 CFU/mL) before dispensing to the 
microtitre plates. Tested concentrations ranged from 32 to 0.03125 μg/mL for both 
antibiotics. The final bacterial concentration corresponded to approximately 
5.0 x105 CFU/mL. E. coli ATCC 25922 (susceptible strain) and E. coli NCTC 13846 (COL 
resistant) were included as quality controls, as recommended by EUCAST (EUCAST, 
2019e). MICs were determined after 24 hours incubation at 37 ± 1ºC as mentioned in the 
previous paragraph. The susceptible, intermediate, or resistant status towards TIG and COL 
was determined according to EUCAST’s breakpoints (EUCAST, 2019b). 
4.2.3.1.2 Antibiotic susceptibility testing using disc-diffusion assay 
Disc-diffusion assays were performed according to EUCAST’s recommendations 
(EUCAST, 2019a) to assess possible changes in susceptibility profiles following exposure 
to CHX for other antibiotics, including two aminoglycosides (AK and CN), three 
carbapenems (IPM, MEM, ETP), three cephalosporins (CAZ, FOX, CPM) and a 
monobactam (ATM). Disc cartridges were stored at -20ºC before first use, and at 4ºC in the 
presence of a desiccant when opened. These antibiotics corresponded to the ones for which 
correlations were observed in the previous chapter (see section 3.3.1.1.2 page 75). 
Antibiotic-containing and blank (control) discs were purchased from Oxoid (Basingstoke, 
UK). Mueller-Hinton agar (MHA; Oxoid, Basingstoke, UK) was prepared according to the 
manufacturer’s recommendation, sterilised by autoclave at 121 ± 3ºC for a minimum 
holding time of 15 min, and 25 mL was poured in 90 mm diameter Petri dishes 
(corresponding to a 4 mm height of agar as recommended by EUCAST). 
After a maximum duration of 15 min after their preparation, each OD625nm-adjusted 
bacterial suspension (ranging from 0.150 to 0.175, corresponding to approximately 
1.0 x108 CFU/mL) was swabbed onto the surface of the agar in three directions, ensuring no 
gap was left between the streaks. Antibiotic discs were applied using a disc dispenser (Oxoid, 
Basingstoke, UK), with a maximum of six discs per agar plate, and within 15 min after 
swabbing. Discs were gently pressed upon to ensure their close and even contact with the 
surface of the agar. Plates were incubated for 24 hours at 37 ± 1ºC before measuring the 
inhibition diameters. E. coli ATCC 25922 was included as a quality control (susceptible 
strain). Inhibition diameters lower than 6 mm could not be measured, as this value 
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corresponded to the disc diameters. The susceptible, intermediate or resistant status towards 
the investigated antibiotics was determined according to breakpoints provided by EUCAST 
(EUCAST, 2019b). 
4.2.3.1.3 Statistical analysis 
Mean and standard deviation were calculated for each antimicrobial MIC or 
inhibition diameter, for both strain and under each tested condition. Statistically significant 
differences were assessed using one-way ANOVA followed by Tukey’s multiple 
comparison test using Prism GraphPad 8 for Windows (significant when p<0.05). 
4.2.3.2 Virulence assay using the wax moth larvae model Galleria mellonella 
4.2.3.2.1 Bacterial suspension wash and OD adjustment 
After a 30-hour exposure to either 0 (control condition), 2, or 4 μg/mL CHX, the 
bacterial suspensions were centrifuged at 5,000 g for 10 min at 20ºC. The pellets were 
resuspended in 10 mL sterile distilled water (sdH2O; obtained by filtration through a 0.20 μm 
cellulose acetate membrane filter) and the OD625nm was adjusted to reach a value between 
0.150 and 0.175, corresponding approximately to 1.0 x108 CFU/mL bacteria. Subsequent 
ten-fold dilutions were prepared in sdH2O down to 1.0 x10
6 CFU/mL. Viable counts were 
performed as previously described (see section 2.2.4.2 page 32) to control the bacterial 
concentration. 
4.2.3.2.2 Galleria mellonella maintenance and injection 
The wax moth larvae Galleria mellonella is recognised as an alternate infection 
model to estimate bacterial virulence (Wand et al., 2011). G. mellonella larvae (Livefood 
UK Ltd, Rooks Bridge, UK) were kept in the dark at 4ºC for a maximum of two weeks to 
avoid the formation of pupae (Leuko & Raivio, 2012). To limit the impact of bacteria 
naturally occurring on the larvae’s skin, they were bathed for few seconds in 70 % (v/v) 
ethanol prior injection. They were subsequently placed in sterile 90 mm diameter Petri 
dishes by groups of 10 individuals and allowed to equilibrate to room temperature for an 
hour before injection (Insua et al., 2013). 
G. mellonella larvae were injected with 10 μL of bacterial suspensions containing 
either 1.0 x108, 1.0 x107 or 1.0 x106 CFU/mL, corresponding to bacterial loads of 106, 105 
and 104 CFU, respectively. Injections were performed in the last haemocoel using a 
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Hamilton syringe with a 22-gauge cemented needle (Hamilton, Birmingham, UK); the 
syringe was decontaminated with 70 % (v/v) ethanol and rinsed with sterile distilled water 
(sdH2O) prior to the first injection and between each injection corresponding to different 
bacterial test conditions (Leuko & Raivio, 2012; Insua et al., 2013). The injection protocol 
was validated by including a toxicity control where individuals were injected with 10 μL of 
100 % DMSO (Harding et al., 2013; Allegra et al., 2018). Additional controls, including 
injection of 10 μL sdH2O, individuals ‘stabbed’ without injection, and untreated larvae, were 
also performed to ensure death was not linked to injection trauma or poor health (Insua et 
al., 2013). A schematic view of the injection protocol is presented in Figure 4-4. 
 
Figure 4-4. Outline of the virulence assay using G. mellonella larvae. 
G. mellonella larvae were injected with 10 μL of bacterial suspensions containing either 104, 
105 or 106 CFU, after exposure to either 0, 2 or 4 μg/mL CHX. Control conditions included 
untreated larvae, larvae ‘stabbed’ but without any injection performed, larvae injected with 
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10 μL sdH2O and larvae injected with 10 μL 100 % DMSO. Ten larvae were injected for 
each condition. 
After injection, the wax moth larvae were incubated at 37 ± 1ºC and survival was 
monitored every 24 hours for a period of five days. Larvae were considered dead when no 
movement was observed after gentle stimulation with a sterile pipette tip (Wand et al., 2011; 
Insua et al., 2013). Ten larvae were used for each condition, and experiments were performed 
at least in triplicate (n≥3). 
4.2.3.2.3 Statistical analysis 
The mean and standard deviation (SD) of G. mellonella survival were determined for 
each tested condition using Prism GraphPad 5 for Windows. The differences observed were 
assessed by two-way ANOVA followed by Bonferroni’s multiple comparison test and were 
considered significant when p<0.05. 
4.2.4 Molecular mechanisms involved after exposure to sub-inhibitory 
concentrations of chlorhexidine 
4.2.4.1 Investigation of the presence of plasmids 
The presence of plasmids within Kp-1 and Kp-125 was investigated by S1 digestion 
followed by pulsed field gel electrophoresis (PFGE) with the help of Dr. Refath Farzana 
(School of Medicine, Cardiff University). The S1 nuclease, purified from Aspergillus oryzae, 
is able to linearize plasmids by targeting supercoiled DNA, enabling the migration of 
plasmids in agarose gels to their true molecular size (Rittie & Perbal, 2008; Toleman, 2018). 
The following sections are based on a previously established protocol (Centers for Disease 
Control and Prevention, 2017; Toleman, 2018). 
4.2.4.1.1 Preparation of plugs 
Isolates were streaked onto Brilliance UTI (urinary tract infection) Clarity agar 
(Oxoid, Basingstoke, UK) and grown overnight at 37 ± 1ºC. Two loopfuls of bacteria were 
then transferred in 2 mL of cell suspension buffer (100 mM Tris, 100 mM EDTA, in 
ultrapure sterile water, pH 8.0; both from Sigma-Aldrich, Gillingham, UK) and the 
suspensions OD610nm were adjusted to 0.8-1.0 (approximately 1.0 x10
9 CFU/mL bacteria). 
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Twenty μL of proteinase K (20 mg/mL stock solution, corresponding to 400 μg) was 
added to 400 μL OD610nm-adjusted suspension (approximately 1.0 x109 CFU/mL). A 
subsequent volume of 400 μL of melted agarose (55-60 ºC) was added, and the mixture was 
poured in plug moulds and enabled to solidify. The agarose was prepared using 1 % SeaKem 
Gold agarose (Lonza, Slough, UK) in Tris-EDTA (TE) buffer (10 mM Tris, 1 mM EDTA, 
in ultrapure sterile water, pH 8.0). 
4.2.4.1.2 Bacterial cell lysis in agarose plugs 
Each agarose plug (containing bacteria) was transferred into a 5 mL cell lysis 
solution (50 mM Tris, 50 mM EDTA, 1 % N-Lauroylsarcosine sodium salt [Sigma-Aldrich, 
Gillingham, UK], pH 8.0) containing 0.1 mg/mL proteinase K. Preparations were incubated 
for 1.5 to 2 hours at 55ºC with continuous shaking (175 rpm). The lysis buffered was then 
removed and plugs were washed with 15 mL pre-heated (55ºC) sterile ultrapure water before 
another 15 min incubation at 55ºC with shaking (step repeated twice). After discarding the 
water, seven washes were performed with 15 mL pre-heated (55ºC) TE buffer and 15 min 
incubation at 55ºC with shaking. After the last wash, 10 mL of fresh TE buffer was added to 
the plugs. 
4.2.4.1.3 Digestion with S1 nuclease 
Plugs were sliced using a single edge razor blade into a 2.0 to 2.5 mm wide section; 
one section per isolate was then transferred in 200 μL 1X restriction buffer (Roche Life 
Science, Welwyn Garden City, UK). The preparation was incubated for 10 min at 37 ± 1ºC 
and the buffer discarded. A volume of 200 μL of S1 nuclease mix (50 U S1, 20 μg bovine 
serum albumin, in 1X restriction buffer; Roche Life Science, Welwyn Garden City, UK) was 
added per plug slice, and preparations were incubated at 37 ± 1ºC for 1.5 to 2 hours. 
4.2.4.1.4 Pulsed field gel electrophoresis 
The S1 nuclease mix was discarded and 200 μL of 0.5X Tris-borate EDTA (TBE) 
buffer (5.4 g/L Tris, 2.75 g/L boric acid, 1 mM EDTA, pH 8.0) was added to the plug slices 
and incubated for 5 minutes at room temperature. Each plug slice was then loaded at the 
bottom of a well of the PFGE agarose gel (1 % SeaKem gold agarose in 0.5X TBE). The 
Lambda PFG ladder (New England BioLabs, Ipswich, UK) was also loaded on the gel to 
enable the determination of plasmid sizes. Wells were sealed with a small volume of warm 
PFGE agarose gel. 
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The loaded PFGE agarose gel was then placed into a CHEF DR-II PFGE machine 
(Bio-Rad, Watford, UK) in the presence of approximately 2 L 0.5X TBE. Ethidium bromide 
(Sigma-Aldrich, Gillingham, UK) was added to the TBE at a final concentration 
corresponding to 0.1 μg/mL. The cooling module was set at 10ºC with a pump flow rate of 
1 L/min. The electrophoresis parameters corresponded to a voltage of 6 V/cm of gel for a 
running time of approximately 20 hours. The presence of plasmids was revealed using a UV 
transilluminator and photographed using a UVP Geldoc II imaging system (UVP, 
Cambridge, UK). 
4.2.4.2 Whole genome sequencing 
4.2.4.2.1 Genomic DNA extraction, DNA library preparation and 
sequencing 
The genomic DNA extraction, DNA library preparation and the DNA sequencing 
were performed by Public Health England prior to this study. DNA was extracted using the 
Wizard Genomic DNA Purification kit (Promega, Chilworth Southampton, UK) according 
to the manufacturer’s protocol (Greig et al., 2018). DNA libraries were prepared following 
the manufacturer’s recommendations with the Nextera XT DNA library preparation kit and 
sequenced using a HiSeq 2500 system (both from Illumina, San Diego, USA) with a 
sequencing depth of approximately 100x per sample (Findlay et al., 2016; Martin et al., 
2017). 
4.2.4.2.2 Genome assembly and annotation 
The WGS data assembly and annotation steps were performed by Nicholas Ellaby 
(Public Health England). The sequences were assembled into several contigs using SPAdes 
(http://cab.spbu.ru/software/spades/ accessed on 28/09/2019) with default settings and 
filtering contigs with a coverage higher or equal to 20x and of length greater than 200 bp 
(Bankevich et al., 2012), and Prokka (https://github.com/tseemann/prokka accessed on 
28/09/2019) was used to annotate the genomes (Seemann, 2014). 
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4.2.4.3 RNA sequencing 
4.2.4.3.1 Total RNA extraction 
Bacteria were exposed to either 0 (control), 2 or 4 μg/mL CHX until they reached 
their exponential growth phase (corresponding to an OD600nm of approximately 0.100). Four 
replicates were performed for each condition, except stated otherwise (n=4). Suspensions 
were then snap-frozen by plunging the centrifuge tubes for 1-3 seconds in a mix of absolute 
ethanol and dry ice (approximately -70ºC) in order to inactivate enzymes and prevent RNA 
degradation (Salehi & Najafi, 2014). The suspension was vortex-mixed and the operation 
repeated two additional times before centrifugation at 5,000 g for 10 min at 4ºC. The 
supernatant was discarded and the pellet frozen at -80ºC until recovered after a maximum of 
one week for total RNA extraction. The exposure, total RNA extraction and subsequent steps 
leading to RNA sequencing were performed on four separate replicates, except if stated 
otherwise (n=4). 
The total RNA was extracted using the RiboPure Bacteria kit (Fisher Scientific, 
Loughborough, UK) according to the manufacturer’s instructions. This protocol is based on 
a phenol extraction followed by glass-fibre filter purification of the total RNA. All 
centrifugation steps were performed at 16,000 g at 4ºC. The final elution was performed in 
two steps with an elution of 25 μL each and was followed by DNase I treatment. Samples’ 
quality and concentrations were assessed (see below) and frozen at -80ºC until needed. 
The concentration of total RNA recovered was measured using the Qubit RNA 
Broad-Range assay kit with the Qubit 3.0 reader (Invitrogen-Fisher Scientific, 
Loughborough, UK) following the manufacturer’s instructions. The quality of the samples 
was assessed using a 2200 TapeStation with an RNA ScreenTape (both from Agilent 
Technologies, Stockport, UK) according to the manufacturer’s instructions. 
4.2.4.3.2 Messenger RNA enrichment 
The total RNA extracted underwent messenger RNA (mRNA) enrichment using the 
MICROBExpress kit (Fisher Scientific, Loughborough, UK) according to the 
manufacturer’s instructions. The mRNA enrichment is performed by capturing and 
removing the 16S and 23S ribosomal RNA (rRNA) from the total RNA population. After 
measuring their concentrations and evaluating their quality, mRNA-enriched samples were 
stored at -80ºC until needed. 
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The concentration of each mRNA-enriched sample was assessed using the Qubit 
RNA High-Sensitivity assay kit with the Qubit 3.0 reader (Invitrogen-Fisher Scientific, 
Loughborough, UK). The samples’ quality was determined using a 2200 TapeStation with 
an RNA ScreenTape (both from Agilent Technologies, Stockport, UK) as mentioned above. 
4.2.4.3.3 Library preparation and RNA sequencing 
The library preparation and sequencing steps were performed by Angela Marchbank 
(Genome Hub, School of Biosciences, Cardiff University). The mRNA samples were used 
as templates for the synthesis of complementary DNA enabling the generation of the library 
preparations using the TruSeq Stranded mRNA sample preparation guide (Illumina, San 
Diego, USA) with dual index adapters, according to the manufacturer’s recommendations. 
The sequencing was carried using a NextSeq 500 with a high-output cartridge (1x75, single-
ended; both from Illumina, San Diego, USA) enabling the generation of approximately 
400 million reads in total (corresponding to approximately 13 million reads per sample). 
4.2.4.3.4 Data analysis and interpretation 
The assembly, annotation and differential expression analysis were performed by 
Dr. Barbara Szomolay (School of Medicine, Cardiff University) and Thomas Whalley 
(School of Medicine, Cardiff University). A transcriptome was generated using Trinity with 
default settings and the ‘--normalize by read set flag’ (Grabherr et al., 2011); reads were 
trimmed with Trimmomatic (Bolger et al., 2014). For quality control purposes, the raw reads 
were mapped to the newly created transcriptome using Bowtie2 (http://bowtie-
bio.sourceforge.net/bowtie2/index.shtml accessed on 28/09/2019; Langmead & Salzberg, 
2012). As over 80 % of the raw reads mapped to the transcriptome, this suggested the 
assembly was correct. 
The raw transcripts created by Trinity were then annotated using Trinotate 
(https://github.com/Trinotate/Trinotate.github.io/wiki/Software-installation-and-data-
required accessed on 28/09/2019). The reference database was generated following 
recommendations on the software’s website (Haas, 2018). This enabled the creation of a 
reference database of transcripts from Uniprot (https://www.uniprot.org/ accessed on 
28/09/2019), with predicted proteins using Transdecoder 
(https://github.com/TransDecoder/TransDecoder/releases accessed on 28/09/2019), 
predicted protein domains using HMMER (http://hmmer.org/ accessed on 28/09/2019, 
predicted signal peptides using SignalP (http://www.cbs.dtu.dk/cgi-bin/nph-
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sw_request?signalp accessed on 28/09/2019), predicted transmembrane regions using 
TMHMM (http://www.cbs.dtu.dk/cgi-bin/nph-sw_request?tmhmm accessed on 
28/09/2019) and rRNA identification using RNAMMER (http://www.cbs.dtu.dk/cgi-
bin/sw_request?rnammer accessed on 28/09/2019). These annotations were then merged 
with the names in the downstream expression matrix with a utility perl script supplied with 
Trinotate. When several different genes were associated with one sequence, the first one 
indicated by the software was used for further analysis, as this corresponded to the best hit 
for its identification. However, no confidence interval or probability was associated to the 
gene identified by the software. 
The raw reads were then mapped onto the transcriptome using Kallisto 
(https://pachterlab.github.io/kallisto/about accessed on 28/09/2019; Bryant et al., 2017) with 
default settings and an estimated fragment length of 200 ± 30 bp. Raw reads were also 
quantified during mapping. 
To visualise and detect the presence of outliers, the raw transcript level reads were 
transformed with the variance stabilizing transform using the DESeq2 R package 
(https://bioconductor.org/packages/release/bioc/html/DESeq2.html accessed on 
28/09/2019; Love et al., 2014). Outliers were identified by using the Mahalanbois distance 
after performing principal component analysis and removed from the subsequent analyses. 
Differential expression between the different conditions was performed using the DESeq2 
R package: an internal normalization was performed by dividing the counts obtained for a 
given gene under one specific condition by the mean count measured for the same gene 
across all exposure conditions, therefore enabling the measurement of log2 fold-changes in 
gene expression between two distinct conditions (Love et al., 2014). Genes were considered 
differentially expressed when they had a Benjamin-Hochberg adjusted p-value lower than 
or equal to 0.05 and a log2 fold-change in expression of at least ± 1 (Hassan et al., 2013). 
4.3 Results 
4.3.1 Phenotypic response after exposure to sub-inhibitory concentrations of 
chlorhexidine 
4.3.1.1 Effects on susceptibility profiles to antimicrobials 
The MICs and inhibition diameters obtained for the different investigated antibiotics 
were within the EUCAST’s recommended values (EUCAST, 2019e), except for E. coli 
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ATCC 25922 with COL where the MIC measured (0.11 ± 0.03 μg/mL) was below the range 
(0.25 to 2 μg/mL). However, the COL MIC obtained for the second reference strain, E. coli 
NCTC 13846 (3.6 ± 1.1 μg/mL) agreed with the EUCAST’s target (4 μg/mL, exceptionally 
2 or 8 μg/mL). 
The mean MIC values measured for TIG, COL, BZC and CHX, before and after 
exposure to either 0, 2 or 4 μg/mL CHX are grouped in Table 4-2. Overall, no statistically 
significant differences (one-way ANOVA followed by Tukey’s test; p>0.05) were obtained 
for any of the determined MIC when comparing before and after exposure, and between the 
different exposure conditions, for both isolates. Few statistically significant differences 
(p<0.05) were observed; when comparing the untreated control and all other conditions for 
BZC MIC in Kp-1, between the untreated control and Kp-1 exposed to 0 μg/mL CHX (R2A 
only) for CHX, between the untreated control and the PRE conditions for COL in Kp-125 
and between the untreated control and the PRE condition (0 μg/mL CHX only) for BZC in 
Kp-125. However, the fold-changes in MICs were of approximately 2, which correspond to 
the accepted variability when performing MIC determination (Turnidge & Paterson, 2007). 
No change in susceptibility (susceptible to resistant or vice-versa) was observed for neither 
Kp-1 nor Kp-125 under any of the tested conditions. 
Table 4-2. TIG, COL, BZC and CHX MICs obtained before and after exposure to 0, 2 
or 4 μg/mL CHX. 
A), MIC values obtained for Kp-1 before exposure (first column) or after exposure to 0 
(Kp-1 + 0), 2 (Kp-1 + 2) or 4 (Kp-1 + 4) μg/mL CHX. B), MIC values obtained for Kp-125 
before exposure (first column) or after exposure to 0 (Kp-125 + 0), 2 (Kp-125 + 2) or 4 
(Kp-125 + 4) μg/mL CHX. C), MIC values obtained for Kp-125 after a 48-hour re-exposure 
to 0 (Kp-125 + 0 PRE) or 4 (Kp-125 + 4 PRE) μg/mL CHX. Experiments were performed 
at least in triplicate (n≥3). A red background indicates a resistant phenotype towards the 
corresponding antibiotic and a green background indicates susceptibility, according to 
EUCAST’s breakpoints (EUCAST, 2019b). SD: standard deviation. 
A 
Kp-1 Kp-1 + 0 Kp-1 + 2 Kp-1 + 4 
MIC (µg/mL) MIC (µg/mL) MIC (µg/mL) MIC (µg/mL) 
Mean SD Mean SD Mean SD Mean SD 
TIG 8.0 0.0 9.5 4.8 9.9 3.7 6.4 2.2 
COL 0.18 0.07 0.13 0.10 0.16 0.07 0.12 0.03 
BZC 16.0 0.0 7.6 0.7 7.6 0.7 7.5 1.2 
CHX 8.0 0.0 4.7 1.9 5.0 1.7 6.1 1.5 
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Table 4-2 – Continued. 
B 
Kp-125 Kp-125 + 0 Kp-125 + 2 Kp-125 + 4 
MIC (µg/mL) MIC (µg/mL) MIC (µg/mL) MIC (µg/mL) 
Mean SD Mean SD Mean SD Mean SD 
TIG 4.0 1.9 3.2 1.0 3.0 1.2 3.3 1.6 
COL 0.23 0.15 0.31 0.10 0.35 0.14 0.27 0.10 
BZC 16.0 0.0 21.3 6.2 25.3 6.7 26.7 7.5 
CHX 8.0 0.0 5.5 2.6 6.0 1.3 7.0 2.0 
 
C 
Kp-125 + 0 PRE Kp-125 + 4 PRE 
MIC (µg/mL) MIC (µg/mL) 
Mean SD Mean SD 
TIG 5.0 2.0 4.0 0.0 
COL 0.50 0.00 0.38 0.05 
BZC 32.0 0.0 28.0 5.1 
CHX 8.0 0.0 8.0 0.0 
 
The mean inhibition diameters obtained for the different tested antibiotics before and 
after exposure are presented in Table 4-3. No statistically significant difference (one-way 
ANOVA followed by Tukey’s test; p>0.05) in inhibition zone measure was obtained for any 
antibiotic, for neither Kp-1 nor Kp-125, and under any of the investigated exposure 
conditions. Similarly, no change in susceptibility towards the different investigated 
antibiotics was obtained after exposure to the different CHX concentrations investigated. 
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Table 4-3. Antibiotic inhibition diameters obtained before and after exposure to 0, 2 or 
4 μg/mL CHX 
A), Inhibition diameters obtained for Kp-1 before exposure (first column) or after exposure 
to 0 (Kp-1 + 0), 2 (Kp-1 + 2) or 4 (Kp-1 + 4) μg/mL CHX. B), Inhibition diameters obtained 
for Kp-125 before exposure (first column) or after exposure to 0 (Kp-125 + 0), 2 (Kp-
125 + 2) or 4 (Kp-125 + 4) μg/mL CHX. C), Inhibition diameters obtained for Kp-125 after 
a 48-hour re-exposure to 0 (Kp-125 + 0 PRE) or 4 (Kp-125 + 4 PRE) μg/mL CHX. 
Experiments were carried at least in triplicate (n≥3). A red background indicates a resistant 
phenotype towards the corresponding antibiotic and a green background indicates 
susceptibility, according to EUCAST’s breakpoints (EUCAST, 2019b). AK: amikacin; 
ATM: aztreonam; CAZ: ceftazidime; CIP: ciprofloxacin; CN: gentamycin; CPM: cefepime; 
ETP: ertapenem; FOX: cefoxitin; IPM: imipenem; MEM: meropenem; SD: standard 
deviation. 
A 
Kp-1 Kp-1 + 0 Kp-1 + 2 Kp-1 + 4 
Inhibition (mm) Inhibition (mm) Inhibition (mm) Inhibition (mm) 
Mean SD Mean SD Mean SD Mean SD 
IPM 14.3 1.2 15.6 0.9 16.0 0.9 15.8 1.2 
MEM 13.0 1.0 14.8 1.0 14.5 1.6 14.8 0.8 
ETP 10.3 0.6 11.1 0.6 10.6 2.0 11.2 0.8 
ATM 6.0 0.0 6.0 0.0 6.0 0.0 6.0 0.0 
CIP 6.0 0.0 6.0 0.0 6.0 0.0 6.0 0.0 
CAZ 6.0 0.0 6.0 0.0 6.0 0.0 6.0 0.0 
CPM 12.3 0.6 11.9 1.4 12.5 0.5 12.2 1.2 
FOX 6.0 0.0 6.0 0.0 6.0 0.0 6.0 0.0 
AK 6.0 0.0 6.0 0.0 6.0 0.0 6.0 0.0 
CN 6.0 0.0 6.0 0.0 6.0 0.0 6.0 0.0 
 
B 
Kp-125 Kp-125 + 0 Kp-125 + 2 Kp-125 + 4 
Inhibition (mm) Inhibition (mm) Inhibition (mm) Inhibition (mm) 
Mean SD Mean SD Mean SD Mean SD 
IPM 8.0 0.0 9.5 0.6 9.8 0.5 9.0 0.0 
MEM 6.0 0.0 6.0 0.0 6.0 0.0 6.0 0.0 
ETP 6.0 0.0 6.0 0.0 6.0 0.0 6.0 0.0 
ATM 6.0 0.0 6.0 0.0 6.0 0.0 6.0 0.0 
CIP 6.0 0.0 6.0 0.0 6.0 0.0 6.0 0.0 
CAZ 6.0 0.0 6.0 0.0 6.0 0.0 6.0 0.0 
CPM 7.3 0.6 7.3 0.5 7.3 0.5 7.0 0.0 
FOX 6.0 0.0 6.0 0.0 6.0 0.0 6.0 0.0 
AK 14.0 0.0 14.5 0.6 14.3 0.5 14.5 0.6 
CN 18.3 0.6 19.0 0.0 18.8 0.5 19.0 0.0 
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Table 4-3 – Continued. 
C 
Kp-125 + 0 PRE Kp-125 + 4 PRE 
Inhibition (mm) Inhibition (mm) 
Mean SD Mean SD 
IPM 10.0 0.8 9.8 0.5 
MEM 6.0 0.0 6.0 0.0 
ETP 6.0 0.0 6.0 0.0 
ATM 6.0 0.0 6.0 0.0 
CIP 6.0 0.0 6.0 0.0 
CAZ 6.0 0.0 6.0 0.0 
CPM 7.0 0.0 7.3 0.5 
FOX 6.0 0.0 6.0 0.0 
AK 14.8 0.5 14.0 0.0 
CN 18.8 0.5 19.0 0.8 
 
4.3.1.2 Effects on virulence 
The detailed results obtained for the virulence assay are presented in appendix XII. 
The untreated, ‘stabbed’ (no injection performed) and injected with sdH2O groups harboured 
survival rates of 97.5, 96.3 and 100 % after five days of incubation, respectively. All the 
larvae injected with DMSO had died 24 hours after injection. Important variability in 
survival rates was measured for all the isolates-CHX exposure-bacterial loads combinations. 
No statistically significant (two-way ANOVA followed by Bonferroni’s post-test; p>0.05) 
difference was observed between the different conditions regardless of the isolate when 
larvae were injected with 104 CFU, with survival rates ranging from 83.3 to 96.0 % after five 
days of incubation. For both bacterial isolates, and under all the tested conditions, 
significantly higher (Bonferroni’s post-test; p<0.05) death rates were obtained with 
increasing bacterial loads. 
The results obtained for Kp-1 are presented in Figure 4-5. For a set bacterial load, no 
statistically significant differences were observed in virulence when Kp-1 was exposed to 
the different CHX concentrations. 
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Figure 4-5. G. mellonella larvae survival rates after injection of several bacterial loads 
of Kp-1 previously exposed to different CHX concentrations. 
Experiments were carried out at least in triplicate (n≥3). Survival rates (in %) were measured 
after one to five days incubation following injection of either 106, 105 or 104 CFU of Kp-1 
previously exposed to either 0 (Kp-1+0), 2 (Kp-1+2) or 4 (Kp-1+4) μg/mL CHX. Reported 
values corresponded to mean and standard deviation obtained for each condition. 
The results obtained for Kp-125 are presented in Figure 4-6. When 106 CFU were 
injected, a significant (Bonferroni’s post-test; p<0.05) decrease in survival was observed 
with increasing concentrations of CHX the isolate was exposed to, for the first exposure only 
(no difference was obtained in survival rate when comparing secondary exposure to either 0 
or 4 μg/mL CHX at this bacterial load). This phenomenon was however not observed when 
105 CFU were injected. No statistically significant differences were observed in virulence 
after re-exposure between exposure 0 and 4 μg/mL CHX (Bonferroni’s post-test; p>0.05). 
For a set CHX concentration, survival rates were found to be significantly lower after re-
exposure for 0 μg/mL (R2A only) when compared to virulence measured after the first 
exposure to the same concentration (with 106 CFU only). The virulence observed in Kp-125 
after re-exposure to 4 μg/mL CHX with a bacterial load of 105 CFU was significantly less 
important than the one measured for Kp-125 after the first exposure to the same CHX 
concentration. 
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Figure 4-6. G. mellonella larvae survival rates after injection of several bacterial loads 
of Kp-125 previously exposed to different CHX concentrations. 
Experiments were carried out at least in triplicate (n≥3). Survival rates (in %) were measured 
after one to five days incubation following injection of either 106, 105 or 104 CFU of Kp-125 
previously exposed to either 0 (Kp-125+0), 2 (Kp-125+2) or 4 (Kp-125+4) μg/mL CHX, or 
after a second exposure to 0 (Kp-125+0PRE) or 4 (Kp-125+4PRE) μg/mL CHX. Reported 
values corresponded to mean and standard deviation obtained for each condition. 
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When comparing both isolates, Kp-1 was found to be significantly (Bonferroni’s 
post-test; p<0.05) more virulent than Kp-125. Indeed, the survival rates observed when 
injecting 106 CFU after exposure to any of the CHX concentrations were lower in Kp-1 than 
in Kp-125 (similar observations were made with a bacterial load of 105 CFU). 
4.3.2 Molecular changes after exposure to sub-inhibitory concentrations of 
chlorhexidine 
4.3.2.1 Detection of plasmids 
Several plasmids were detected by PFGE following S1 digestion for both isolates, as 
illustrated in Figure 4-7. The top, very bright band observed in both lanes corresponded to 
the chromosomal DNA. Three bands were observed for Kp-1 (approximately 340 kb, 240 kb 
and 190 kb) and four bands were obtained for Kp-125 (approximately 194 kb, 150 kb, 97 kb 
and < 48 kb). 
 
Figure 4-7. Plasmid detection using PFGE following S1 digestion for Kp-1 and Kp-125. 
S1 digestion linearized the isolates’ plasmids, enabling them to migrate to their true 
molecular size on the electrophoresis gel. 
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4.3.2.2 Whole genome sequencing 
An overall of 495,706 and 247,697 bp were obtained from WGS for Kp-1 and 
Kp-125, respectively. These numbers went down to 487,543 and 245,509 when considering 
contigs with a minimum coverage of 20x and a minimum length of 200 bp. This represented 
however only a small fraction (<10 %) of the expected genome size; indeed, another 
K. pneumoniae ST258 isolate possesses a chromosome of approximately 5,400,000 bp 
(GenBank access number: LAKK01000012.1). Because of this, a de novo transcriptome 
assembly was preferred for the differential expression analysis instead of mapping the reads 
to a reference genome. 
4.3.2.3 RNA sequencing 
The genes for which expression was statistically significant (Benjamin-Hochberg 
adjusted p-value; p<0.05, and log2 fold-change of at least ± 1.0) between the different 
exposure conditions for Kp-1 are grouped in Table 4-4. Overall, more genes had their 
expression altered by exposure to 4 μg/mL than by 2 μg/mL CHX when compared to the 
control condition (0 μg/mL CHX). When the same gene’s expression was altered under both 
CHX treatments, the fold-change in expression was equivalent or more important at 4 μg/mL 
CHX. A wide range of cellular activities were impacted by exposure to CHX, including 
various metabolism pathways, cellular respiration and electron transfer (upregulation up to 
2 log2 fold-change after exposure to both CHX concentrations when compared to the 
control), stress response (mainly upregulation after CHX exposure) and efflux and transport 
activities (mainly upregulation after exposure to 4 μg/mL CHX). Regarding efflux, several 
genes encoding multi-drug efflux pumps were found to be upregulated after exposure to 
4 μg/mL CHX, including acrD (log2 fold-change: 1.1), mdtB (1.2) and the cationic efflux 
pump-encoding gene smvA (3.5). The expressions of genes encoding a DNA polymerase 
(dnaE) and a DNA gyrase (gyrA) involved in cell replication activities were found to be 
downregulated after CHX treatment. The expression of genes encoding for chaperonins were 
upregulated, except for asmA which expression was downregulated (involved in the 
prevention of misfolding for outer membrane protein mutants). Genes encoding proteins 
involved or associated with ribosomes were globally downregulated. The production of 
fimbriae was decreased after CHX treatment, and degradation of putrescine was increased. 
No change in the expression profiles of global regulators including mar and sox were 
detected, but increased expression of phnM (part of the Pho regulon) was observed after 
exposure to both CHX concentrations.  
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Table 4-4. Differential expression analysis between exposure to different CHX 
concentrations for Kp-1. 
Exposure of Kp-1 to either 0 or 4 μg/mL CHX was performed in quadruplicate (n=4), and 
exposure to 2 μg/mL CHX was performed in triplicate (one outlier removed; n=3). 
Differential expression analysis was performed by comparing Kp-1 exposed to 2 μg/mL 
CHX (Kp-1 2/0) or exposed to 4 ug/mL CHX (Kp-1 4/0) to the control condition (0 μg/mL 
CHX). Differential expression was expressed in log2 fold-change (FC). Only genes for which 
the differential expression was statistically significant (Benjamin-Hochberg adjusted p 
value; p<0.05) and with at least ± 1 log2 fold-change are presented in this table. Upregulated 
genes are highlighted in green, and downregulated genes in red. When numbers are indicated 
in brackets, it means several different sequences were identified as the same gene in the 
database. ns: not significant and/or with a log2 fold-change lower than ± 1; OM: outer 
membrane; OMP: outer membrane protein; rRNA: ribosomal RNA; tRNA: transfer RNA. 
Gene name 
Kp-1 2/0 Kp-1 4/0 
Associated function Reference 
log2 FC log2 FC 
Mean SD Mean SD 
Antibiotic resistance         
  ampC ns   -1.0 0.2 β-lactamase Jacoby, 2009 
Cellular respiration / electron transfer     
  fdhF ns   1.5 0.6 Formate dehydrogenase 
Wang & Gunsalus, 
2003 
  fdnG ns   2.1 0.7 Formate dehydrogenase 
Wang & Gunsalus, 
2003 
  fhlA ns   1.3 0.5 Formate dehydrogenase 
Maupin & 
Shanmugam, 1990 
  narK ns   2.0 0.7 
Nitrate/nitrite 
transporter 
Bueno et al., 2012 
  narU 1.8 0.2 2.1 0.1 
Nitrate/nitrite 
transporter 
  narZ ns   1.3 0.4 Nitrate reductase 
  nasR 1.9 0.6 1.8 0.5 Nitrate regulation Goldman et al., 1994  
  nfsB ns  1.5 0.1 Nitrate reductase Rau & Stolz, 2003 
Cell wall synthesis and/or maintenance     
  dapE -1.1 0.3 ns   
Diaminopimelic acid 
synthesis Wu et al., 1992 
  mltC 1.0 0.3 ns   Murein transglycolase 
Artola-Recolons et al., 
2014 
DNA modification and/or transfer       
  dnaE ns   -1.4 0.4 DNA polymerase 
Tomasiewicz & 
McHenry, 1987 
  gyrA ns   -1.6 0.4 DNA gyrase 
Pourahmad Jaktaji & 
Mohiti, 2010 
  mukB 10.5 1.7 12.1 1.6 Chromosome partition Niki et al., 1992 
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Table 4-4 – Continued. 
Gene name 
Kp-1 2/0 Kp-1 4/0 
Associated function Reference 
log2 FC log2 FC 
Mean SD Mean SD 
Efflux and transport           
  acrB ns   -1.4 0.5 
Multi-drug efflux pump, 
RND family Alav et al., 2018 
  acrD ns  1.1 0.3 
Multi-drug efflux pump, 
RND family Alav et al., 2018 
  bepG ns  1.6 0.2 
Multi-drug efflux pump, 
RND family (Brucella 
spp.) Martin et al., 2009 
  mchF ns   1.1 0.3 
Microcin secretion, 
bacteriocin transport Poey et al., 2006 
  mdtB ns   1.2 0.3 
Multi-drug efflux pump, 
RND family Kim & Nikaido, 2012 
  mdtM ns  1.1 0.2 
Multi-drug efflux pump, 
MFS family Krizsan et al., 2015 
  rbtT ns   1.4 0.3 
Ribitol transporter, 
MFS family Pao et al., 1998 
  smvA 3.1 0.4 3.5 0.3 
Cationic compounds 
efflux pump, MFS 
family Villagra et al., 2008 
Stress response           
  acnA ns  1.1 0.2 
RNA regulatory protein 
linked to oxidative 
stress Gruer & Guest, 1994 
  adhP ns   1.4 0.2 
Alcohol dehydrogenase 
linked to DNA damage 
Khil & Camerini-
Otero, 2002 
  gcvA -1.1 0.3 ns  
Transcriptional 
activator linked to UV 
exposure Sargentini et al., 2016 
  otsA ns   1.0 0.2 
Involved in trehalose 
synthesis and 
osmoprotection Joseph et al., 2010 
Transcription, translation and post-translation modifications   
  asmA ns   -1.3 0.2 
Prevents misfolding of 
mutant OMPs Prieto et al., 2009  
  groL (1) 1.2 0.4 1.2 0.3 
Chaperonin 
Goltermann et al., 
2015  
  groL (2) 1.2 0.3 1.2 0.3 
  groL (3) 1.6 0.5 1.5 0.4 
  lysS ns   1.9 0.5 Lysine-tRNA ligase Leveque et al., 1990 
  rbbA ns   -1.6 0.6 
Ribosome-associated 
ATPase Ganoza & Kiel, 2001 
  rlhA -6.0 1.9 ns   
Modification of 23S 
rRNA Kimura et al., 2017 
Virulence-associated         
  fimD (1) ns   -11.1 3.0 Involved in 
export/assembly of 
fimbriae Nishiyama et al., 2008 
  fimD (2) ns   -3.1 0.8 
  fimD (3) ns   -1.3 0.3 
  puuB ns  1.5 0.2 
Involved in putrescine 
degradation Nemoto et al., 2012 
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Table 4-4 – Continued. 
Gene name 
Kp-1 2/0 Kp-1 4/0 
Associated function Reference 
log2 FC log2 FC 
Mean SD Mean SD 
Other             
  aldA 1.3 0.4 1.6 0.4 
Lactaldehyde 
dehydrogenase Limon et al., 1997 
  argI ns   1.1 0.3 
Involved in arginine 
biosynthesis Celis, 1977 
  bisC -2.1 0.4 -1.3 0.4 
Biotin sulfoxide 
reductase 
Pierson & Campbell, 
1990 
  budB ns   1.7 0.4 Acetolactate synthase Blomqvist et al., 1993 
  cbiD ns   1.1 0.4 
Involved in cobalamin 
synthesis 
Moore et al., 2013   cbiF ns   1.7 0.5 
Involved in cobalamin 
synthesis 
  crnA ns   1.3 0.5 
Creatinine 
amidohydrolase Beuth et al., 2003  
  cysI ns   4.7 1.4 Sulfite reductase Ostrowski et al., 1989 
  cysN ns   -1.2 0.3 
Sulfate adenylyl-
transferase 
Hummerjohann et al., 
1998 
  dcp ns   2.8 0.9 Carboxypeptidase Henrich et al., 1993 
  eutB 1.7 0.5 2.0 0.5 
Ethanolamine 
degradation 
Bovell & Warncke, 
2013 
  gapA ns   1.1 0.2 
Involved in glycolysis 
and glyconeogenesis 
Charpentier & 
Branlant, 1994 
  gltA -1.2 0.4 -1.0 0.3 Citrate synthase Park et al., 1994 
  mtfA -1.1 0.3 -1.2 0.3 
Glucose-related 
peptidase, involved in 
entry into stationary 
growth phase Gohler et al., 2012  
  phnM 1.2 0.4 1.7 0.3 
Part of the Pho regulon, 
global regulation 
Jochimsen et al., 2011; 
Santos-Beneit, 2015 
  rutG ns   2.4 0.6 Pyrimidine permease Kozmin et al., 2013 
Unknown / putative           
  ybgA 3.0 0.9 ns   Uncharacterized protein 
UniProt 
(YBGA_ECOLI) 
  ybhD ns   1.1 0.3 
Uncharacterized, 
putative transcriptional 
regulator 
Flores-Bautista et al., 
2018 
  ydhK ns   1.7 0.4 Uncharacterized protein 
UniProt 
(YDHK_ECOLI) 
  ydhS ns   1.9 0.6 Uncharacterized protein 
UniProt 
(YDHS_ECOLI) 
  yejA 2.6 0.7 ns   
Uncharacterized, might 
be part of the ABC 
transporter family 
Vondenhoff et al., 
2011 
  ygaD ns   1.7 0.5 Uncharacterized protein 
UniProt 
(Q1R800_ECOUT) 
  yhdP 1.0 0.3 ns  
Uncharacterized, might 
be involved in OM 
permeability 
Mitchell et al., 2017; 
Mitchell et al., 2018 
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The genes for which expression was statistically significant (Benjamin-Hochberg 
adjusted p-value; p<0.05, and log2 fold-change of at least ± 1.0) between the different 
exposure conditions (first exposure only) for Kp-125 are grouped in Table 4-5. Similarly to 
Kp-1, more genes were differentially expressed after exposure to 4 μg/mL than 2 μg/mL 
when compared to the control condition (0 μg/mL CHX), and when the expression of a gene 
was altered in both conditions, the effect was mainly more important after exposure to 
4 μg/mL CHX than to 2 μg/mL CHX. The impact of CHX exposure on the different cellular 
activities seemed more contrasted, with genes linked to the same cellular activity found both 
upregulated and downregulated. As seen with Kp-1, most genes involved in cellular 
respiration and several multi-drug efflux pump-encoding genes were found to be 
upregulated, especially after exposure to 4 μg/mL CHX: acrD (log2 fold-change: 1.2), emrD 
(1.3 after exposure to 2 μg/mL CHX) and smvA (1.9). However, genes encoding proteins 
related to iron transport were downregulated. The expression of several DNA-related genes 
(DNA polymerase and gyrase, helicase, integrase, transposase, recombinase) was found to 
be downregulated after CHX exposure, while other were upregulated (genes related to 
plasmid transfer and conjugation, mismatch repair). An overall decrease of the expression 
of genes involved in transcriptional, translational and post-translational modifications, and 
related to virulence, was observed. The expression of phnM, as previously seen for Kp-1, 
was also increased after CHX exposure in Kp-125. 
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Table 4-5. Differential expression analysis between exposure to different CHX 
concentrations for Kp-125. 
Exposure of Kp-125 to either 0, 2 or 4 μg/mL CHX was performed in quadruplicate (n=4). 
Differential expression analysis was performed by comparing Kp-125 exposed to 2 μg/mL 
CHX (Kp-125 2/0) or exposed to 4 ug/mL CHX (Kp-125 4/0) to the control condition 
(0 μg/mL CHX). Differential expression was expressed in log2 fold-change (FC). Only genes 
for which the differential expression was statistically significant (Benjamin-Hochberg 
adjusted p value; p<0.05) and with at least ± 1 log2 fold-change are presented in this table. 
Upregulated genes are highlighted in green, and downregulated genes in red. When numbers 
are indicated in brackets, it means several different sequences were identified as the same 
gene in the database. ns; not significant and/or with a log2 fold-change lower than ± 1. 
Gene 
name 
Kp-125 2/0 Kp-125 4/0 
Associated function Reference 
log2 FC log2 FC 
Mean SD Mean SD 
Cellular respiration / electron transfer 
  ccmF ns   -1.1 0.3 Cytochrome c synthesis Thony-Meyer et al., 1995 
  hemA ns   -9.6 2.4 Involved in heme synthesis Darie & Gunsalus, 1994 
  narU 1.1 0.2 1.7 0.2 Nitrate/nitrite transporter Bueno et al., 2012 
  nfsB ns   1.2 0.3 Nitrate reductase Rau & Stolz, 2003 
  pntB 7.9 1.6 10.3 1.6 NAD(P) transhydrogenase Clarke et al., 1986 
Cell wall synthesis and/or maintenance 
  nlpC ns   1.5 0.4 
Endopeptidase involved in 
peptidoglycan turnover Xu et al., 2015 
  rfbD 1.4 0.4 1.6 0.4 
Involved in O antigen 
synthesis Boels et al., 2004 
DNA modification and/or transfer 
  dnaE ns   -1.1 0.2 DNA polymerase 
Tomasiewicz & 
McHenry, 1987 
  gyrA (1) ns   -1.8 0.5 
DNA gyrase 
Pourahmad Jaktaji & 
Mohiti, 2010   gyrA (2) ns   -1.4 0.5 
  helD -2.4 0.8 ns   DNA helicase Mendonca et al., 1993 
  intB (1) -1.0 0.2 -1.1 0.2 
Integrase Hochhut et al., 2006   intB (2) ns   -1.1 0.2 
  mobA 1.5 0.5 2.1 0.5 
Involved in plasmid 
transfer 
Henderson & Meyer, 
1999 
  mukB 1.4 0.5 2.2 0.5 Chromosome partition Niki et al., 1992 
  mutS 4.9 1.2 6.0 1.2 Mismatch repair Acharya et al., 2003 
  recC -1.4 0.4 -1.1 0.4 
DNA repair and 
recombination Myers & Stahl, 1994 
  sopA 1.0 0.2 ns   Plasmid partition Kim & Shim, 1999 
  tnpA -2.1 0.5 -1.4 0.4 Transposase Horak & Kivisaar, 1998 
  traH 2.2 0.6 2.7 0.6 
Involved in F pilus 
formation (conjugation) Arutyunov et al., 2010 
  xerC ns   -1.1 0.3 Recombinase Cornet et al., 1997  
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Table 4-5 – Continued. 
Gene 
name 
Kp-125 2/0 Kp-125 4/0 
Associated function Reference 
log2 FC log2 FC 
Mean SD Mean SD 
Efflux / transport 
  acrD ns   1.2 0.3 
Multi-drug efflux pump, 
RND family Alav et al., 2018 
  appF 1.9 0.4 2.7 0.4 
Oligopeptides ABC 
transporter (Bacillus spp.) Koide & Hoch, 1994 
  aroP 2.0 0.6 ns   
Permease involved in 
aromatic amino acid 
transport Cosgriff & Pittard, 1997 
  emrD 1.3 0.4 ns   
Multi-drug efflux pump, 
MFS family Alav et al., 2018 
  entE -1.9 0.5 -1.6 0.5 Enterobactin synthesis 
(iron transport) Raymond et al., 2003   entF -1.8 0.5 ns   
  fcuA ns   -1.0 0.1 
Associated with iron 
transport 
Ozenberger et al., 1987; 
Miethke & Marahiel, 
2007; Grim et al., 2012 
  fepA -2.5 0.6 ns   
  fepC -2.0 0.4 -1.6 0.4 
  fes -2.1 0.6 ns   
  kdpA ns   1.6 0.4 
P-type ATPase, involved 
in cation transport 
(potassium) 
Sardesai & 
Gowrishankar, 2001 
  pgtP ns   1.2 0.2 
Phosphoglycerate 
transport, MFS family 
Varadhachary & 
Maloney, 1991 
  rbtT (1) ns   1.7 0.3 Ribitol transporter, MFS 
family Pao et al., 1998   rbtT (2) 1.6 0.4 2.5 0.4 
  smvA 1.4 0.3 1.9 0.3 
Cationic compounds efflux 
pump, MFS family Villagra et al., 2008 
  ssuA ns   -1.2 0.4 
ABC transporter involved 
in uptake of sulfonates Eichhorn et al., 2000 
  trkA -2.2 0.6 ns   
Involved in potassium 
uptake Bossemeyer et al., 1989 
Stress response 
  bluF ns   1.0 0.2 
Antirepressor linked to 
blue light exposure Tschowri et al., 2009 
  cspE 1.1 0.3 ns   
Involved in acclimatation 
of nutritionally starved 
bacteria in fresh media Bae et al., 1999 
  otsA ns   1.1 0.1 
Involved in trehalose 
synthesis and 
osmoprotection Joseph et al., 2010 
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Table 4-5 – Continued. 
Gene 
name 
Kp-125 2/0 Kp-125 4/0 
Associated function Reference 
log2 FC log2 FC 
Mean SD Mean SD 
Transcription, translation and post-translation modifications 
  epmA ns   -1.6 0.6 
Translation elongation 
factor aminoacetylase Vivijs et al., 2016 
  ileS ns   -3.5 1.3 Isoleucine-tRNA ligase Chalker et al., 1994 
  lysS 1.8 0.2 ns   Lysine-tRNA ligase Leveque et al., 1990 
  rapA (1) ns   -1.1 0.2 
RNA polymerase-
associated protein Sukhodolets & Jin, 1998    rapA (2) ns   1.9 0.5 
  rlhA ns   -23.6 2.9 Modification of 23S rRNA Kimura et al., 2017 
  rplA ns   -4.0 1.4 
50S ribosomal protein L1 
synthesis Fu et al., 2013 
Virulence associated 
  fimD -1.1 0.3 -1.2 0.3 
Involved in 
export/assembly of 
fimbriae Nishiyama et al., 2008 
  gss ns   -3.1 1.1 
Involved in spermidine 
metabolism 
Jelsbak et al., 2012; 
Chattopadhyay et al., 
2013 
  hcpA 1.3 0.4 ns   Fimbriae synthesis Hernandes et al., 2011 
  higA ns   -2.8 1.0 Antitoxin Wood & Wood, 2016 
  yefM ns   1.1 0.3 Antitoxin Cherny & Gazit, 2004 
Other 
  acs ns   -22.3 3.9 
Acetyl-coenzyme A 
synthetase Kumari et al., 2000 
  agP ns   1.0 0.2 Glucose-1-phosphatase Pradel & Boquet, 1989 
  bisC ns   -4.0 1.3 Biotin sulfoxide reductase 
Pierson & Campbell, 
1990 
  can ns   1.9 0.7 Carbonic anhydrase Merlin et al., 2003 
  carB 1.4 0.2 1.2 0.2 
Carbamoyl phosphate 
synthetase Nyunoya & Lusty, 1983 
  cysI ns   1.7 0.6 Sulfite reductase Ostrowski et al., 1989 
  dxs ns   4.0 0.9 
Involved in pyruvate 
degradation Handa et al., 2013 
  glnE 2.1 0.4 1.3 0.4 
Glutamine synthetase 
adenylyl-transferase Rhee et al., 1985 
  guaA -1.3 0.4 -1.4 0.4 
Guanosine monophosphate 
synthetase Tiedeman et al., 1985 
  idi 7.6 2.0 ns   
Isopentenyl disphosphate 
isomerase Hahn et al., 1999 
  livF 1.1 0.2 ns   
Involved in aromatic 
amino acid accumulation Koyanagi et al., 2004 
  lsrK -6.8 1.9 ns   
Transcriptional regulator 
involved in quorum 
sensing Xavier & Bassler, 2005 
  mscK 1.2 0.4 ns   
Mechanosensitive channel 
involved in ion regulation Li et al., 2002 
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Table 4-5 – Continued. 
Gene 
name 
Kp-125 2/0 Kp-125 4/0 
Associated function Reference 
log2 FC log2 FC 
Mean SD Mean SD 
Other (continued) 
  phnM 1.1 0.2 1.5 0.2 
Part of the Pho regulon, 
global regulation 
Jochimsen et al., 2011; 
Santos-Beneit, 2015 
  pta 1.1 0.4 1.1 0.4 
Phosphate acetyl-
transferase involved in 
acetate metabolism 
Castano-Cerezo et al., 
2009 
Unknown / putative 
  no name 3.7 1.2 ns   
Putative transposase for 
insertion sequence UniProt 
  ybgA -1.1 0.4 ns   Uncharacterized protein 
UniProt 
(YBGA_ECOLI) 
  ybhD ns   1.3 0.5 
Uncharacterized, putative 
transcriptional regulator 
Flores-Bautista et al., 
2018 
  yejM 4.9 1.3 4.5 1.3 
Inner membrane protein 
(unknown function) De Lay & Cronan, 2008 
  yhfK ns   4.2 1.5 Uncharacterized protein UniProt (YHFK_ECOLI) 
  yjiR 1.2 0.4 ns   
Uncharacterized, putative 
transcriptional regulator 
Flores-Bautista et al., 
2018 
  yusV -1.2 0.2 ns   
ATPase associated with 
iron transport (Bacillus 
spp.) Ollinger et al., 2006 
 
The results obtained for the differential expression analysis after re-exposure to either 
0 or 4 μg/mL CHX for Kp-125 are grouped in Table 4-6. Repeated exposure in R2A only 
(Kp-125 0PRE/0) seemed to have an impact on a wide range of biological functions, 
including increased expression of genes involved in cellular respiration and electron transfer, 
in DNA-related functions, and in iron transport, but not in efflux (no change in acrB 
expression, decreased expression for smvA). However, only two replicates were obtained for 
the second exposure to 0 μg/mL CHX (Kp-125 + 0PRE), which could bias the analysis. Few 
significant changes were observed when comparing the first and second exposure to 4 μg/mL 
CHX (Kp-125 4PRE/4), with the most pronounced being an increased expression of rlhA 
(log2 fold-change: 22.7), involved in translation, and acs (19.4), involved in the biosynthesis 
of acetyl coenzyme A. When compared to the first exposure, the second exposure to 4 μg/mL 
CHX resulted in less differentially expressed genes (based on a first or second 4 μg/mL CHX 
exposure versus 0 μg/mL CHX exposure differential expression analysis) but with similar 
effects, e.g. increased expression of respiration-associated genes and of smvA. The second 
exposure to 4 μg/mL CHX had an important impact on a wide range of cellular functions 
when compared to the second exposure to 0 μg/mL CHX (Kp-125 4PRE/0PRE): cellular 
respiration and electron transfer-related genes were found to be upregulated, as were efflux 
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and transport-related genes (including acrD, silA and smvA) except for iron transport, and 
genes encoding proteins involved in transcriptional, translational or post-translational 
modifications. Similarly to the differences observed after single exposure to both 0 or 
4 μg/mL CHX, chaperonin-encoding genes and several DNA-related genes were found to 
be downregulated (helicase, integrase, replication initiation, recombinase) while genes 
related to plasmid transfer and mismatch repair were upregulated. 
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Table 4-6. Differential expression analysis between before and after re-exposure to different CHX concentrations for Kp-125. 
Exposure of Kp-125 to either 0, 2 or 4 μg/mL CHX was performed in quadruplicate (n=4); re-exposure to 0 μg/mL was only obtained over two different 
experiments (n=4), while re-exposure to 4 μg/mL CHX was performed in quadruplicate (n=4). Differential expression analysis was performed by 
comparing Kp-125 before and after re-exposure to 0 μg/mL CHX (Kp-125 0PRE/0), before and after re-exposure to 4 μg/mL CHX (Kp-125 4PRE/4), 
and by comparing Kp-125 re-exposed to 4 μg/mL CHX with the control condition (one exposure to 0 μg/mL CHX; Kp-125 4PRE/0) and with re-exposure 
to 0 μg/mL CHX (Kp-125 4PRE/0PRE). Differential expression was expressed in log2 fold-change (FC). Only genes for which the differential expression 
was statistically significant (Benjamin-Hochberg adjusted p value; p<0.05) and with at least ± 1 log2 fold-change are presented in this table. Upregulated 
genes are highlighted in green, and downregulated genes in red. When numbers are indicated in brackets, it means several different sequences were 
identified as the same gene in the database. ns: not significant and/or with a log2 fold-change lower than ± 1. 
Gene name 
Kp-125 0PRE/0 Kp-125 4PRE/4 Kp-125 4PRE/0 Kp-125 4PRE/0PRE 
Associated function Reference 
log2 FC log2 FC log2 FC log2 FC 
Mean SD Mean SD Mean SD Mean SD 
Cellular respiration / electron transfer 
  fdnG ns   ns   1.2 0.3 1.4 0.4 Formate dehydrogenase 
Wang & Gunsalus, 
2003 
  hemA -1.1 0.3 ns   ns   1.2 0.3 Involved in heme synthesis 
Darie & Gunsalus, 
1994 
  narU ns   ns   ns   1.8 0.2 Nitrate/nitrite transporter 
Bueno et al., 2012 
  narV ns   ns   1.2 0.3 ns   Nitrate reducatse 
  narZ ns   ns   ns   1.9 0.6 Nitrate reductase 
  nfsB ns   ns   ns   1.3 0.3 Nitrate reductase Rau & Stolz, 2003 
  pntB -6.5 2.1 ns   ns   7.4 2.0 NAD(P) transhydrogenase Clarke et al., 1986 
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Table 4-6 – Continued. 
Gene name 
Kp-125 0PRE/0 Kp-125 4PRE/4 Kp-125 4PRE/0 Kp-125 4PRE/0PRE 
Associated function Reference 
log2 FC log2 FC log2 FC log2 FC 
Mean SD Mean SD Mean SD Mean SD 
Cell wall synthesis and/or maintenance 
  rfbD (1) ns   ns   ns   -6.6 2.3 Involved in O antigen 
synthesis Boels et al., 2004   rfbD (2) -2.6 0.5 ns   ns   3.4 0.5 
DNA modification and/or transfer 
  helD (1) ns   ns   ns   -2.5 0.9 
DNA helicase 
Mendonca et al., 
1993   helD (2) 1.2 0.2 ns   ns   -1.4 0.2 
  hupB -22.3 4.6 ns   ns   13.9 4.5 
Nucleoid-associated protein 
(DNA compaction) 
Holowka et al., 
2017 
  intB (1) 1.0 0.2 ns   ns   -1.7 0.2 
Integrase 
Hochhut et al., 
2006   intB (2) 1.2 0.2 ns   ns   -1.2 0.2 
  mobA ns   ns   ns   2.6 0.6 
Involved in plasmid 
transfer 
Henderson & 
Meyer, 1999 
  mukB ns   ns   ns   1.8 0.6 Chromosome partition Niki et al., 1992 
  mutS -6.5 1.4 ns   ns   7.8 1.4 Mismatch repair 
Acharya et al., 
2003 
  repA ns   ns   ns   -1.2 0.2 
Replication initiation 
protein 
Betteridge et al., 
2004e 
  tnpA 1.9 0.5 ns   ns   -2.1 0.5 Transposase 
Horak & Kivisaar, 
1998 
  traE ns   1.5 0.4 1.5 0.4 2.7 0.5 
Involved in F pilus 
formation (conjugation) 
Arutyunov et al., 
2010 
  xerC 1.1 0.3 ns   ns   -1.7 0.3 Recombinase Cornet et al., 1997  
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Table 4-6 – Continued. 
Gene name 
Kp-125 0PRE/0 Kp-125 4PRE/4 Kp-125 4PRE/0 Kp-125 4PRE/0PRE 
Associated function Reference 
log2 FC log2 FC log2 FC log2 FC 
Mean SD Mean SD Mean SD Mean SD 
Efflux and transport 
  acrB ns   ns   ns   1.2 0.2 
Multi-drug efflux pump, 
RND family Alav et al., 2018 
  appF (1) ns   1.0 0.2 1.1 0.2 1.4 0.2 Oligopeptides ABC 
transporter (Bacillus spp.) 
Koide & Hoch, 
1994   appF (2) -2.1 0.5 ns   1.4 0.4 3.5 0.4 
  citH ns   ns   ns   2.4 0.9 Citrate-proton symporter Pos et al., 1998 
  entE -21.4 4.3 ns   ns   20.6 4.1 Enterobactin synthesis (iron 
transport) 
Raymond et al., 
2003   entS 4.0 1.2 ns   ns   ns   
  fepC 1.8 0.4 ns   ns   -1.2 0.4 
Associated with iron 
transport 
Ozenberger et al., 
1987; Miethke & 
Marahiel, 2007; 
Grim et al., 2012   fes 2.0 0.7 ns   ns   ns   
  kdpA ns   ns   ns   2.2 0.6 
P-type ATPase, involved in 
cation transport (potassium) 
Sardesai & 
Gowrishankar, 
2001 
  pgtP ns   ns   ns   1.1 0.2 
Phosphoglycerate transport, 
MFS family 
Varadhachary & 
Maloney, 1991 
  rbtT (1) ns   ns   ns   1.6 0.3 Ribitol transporter, MFS 
family Pao et al., 1998   rbtT (2) -2.0 0.5 ns   ns   3.1 0.5 
  silA ns   ns   ns   6.2 2.4 
Silver efflux pump, RDN 
family 
Ortega Morente et 
al., 2013rt 
  smvA -1.3 0.4 ns   1.1 0.3 2.4 0.4 
Cationic compounds efflux 
pump, MFS family Villagra et al., 2008 
  trkA ns   ns   ns   2.3 0.7 
Involved in potassium 
uptake 
Bossemeyer et al., 
1989 
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Table 4-6 – Continued. 
Gene name 
Kp-125 0PRE/0 Kp-125 4PRE/4 Kp-125 4PRE/0 Kp-125 4PRE/0PRE 
Associated function Reference 
log2 FC log2 FC log2 FC log2 FC 
Mean SD Mean SD Mean SD Mean SD 
Stress response 
  adhP ns   ns   1.5 0.3 2.0 0.4 
Alcohol dehydrogenase 
linked to DNA damage 
Khil & Camerini-
Otero, 2002 
  otsA ns   ns   ns   1.2 0.2 
Involved in trehalose 
synthesis and 
osmoprotection Joseph et al., 2010 
Transcription, translation and post-translation modifications 
  cpdB ns   ns   ns   -1.1 0.3 
Involved in RNA 
degradation 
Lopez-Villamizar et 
al., 2016 
  cysS -1.9 0.5 ns   ns   ns   Cysteine-tRNA ligase Zhang et al., 2003 
  epmA ns   ns   ns   -1.3 0.3 
Translation elongation 
factor aminoacetylase Vivijs et al., 2016 
  groL (1) ns   ns   ns   2.0 0.6 
Chaperonin 
Goltermann et al., 
2015  
  groL (2) ns   ns   ns   2.3 0.7 
  groL (3) ns   ns   ns   2.7 0.7 
  ileS ns   ns   -4.2 1.2 ns   Isoleucine-tRNA ligase Chalker et al., 1994 
  lysS -1.8 0.2 ns   ns   1.8 0.2 Lysine-tRNA ligase 
Leveque et al., 
1990 
  rapA -1.6 0.5 ns   ns   2.7 0.5 
RNA polymerase-
associated protein 
Sukhodolets & Jin, 
1998  
  rlhA (1) ns   ns   1.0 0.2 1.0 0.2 
Modification of 23S rRNA Kimura et al., 2017   rlhA (2) ns   22.7 2.9 ns   ns   
  rlmM ns   ns   ns   -1.2 0.3 Modification of 23S rRNA Punekar et al., 2012 
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Table 4-6 – Continued. 
Gene name 
Kp-125 0PRE/0 Kp-125 4PRE/4 Kp-125 4PRE/0 Kp-125 4PRE/0PRE 
Associated function Reference 
log2 FC log2 FC log2 FC log2 FC 
Mean SD Mean SD Mean SD Mean SD 
Transcription, translation and post-translation modifications (continued) 
  rplA ns   ns   ns   -5.1 1.6 
50S ribosomal protein L1 
synthesis Fu et al., 2013 
  rpsT ns   ns   ns   -1.2 0.4 30S ribosomal subunit S20 
Celesnik et al., 
2007 
Virulence-associated 
  fimD 1.8 0.4 ns   ns   -1.9 0.4 
Involved in 
export/assembly of fimbriae 
Nishiyama et al., 
2008 
  prr ns   1.0 0.2 ns   ns   
Gamma-
aminobutyraldehyde 
dehydrogenase involved in 
putrescine degradation 
Schneider & 
Reitzer, 2012 
  virB4 ns   ns   ns   2.3 0.6 Type IV secretion system Durand et al., 2010 
Other 
  acs ns   19.4 3.9 ns   ns   
Acetyl-coenzyme A 
synthetase Kumari et al., 2000 
  adhE -1.4 0.4 ns   ns   1.2 0.3 
Aldehyde alcohol 
dehydrogenase 
Membrillo-
Hernandez et al., 
2000 
  amn ns   ns   ns   -1.1 0.1 
Adenosine monophosphate 
nucleosidase 
Morrison & Shain, 
2008 
  bcsE ns   ns       1.0 0.3 
Involved in cellulose 
synthesis Fang et al., 2014 
  bisC ns   ns   ns   -5.7 1.5 Biotin sulfoxide reductase 
Pierson & 
Campbell, 1990 
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Table 4-6 – Continued. 
Gene name 
Kp-125 0PRE/0 Kp-125 4PRE/4 Kp-125 4PRE/0 Kp-125 4PRE/0PRE 
Associated function Reference 
log2 FC log2 FC log2 FC log2 FC 
Mean SD Mean SD Mean SD Mean SD 
Other (continued) 
  budB ns   1.4 0.3 1.4 0.3 1.7 0.3 Acetolactate synthase 
Blomqvist et al., 
1993 
  can ns   ns   ns   3.6 1.1 Carbonic anhydrase Merlin et al., 2003 
  carB -1.3 0.2 ns   ns   1.2 0.2 
Carbamoyl phosphate 
synthetase 
Nyunoya & Lusty, 
1983 
  crnA ns   1.7 0.5 ns   1.4 0.5 Creatinine amidohydrolase Beuth et al., 2003  
  cynT ns   ns   ns   1.2 0.2 Carbonic anhydrase Merlin et al., 2003 
  cysI ns   -2.4 0.6 -2.1 0.6 ns   Sulfite reductase 
Ostrowski et al., 
1989 
  dcp -10.5 2.0 ns   ns   11.3 1.9 Carboxypeptidase Henrich et al., 1993 
  gabD 1.1 0.2 ns   ns   -1.1 0.2 
Succinic semialdehyde 
dehydrogenase 
Langendorf et al., 
2010 
  livF -1.1 0.3 ns   ns   ns   
Involved in aromatic amino 
acid accumulation 
Koyanagi et al., 
2004 
  lsrK 7.4 2.1 ns   ns   ns   
Transcriptional regulator 
involved in quorum sensing 
Xavier & Bassler, 
2005 
  metE -1.1 0.4 ns   ns   1.6 0.4 
Involved in methionine 
synthesis 
Weissbach & Brot, 
1991 
 mscK -1.6 0.5 ns   ns   1.3 0.5 
Mechanosensitive channel 
involved in ion regulation Li et al., 2002 
  mtfA ns   ns   ns   -1.1 0.2 
Glucose-related peptidase, 
involved in entry into 
stationary growth phase Gohler et al., 2012 
  pdeB ns   ns   ns   -1.2 0.3 Phosphodiesterase Chao et al., 2013 
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Table 4-6 – Continued. 
Gene name 
Kp-125 0PRE/0 Kp-125 4PRE/4 Kp-125 4PRE/0 Kp-125 4PRE/0PRE 
Associated function Reference 
log2 FC log2 FC log2 FC log2 FC 
Mean SD Mean SD Mean SD Mean SD 
Other (continued) 
  phnC ns   ns   ns   1.2 0.5 
Part of the Pho regulon, 
global regulation 
Jochimsen et al., 
2011; Santos-
Beneit, 2015 
  phnM -1.2 0.3 ns   ns   1.6 0.3 
  phnU ns   ns   ns   -2.0 0.6 
  pta -1.5 0.5 ns   ns   1.2 0.5 
Phosphate acetyl-
transferase involved in 
acetate metabolism 
Castano-Cerezo et 
al., 2009 
  sufB ns   ns   ns   1.0 0.3 
Involved in iron-sulfur 
cluster synthesis Yuda et al., 2017 
  tenA -1.2 0.4 ns   ns   1.4 0.4 
Involved in regulation of 
protease production 
(Bacillus spp.) Toms et al., 2005 
Unknown / putative 
  kpn78578 -19.6 4.9 ns   ns   21.1 4.7 Putative transport protein 
UniProt 
(Y4047_KLEP7) 
  ybhD ns   ns   1.5 0.4 1.8 0.5 
Uncharacterized, putative 
transcriptional regulator 
Flores-Bautista et 
al., 2018 
  ybjX ns   1.3 0.2 ns   ns   Uncharacterized protein 
UniPrit 
(YBJX_ECOLI) 
  ydcI ns   ns   1.1 0.3 1.0 0.3 
Uncharacterized, putative 
transcriptional regulator 
Solomon et al., 
2014 
  yddG ns   1.1 0.2 ns   ns   
Uncharacterized protein, 
putative drug/metabolite 
transporter 
Santiviago et al., 
2002 
  yddH ns   1.0 0.3 1.2 0.3 1.3 0.3 Uncharacterized protein 
UniProt 
(YDDH_ECOLI) 
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Table 4-6 – Continued. 
Gene name 
Kp-125 0PRE/0 Kp-125 4PRE/4 Kp-125 4PRE/0 Kp-125 4PRE/0PRE 
Associated function Reference 
log2 FC log2 FC log2 FC log2 FC 
Mean SD Mean SD Mean SD Mean SD 
Unknown / putative (continued) 
  yejM -7.4 1.8 ns   ns   6.8 1.8 
Inner membrane protein 
(unknown function) 
De Lay & Cronan, 
2008 
  yjiR ns   ns   ns   -2.3 0.7 
Uncharacterized, putative 
transcriptional regulator 
Flores-Bautista et 
al., 2018 
  yncG ns   ns   ns   1.1 0.3 Uncharacterized protein 
UniProt 
(YNCG_ECOLI) 
  yxjC ns   1.2 0.3 ns   ns   
Uncharacterized, putative 
transporter (Bacillus spp.) 
UniProt 
(YXJC_BACSU) 
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The comparison between the differential expression profiles obtained for both Kp-1 
and Kp-125 following a single exposure to either 2 or 4 μg/mL CHX when compared to the 
control condition (R2A only, 0 μg/mL CHX) is presented in Figure 4-8. Although a majority 
of the genes of which the expression was altered is present only in one isolate, some were 
consistently up- or down-regulated consistently across both isolates. Among them, efflux-
related genes, such as acrD and smvA, were found to be upregulated, as well as phnM, a part 
of the Pho regulon. The expression of two genes associated with DNA modification, dnaE 
(DNA polymerase) and gyrA (DNA gyrase), was downregulated following CHX exposure 
in both isolates, as well as rlhA (modification of 23S rRNA) and fimD (export and assembly 
of fimbriae). A gene encoding an uncharacterized protein, ybgA, was found to be upregulated 
following CHX exposure in Kp-1 but downregulated in Kp-125. 
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Figure 4-8. Differential expression patterns following a single exposure to either 2 or 
4 μg/mL CHX compared to R2A only obtained for both Kp-1 and Kp-125. 
Exposure to either 0 (R2A only), 2 or 4 μg/mL CHX was performed at least in triplicate for 
both isolates. Only genes for which the differential expression was statistically significant 
(Benjamin-Hochberg adjusted p value; p<0.05) and with at least ± 1 log2 fold-change are 
considered for this diagram. The number of up- or down-regulated genes for each strain is 
indicated in the corresponding section, with the associated percentage of the total amount of 
genes for which the expression was altered indicated in brackets. 
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4.4 Discussion 
Exposure to sub-inhibitory concentrations of CHX did not result in reduced 
susceptibility to either CHX, BZC or different antibiotics including carbapenems, 
cephalosporins, ATM, aminoglycosides, TIG and COL. However, for most antibiotics 
(ATM, CIP, CAZ, FOX, AK and CN for Kp-1; MEM, ETP, ATM, CIP, CAZ and FOX for 
Kp-125), susceptibility testing was performed using the disc diffusion method, and the 
inhibition diameters measured before exposure already corresponded to the lowest 
measurable value (6 mm, corresponding to the disc diameters). As a consequence, it was not 
always possible to assess a potential reduced susceptibility for these antibiotics after 
exposure to CHX, which could have biased our observations. Moreover, although the disc 
diffusion method has advantages, such as a reduced cost and an easy implementation, 
especially for multiple drug testing as performed in this studies, its results are qualitative 
(i.e. resistant, intermediate, susceptible), as opposed to quantitative results obtained with 
broth dilution methods, i.e. MIC values (Dickert et al., 1987; Reller et al., 2009). Indeed, it 
seems difficult to establish correlations between inhibition zone diameters and MICs 
(Dickert et al., 1987; Humphries et al., 2018); therefore, changes in inhibition diameters 
might not indicate a change in MIC, but would be able to show a switch in susceptibility 
category, e.g. from susceptible to resistant (Reller et al., 2009; Humphries et al., 2018). 
Regarding colistin, exposure to stepwise increasing CHX concentrations has been reported 
to lead to reduced susceptibility to COL (which was not observed in this study) but without 
any impact on BZC or other antibiotic MICs in K. pneumoniae isolates, and thought to be 
linked to an enhanced efflux or mutations in specific genes related to colistin resistance 
(Wand et al., 2017; Hashemi et al., 2019; Zhang et al., 2019). Such differences in the results 
obtained could however be linked to the exposure method used, i.e. a single exposure to MIC 
concentrations corresponding to half the organism’s MIC in this study versus an adaptation 
to stepwise increasing CHX concentrations reaching up to 32-fold of the organism’ original 
MIC in the above-mentioned publications. No change in antibiotic susceptibility profile was 
observed after long-term exposure to BZC in Klebsiella michiganensis (Kim et al., 2018b). 
Regarding virulence, exposure to CHX did not seem to have an effect on the 
pathogenesis of Kp-1, but virulence increased with increasing CHX concentrations for 
Kp-125. However, re-exposure to 4 μg/mL resulted in a decreased virulence when compared 
to the first exposure. Virulence has previously been reported to be reduced after prolonged 
exposure to increasing CHX concentrations in K. pneumoniae (Wand et al., 2017). In E. coli, 
a prolonged exposure to BZC also led to a decrease in virulence using the G. mellonella 
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model (Henly et al., 2019). Exposure to octenidine, a compound related to CHX, did not 
result in an increased virulence in P. aeruginosa either (Shepherd et al., 2018). Kp-1 was 
found to be more virulent than Kp-125, despite belonging to a ST less widespread than the 
‘high-risk’ ST258 of which Kp-125 is part of. This seemed however to be in accordance 
with the literature, where virulence in ST258 K. pneumoniae isolates is described as isolate-
dependant but not more important than in other STs (Mathers et al., 2015). 
Both isolates possessed several large plasmids. K. pneumoniae isolates belonging to 
ST258 appear to possess a pKpQIL-like plasmid of approximatively 113 kb, carrying the 
blaKPC gene, and the presence of these plasmids seemed to be related to the ability of these 
isolates to persist and spread in the environment (Mathers et al., 2015). A plasmid of 
approximately 97 kb was detected for Kp-125 by S1 digestion followed by PFGE, which 
could be compatible with the presence of a pKpQIL-like plasmid. Unfortunately, the WGS 
data did not enable the construction of closed sequences corresponding to either the 
chromosome or the plasmids present within Kp-1 or Kp-125, with a coverage of less than 
10 % when compared to the published sequence of the chromosome of a K. pneumoniae 
ST258 isolate (GenBank access number: LAKK01000012.1). 
We chose to perform a single exposure to CHX (with one repeated exposure for 
Kp-125 without increasing the CHX concentration), while most of the studies mentioned in 
the following paragraphs based their observations following long-term and/or adaptation 
with increasing concentrations of biocides, which might not reflect real conditions (Soumet 
et al., 2012). This difference in exposure protocol could explain some of the discrepancies 
between the literature and the work performed in this study. Repeated exposure in R2A only 
had a significant impact on various biological functions for Kp-125, including an overall 
downregulation of genes involved in cellular respiration and electron transfer, which was 
not consistent with previous findings reporting increased expression of genes related to these 
functions in E. coli (Forbes et al., 2019). No change in the expression of efflux-related 
(except a decreased expression in smvA) was observed after re-exposure to 0 μg/mL CHX. 
Only two replicates were obtained for this condition (Kp-125+0PRE), which could bias the 
analysis. 
The expression of groL, encoding a chaperonin, was found to be upregulated 
following CHX exposure. Chaperones interact with proteins at a post-translational level to 
ensure their correct folding. Overexpression of chaperone-encoding genes, especially groL, 
has been previously shown to result in reduced susceptibility to aminoglycosides, as these 
antibiotics are known to promote translational misreading (Goltermann et al., 2015). 
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Association between upregulation of groL and reduced susceptibility to aminoglycosides 
was however not observed in this study. Overproduction of chaperones was also found to be 
related to stress response following exposure to increasing concentrations of CHX in 
P. aeruginosa (Hashemi et al., 2019). Similarly, the expression of gyrA, encoding a DNA 
gyrase, was found to be downregulated following CHX exposure. Quinolones target the 
DNA gyrase to exert their antimicrobial activity, and mutations in gyrA or gyrB have been 
previously reported to impair the effects of these antibiotics (Mc Cay et al., 2010; 
Pourahmad Jaktaji & Mohiti, 2010; Sanchez-Cespedes et al., 2015). However, changes in 
CIP susceptibility following CHX exposure could not be assessed as both isolates showed 
important resistance to this antibiotic already. Regarding resistance to β-lactams, no 
significant change in expression was observed neither for blaNMD-1 (Kp-1) nor blaKPC-2 (Kp-
125); ampC was found to be downregulated in Kp-1 only after exposure to 4 μg/mL CHX. 
No changes in susceptibility profiles to carbapenems, cephalosporins or ATM were observed 
after CHX exposure, but both isolates already harboured important levels of resistance 
towards these antibiotics. For polymyxins (including colistin, polymyxin E), increased MICs 
have been reported following exposure to CHX or BZC, but were mainly linked to mutations 
in pmrB, ultimately resulting in a decrease of the net negative charges of the outer membrane, 
decreasing the affinity of these antibiotics (Wand et al., 2017; Kim et al., 2018b). Neither 
increase in colistin MIC nor decrease or change in pmrB expression was observed in this 
study. 
For both isolates, exposure to sub-inhibitory concentrations of CHX (especially 
4 μg/mL, corresponding to half their MIC) led to an increased expression of efflux systems, 
including acrB or acrD, emrD (Kp-125 exposed to 2 μg/mL CHX only), mdtB, mdtM, smvA 
and, to some extent, silA (Kp-125 after second exposure to 4 μg/mL CHX only). No 
statistically significant difference in the expression of qac genes (linked to QAC efflux; 
Abuzaid et al., 2012), or the cus efflux system (extruding copper and silver; Ortega Morente 
et al., 2013) was detected. AcrB, AcrD and MdtB are part of the RDN efflux pump family, 
with AcrB and MdtB involved in efflux of a wide range of antimicrobial compounds, and 
AcrD harbouring a narrower spectrum, mainly restricted to aminoglycosides (Anes et al., 
2015). EmrD and SmvA are part of the MFS efflux pump family and have been reported to 
expel amphipathic compounds for EmrD and cationic compounds (including CHX, 
octenidine, some QACs) among several bacterial species such as K. pneumoniae or 
P. mirabilis for SmvA (Yin et al., 2006; Pelling et al., 2019; Wand et al., 2019). MdtM, 
another member of the MFS family, is thought to be involved in pH regulation and extrusion 
of bile salts (Holdsworth & Law, 2012; Li et al., 2015). SilA, another member of the RND 
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family, has been reported to mediate efflux of silver ions in Gram-negative bacteria (Ortega 
Morente et al., 2013). Similarly to this work, upregulation of the expression of smvA linked 
to the loss of its repressor SmvR (Wand et al., 2017; Wand et al., 2019), or cepA (Zhang et 
al., 2019) following exposure to increasing CHX concentrations in K. pneumoniae has been 
previously reported, and in P. mirabilis as well for smvA (Pelling et al., 2019). Regarding 
smvA, in the highlighted studies, overexpression of smvA was directly linked to increased 
CHX MICs in the Gram-negative organisms investigated. Exposure to increasing 
concentrations of BZC has also been reported to increase the expression of acrB and acrF 
in triclosan-resistant K. pneumoniae (Gadea et al., 2017a), as well as in E. coli with 
increased expression of acrA, acrB and tolC (Bore et al., 2007; Moen et al., 2012) and 
mdtED, mdtNOP and mdtM (Forbes et al., 2019). The expression of mexA or mexB (but not 
smvA), part of the RND efflux pump family, was upregulated in P. aeruginosa following 
adaptation to CHX or BZC (Mc Cay et al., 2010; Kim et al., 2018a; Hashemi et al., 2019). 
The equivalent efflux system in Acinetobacter baumannii, adeABC, thought to be related to 
CHX efflux, was also found to be upregulated following CHX exposure in this species 
(Hassan et al., 2013). Interestingly, increased expression of efflux pump-encoding genes was 
not linked to a reduced susceptibility to CHX, BZC or any of the investigated antibiotics in 
this work, as opposed to the above-mentioned studies. 
No change in expression of outer membrane protein-encoding genes was detected in 
this study, while this phenomenon has been reported following exposure to BZC or CHX in 
several Gram-negative bacteria (Bore et al., 2007; Forbes et al., 2019). However, a decreased 
expression of asmA, of which the corresponding protein is known to be involved in the 
prevention of misfolding of outer membrane protein mutants (Prieto et al., 2009), was 
observed. 
The expression of global regulators, including the mar operon involved in multi-drug 
resistance or soxRS involved in stress response (Duval & Lister, 2013), was not impacted by 
exposure to sub-inhibitory concentrations of CHX. These findings were similar to another 
study performed in E. coli after long-term exposure to low (0.0002 to 0.002 % of their MIC) 
BZC concentrations (Forbes et al., 2019). On the contrary, other reports measured an 
increase in the expression of the global regulators following exposure to increasing 
concentrations of antimicrobials (Bore et al., 2007; Buffet-Bataillon et al., 2012a; Curiao et 
al., 2015). 
Regarding virulence-related genes, expression of fimD, involved in fimbriae 
assembly and export (Nishiyama et al., 2008), was found to be downregulated following 
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CHX exposure, while enhanced expression of motility-related genes after long-term 
exposure to BZC has been previously reported in E. coli (Forbes et al., 2019). Fimbriae have 
been shown to be linked to virulence and pathogenicity especially through enhanced 
adhesion (Jonson et al., 2005). Putrescine and spermidine, two polyamines involved in the 
stabilisation of the outer membrane, have been linked to virulence in Enterobacteriaceae 
(Jelsbak et al., 2012). Genes related to putrescine degradation (pub and prr) were found to 
be upregulated, and gss, involved in spermidine metabolism, was downregulated following 
CHX exposure. These findings disagreed with an increase of spermidine biosynthesis 
observed in P. aeruginosa following long-term exposure to BZC (Kim et al., 2018a). After 
second exposure to 4 μg/mL CHX only, virB4, encoding a type IV secretion system, known 
to be involved in virulence (Voth et al., 2012), was found to be upregulated when compared 
to its expression following to second exposure to R2A only (0 μg/mL CHX). The overall 
response following CHX exposure suggested either an unchanged or a decreased virulence 
for both isolates. This was in accordance with the results observed when performing the 
virulence assay using G. mellonella larvae. 
Overall, even though some changes were observed at the molecular level with the 
RNA-sequencing data, this did not have an impact on the phenotypical level, i.e. no changes 
in antimicrobial susceptibility or virulence were obtained. It seems important to highlight 
the fact that increased expression, i.e. increased amount of mRNA obtained for a given gene, 
does not correlate with an increase in the corresponding protein production (Picard et al., 
2012; Pelling et al., 2019). Indeed, several regulation levels are present between both stages, 
including post-transcriptional regulation with mRNA degradation, small RNAs or RNA-
binding proteins, among others (Arraiano, 1993; Van Assche et al., 2015); translational 
regulation with for example differences in ribosome occupancy and density observed across 
a global mRNA population (Picard et al., 2012); and post-translational regulation, e.g. 
protein phosphorylation (Grangeasse et al., 2015; Macek et al., 2019). It is then possible to 
hypothesize that the alterations in gene expression observed in this study did not result in an 
increased or decreased production of the corresponding proteins, which could explain the 
absence of phenotypical changes for both investigated isolates. Complementary assays 
would have been necessary to understand better the role and involvement of the key genes 
identified by RNA-sequencing in response to CHX exposure, in order to obtain overlapping 
information between the different datasets (Bore et al., 2007; Forbes et al., 2019). Among 
them, quantitative real-time PCR, targeting a smaller amount of genes but less time-
consuming and more sensitive than RNA-sequencing, can be used in order to confirm the 
observations made previously (Bore et al., 2007; Costa et al., 2013); inactivation of some of 
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these genes by generation of deletion mutants could be of interest in order to assess their 
direct impact on MIC for example, as performed by Wand and colleagues for smvA and smvR 
(Wand et al., 2019); proteomic approaches, where changes in the protein profiles following 
antimicrobial exposure can be assessed, would be able to provide the missing link between 
alterations in the transcriptome and the observed phenotype (Bore et al., 2007; Hashemi et 
al., 2019). 
4.5 Conclusion 
In conclusion, exposure to sub-inhibitory concentrations of CHX led to an altered 
expression profile of several genes, including the efflux pump-encoding genes acrB and 
acrD involved in antibiotic resistance, and smvA, involved in CHX efflux, which were found 
to be upregulated following a single CHX exposure. However, the effects observed at the 
molecular level did not engender phenotypical changes, i.e. decreased susceptibility to other 
antimicrobials or increased virulence. 
  
Hélène Hérault Cardiff University 2019 
Page 166 
  
Impact of commonly used antimicrobial biocides on resistance and cross-resistance in 
carbapenemase-producing Enterobacteriaceae 
Page 167 
Chapter 5. General discussion 
Susceptibility profiles to biocides and antibiotics have been established for 210 
carbapenemase-producing E. coli and K. pneumoniae clinical isolates in this study. Thanks 
to standard protocols and available breakpoints for antibiotic susceptibility testing 
(following BSAC’s recommendations in this study: Andrews, 2001; BSAC, 2015), it was 
possible to categorise these isolates as multi-drug resistant. However, such established 
guidelines do not exist for biocides making it difficult to compare MICs with the literature. 
Indeed, MIC values can be impacted by a wide range of factors, including the method (agar 
dilution, broth macro- or micro-dilution protocol), the media and its composition in nutrients 
and especially cations (e.g. CAMHB is recommended for antibiotic susceptibility testing 
using broth microdilution protocol by EUCAST and CLSI, and contains increased 
concentrations of Ca2+ and Mg2+; CLSI, 2012; EUCAST, 2019c), and, for broth 
microdilution, the material the microtitre plates are made of and the nature (if any) of the 
coating (Maillard et al., 2013; Wessels & Ingmer, 2013; Bock et al., 2018). The MIC values 
obtained within this study were within the same order of magnitude as MICs described in 
the literature for these organisms while being on the lower side of the range (see Table 2-10 
page 51 and Table 2-11 page 53), except for CS where MICs measured in this study were 
found to be up to 1,500 times lower than the ones reported in E.coli (lowest CS MIC 
measured in this study: 7.8 μg/mL; highest CS MIC reported in Table 2-11: 12,500 μg/mL 
by Biagi et al., 2014). The broth used in our study, R2A, contains less nutrients (including 
Ca2+ and Mg2+) than the CAMHB used by Biagi and colleagues, which could partly explain 
the differences observed. 
For BZC, CHX and CS, K. pneumoniae isolates seemed to harbour higher MIC 
values than E. coli isolates, which was consistent with previous reports (Koljalg et al., 2002; 
Guet-Revillet et al., 2012). It has been previously highlighted that E. coli might lack the gene 
smvA, encoding an efflux pump of particular importance in K. pneumoniae and involved in 
extrusion of cationic compounds, including CHX (Wand et al., 2019). In this study, exposure 
to sub-inhibitory concentrations of CHX for two K. pneumoniae also led to an upregulation 
of smvA, which could play a role in the difference observed in CHX susceptibility between 
K. pneumoniae and E. coli. 
For each biocide, the MIC distribution of both K. pneumoniae and E. coli isolates 
was not affected by the type of carbapenemase (NDM, VIM, OXA-48-like or KPC) 
produced, which disagreed with a previous study where differences in MICs were linked to 
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the ESBLs produced in E. coli (Deus et al., 2017). When Spearman’s correlations were 
determined, different correlations between antibiotic and biocide MICs were obtained 
according to the type of carbapenemase produced in this study, especially for K. pneumoniae 
where most correlations were obtained for VIM- and OXA-48-like-producers. Following 
exposure to sub-inhibitory concentrations of CHX, however, no differences in antimicrobial 
susceptibility profiles were observed for neither Kp-1 (NDM-producer) nor Kp-125 (KPC-
producer). Moreover, no significant difference in the expression of blaNDM-1 (Kp-1) or 
blaKPC-2 (Kp-125) was observed following exposure to CHX. Overall, we did not observe 
different effects according to the type of carbapenemase produced in the K. pneumoniae and 
E. coli populations studied. 
The correlation study performed in this work unveiled links between susceptibility 
to CHX and different antibiotics (amikacin, aztreonam, ciprofloxacin, tigecycline, 
minocycline) especially when considering the overall K. pneumoniae isolates. We 
formulated the hypothesis of a possible involvement of efflux pumps, a cross-resistance 
mechanism, especially as efflux has been previously described to be involved in reduced 
susceptibility to ciprofloxacin and tetracyclines (Ball et al., 1980; Poole, 2007). Another 
cross-resistance mechanism especially described when cationic compounds like 
polymyxins, CHX and BZC are involved, is a reduced membrane permeability (Kim et al., 
2018b; Hashemi et al., 2019). Addition of CCCP, acting as an efflux pump inhibitor through 
disruption of the associated proton-motive force (Marquez, 2005; Alav et al., 2018), reduced 
significantly the CHX MIC for most isolates, which was in accordance with previous reports 
(Abuzaid et al., 2012; Wand et al., 2017). On the other hand, addition of EDTA, known to 
disturb the membrane and enhance permeability (Pelletier et al., 1994; Sawer et al., 1997), 
did not potentiate the activity of CHX at the tested concentration in this collection of isolates, 
as previously observed (Russell, 1986). Together, these results seemed to favour the 
hypothesis of the involvement of efflux pumps rather than altered membrane permeability 
as a common resistance able to counteract the effects of CHX and several unrelated 
antibiotics in CPE. Growth pattern analysis revealed a significant increase in lag phase 
duration for K. pneumoniae isolates when growing in R2A containing a CHX concentration 
corresponding to half their MIC. An extended lag phase has been previously reported in both 
E. coli and K. pneumoniae following exposure to sub-inhibitory concentrations of triclosan 
and associated with an unknown mechanism involving a high fitness cost (Curiao et al., 
2015). Similar observations have been made in P. aeruginosa following long-term exposure 
to BZC, where changes in growth patterns were associated with a general decrease in global 
metabolism (Kim et al., 2018a). Efflux pumps have been shown to be associated with an 
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important fitness cost in bacteria, rendering them unlikely to be selected at very low 
antimicrobial concentrations (Andersson & Hughes, 2012). Transcriptomic analysis 
following exposure to sub-inhibitory concentrations of CHX in two K. pneumoniae isolates 
indicated a global upregulation of genes involved in antimicrobial efflux, including acrB 
involved in the extrusion of various antibiotics and biocides and acrD, expelling mainly 
aminoglycosides (Anes et al., 2015), and smvA, described as a cationic compounds efflux 
pump especially relevant for extrusion of CHX in K. pneumoniae (Wand et al., 2019). On 
the other hand, contradicting expression profiles were observed for genes involved in cell 
wall synthesis and maintenance, sometimes being up- or down-regulated following CHX 
exposure. While it was not possible to draw conclusions regarding the involvement of altered 
membrane permeability as a common resistance mechanism between antibiotics and CHX, 
this work showed that upregulation of efflux pump-encoding genes was part of the response 
observed following CHX exposure in CPE. However, it seems of importance to highlight 
the fact that a cooperation between altered permeability and increased influx is possible and 
act synergistically to confer a reduced susceptibility to some antimicrobials; in 
K. pneumoniae, but also in P. mirabilis, an increased expression of smvA was observed 
following CHX exposure, as well as changes in the LPS structure, reducing the negative net 
charges on the membrane and consequently decreasing the affinity of CHX, a cationic 
biocide, for it (Pelling et al., 2019; Wand et al., 2019). 
We chose to investigate the effects of exposure to CHX concentrations corresponding 
to half or a quarter of the organism’s MIC. Indeed, these were the concentrations at which 
most effects were observed on growth rates and lag phase durations at the time of the design 
of the following set of experiments (i.e. evaluation of the phenotypical and molecular effects 
following exposure to sub-inhibitory concentrations of CHX). These concentrations were 
within the ‘traditional selective window’ as defined by Gullberg and colleagues, i.e. between 
the MIC measured for the isolate harbouring reduced susceptibility (upper limit) and the one 
measured for the reference, susceptible strain (lower limit), as opposed to the ‘sub-MIC 
selective window’ corresponding to lower concentrations comprised between the MIC of the 
reference strain (upper limit) and the concentration up to which the reference strain is able 
to outcompete the growth of the less susceptible strain (lower limit, corresponding to the 
MSC), as shown in Figure 3-8 page 111 (Gullberg et al., 2011). In our study, MSCs could 
only be defined for a minority of K. pneumoniae isolates (and corresponded to 2 μg/mL CHX 
in these cases), and CHX MICs measured for the clinical isolates and the K. pneumoniae 
ATCC 13883 reference strain were within the same magnitude order (CHX MICs ranged 
from 2-16 μg/mL for the clinical isolates, and CHX MIC measured for the reference strain 
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ranged from 1-2 μg/mL). It has however been shown that long-term exposure to 
concentrations as little as ones corresponding to 0.0002 and 0.002 % of the organism’ BZC 
MIC was enough to alter the transcriptomic profile in E. coli, including for the upregulation 
of efflux-related genes (Forbes et al., 2019). Moreover, we investigated the effects following 
a single (or once repeated for Kp-125) exposure to CHX. While adaptation protocols 
involving exposure to increasing concentrations of antimicrobials are widely described 
(Wand et al., 2017; Henly et al., 2019; Zhang et al., 2019), they might not specifically reflect 
real conditions of exposure e.g. in the healthcare environment (Soumet et al., 2012; Forbes 
et al., 2019). However, the increased effects observed in these studies compared to the 
present work could potentially be linked to the discrepancies in the protocols followed 
(adaptation to increasing concentrations of antimicrobials over a long period of time versus 
single to dual exposure to constant CHX concentration in this study). 
Mechanisms leading to reduced susceptibility to antimicrobials can appear through 
mutations but also resistance determinant acquisition, including by HGT (Tezel & 
Pavlostathis, 2015). HGT can occur through three different events: transformation, 
corresponding to the ability of bacteria to acquire naked DNA from the environment; 
transduction, corresponding of the transfer of genetic material between two bacterial cells 
through a bacteriophage; conjugation, corresponding to an exchange of DNA (e.g. plasmids) 
mediated by cell-to-cell contact via a pilus produced by the donor bacteria (Blakely, 2015; 
Sun, 2018). No measurement of plasmid transfer rates was performed in our study. Indeed, 
both Kp-1 and Kp-125 possessed several, large plasmids of unknown sequences, and both 
harboured resistant phenotypes towards a wide range of antibiotics, limiting the possibilities 
for antibiotic selection following conjugation. The results obtained from the RNA 
sequencing seemed contradictory regarding horizontal gene transfer. No significant changes 
were observed in the expression of genes involved in plasmid transfer for Kp-1. However, 
for Kp-125, after exposure to 4 μg/mL CHX, traH, involved in the formation of a 
conjugative pilus (Arutyunov et al., 2010), was found to be upregulated, as well as mobA, 
involved in plasmid transfer during conjugation (Henderson & Meyer, 1999). On the other 
hand, intB, and xerC, two recombinases involved in site-specific recombination, and recC, 
involved in homologous recombination (Myers & Stahl, 1994; Cornet et al., 1997; Hochhut 
et al., 2006; Blakely, 2015), were downregulated following CHX exposure. These 
conflicting results did not enable us to identify a trend regarding altered conjugation rates 
following exposure to sub-inhibitory concentrations of CHX in K. pneumoniae; 
phenotypical assessment of the impact of exposure to sub-inhibitory concentrations of CHX 
on HGT would have been necessary to conclude. Indeed, Jutkina and colleagues reported an 
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increase in bacterial conjugation rates following exposure to tetracycline concentrations 
equivalent to 1/150 of the micro-organism’s MIC (Jutkina et al., 2016) and to triclosan (a 
widely used biocide) and CHX concentrations equivalent to 1/20 and 1/200 of the micro-
organism’s MIC, respectively (Jutkina et al., 2018), using an E. coli recipient strain. These 
findings highlighted the risk of transmission of resistance determinants between bacteria 
under selective pressure applied by both antibiotics and biocides, which could enhance the 
spread of multi-drug resistant bacteria, especially within healthcare settings. 
In this study, we investigated the effects of exposure to CHX in planktonic bacteria. 
Biofilms, corresponding to bacterial communities attached onto a surface and living within 
an extracellular matrix (containing a wide range of substances including lipids, 
polysaccharides, proteins) represent however the prevailing lifestyle for bacteria (Lindsay & 
von Holy, 2006; Hobley et al., 2015). Biofilm formation follows the attachment and 
multiplication of bacterial cells onto a surface, and is especially relevant in healthcare 
settings (Donlan, 2001; Lindsay & von Holy, 2006). Indeed, biofilms have been previously 
associated with medical devices such as endoscopes and protheses (Donlan, 2001; Vickery 
et al., 2013), but also with hospital surfaces as ‘dry surface biofilms’ where they may be 
involved in healthcare-associated infections (Ledwoch et al., 2018). Bacteria living within 
biofilms have been shown to be less susceptible to antimicrobials through several 
mechanisms, including protection from the extracellular matrix, acting as a barrier and 
impacting the penetration and/or stability of the antimicrobial agent, a reduced growth rate, 
especially for bacteria at the bottom of the biofilm structure (linked to a gradient in oxygen 
and nutrients from the surface to the bottom of the structure), impairing the effects of 
antimicrobials acting on active metabolism and/or cell division, and enhanced exchanges of 
DNA molecules including plasmids containing resistance determinants between the different 
bacteria present within the biofilm (Donlan, 2001; Lindsay & von Holy, 2006; Bridier et al., 
2011; Stewart, 2015). An enhanced biofilm formation has been reported following exposure 
to CHX in K. pneumoniae (Forbes et al., 2014) and after adaptation to BZC in E. coli (Henly 
et al., 2019). The effects of low concentrations on biocides on biofilm formation and 
bacterial communities living within should consequently not be overlooked. 
Overall, biocide MICs measured in this study were much lower than in-use 
concentrations found in commercial products, as highlighted in Table 2-3 (page 25). 
Moreover, exposure to sub-inhibitory concentrations of CHX did not result in an increase in 
MIC for neither CHX nor BZC, both cationic compounds, despite an upregulation of the 
expression of smvA following exposure (8- to 11-fold change when compared to growth in 
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R2A only). On the contrary, following adaptation from 4 to 128 μg/mL CHX, the expression 
of smvA has been shown to be upregulated at up to 70-fold in K. pneumoniae, highlighting 
its role in bacterial survival in the presence of this biocide (Wand et al., 2019). The difference 
in the magnitude of the upregulation observed could maybe be linked to the protocol 
(adaptation versus single exposure), as highlighted in a previous paragraph. Exposure to sub-
inhibitory concentrations of CHX did not result in reduced susceptibility to antibiotics in this 
study. Although it was not possible to evaluate changes in susceptibility profiles for some 
antibiotics including ciprofloxacin due to high level of resistance towards these compounds 
before exposure; including other isolates harbouring lower antibiotic MICs in the study 
would have helped identifying a general trend in antibiotic susceptibility profile following 
CHX exposure. Moreover, for all the tested antibiotics but tigecycline and colistin, the disc 
diffusion method was used for its easiness to implement when investigating several 
antibiotics but few isolates; this technique only provides quantitative results which do not 
correlate with MIC values obtained with broth dilution protocol (Dickert et al., 1987; Reller 
et al., 2009; Humphries et al., 2018). In several studies however, a reduced susceptibility to 
colistin especially was observed following CHX exposure in K. pneumoniae (Wand et al., 
2017; Hashemi et al., 2019; Zhang et al., 2019). The increased expression of efflux-related 
genes observed at the molecular level, including acrB and acrD involved in antibiotic efflux, 
did not translate at the phenotypic level in our study, as similarly observed in E. coli exposed 
to low concentrations of BZC (Forbes et al., 2019). However, it seems important to keep in 
mind that alterations in gene expression profiles, i.e. changes in the corresponding amount 
of mRNA, does not always correlate with changes in protein production, as several levels of 
regulations are involved between mRNA synthesis and the production of the corresponding 
functional protein (Picard et al., 2012; Pelling et al., 2019). Moreover, pathogenicity, 
although increased following the first exposure to CHX in Kp-125, was found to be 
decreased following the second exposure, and virulence in Kp-1 was not affected by 
exposure to CHX. Taken together, these results would suggest that, despite adaptation to 
CHX seemed to be ongoing at the transcriptomic level, phenotypical changes, if any, were 
not clinically relevant, i.e. did not affect susceptibility nor pathogenicity and, consequently, 
possibilities of treatment of infection due to these organisms. The clinical relevance of 
common mechanisms between reduced susceptibility to biocides and antibiotics has been 
widely discussed within the scientific community and does not seem to reach a consensus 
(Maillard et al., 2013; Oggioni et al., 2013; Harbarth et al., 2014; Kampf, 2016; Kampf, 
2019). In the absence of a standardised method to assess susceptibility to biocides and their 
potential impact on co-selection (co-resistance, cross-resistance, co-regulation) mechanisms 
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(SCENIHR, 2009; SCENIHR, 2010), precaution principles should be applied to limit the 
current overuse and misuse of biocides. 
Taking this work forward, making a parallel between planktonic-growing and 
biofilm-growing bacteria might have been of relevance, as biofilms represent the 
predominant form of bacterial life, as highlighted earlier. The determination of minimum 
biofilm eradication concentrations (MBEC; Maillard et al., 2013) and the assessment of 
changes in MBECs following antimicrobial exposure could have brought insight in that 
regard (Henly et al., 2019). Moreover, after establishing baseline susceptibility data for the 
210 isolates, we chose to pursue further experimental work with CHX only; despite its 
clinical relevance and the fact that most correlations between biocide and antibiotic MICs 
were obtained with CHX, BZC was also a good candidate. Several studies have reported 
changes in transcriptomic profiles and/or antibiotic susceptibility profiles following BZC 
exposure (Kim et al., 2018a; Forbes et al., 2019; Henly et al., 2019); therefore, including 
BZC in our study might have added additional information to the current knowledge. 
Regarding our transcriptomic data, confirmation of the changes observed with the RNA-
sequencing by quantitative real-time PCR and/or using a proteomic approach might have 
enabled us to draw more robust conclusions and to explain the discrepancies observed 
between the molecular and phenotypical levels (Pelling et al., 2019). Furthermore, the 
addition of experiments assessing the functional consequences of CHX exposure, such as 
uptake/extrusion studies enabling the visualisation of direct consequences on permeability 
or efflux (Gnanadhas et al., 2013; Srinivasan et al., 2014) or horizontal gene transfer rate 
measurements (Jutkina et al., 2016; Jutkina et al., 2018) would also have strengthened our 
position regarding the impact of exposure to sub-inhibitory concentrations of CHX in CPE. 
Finally, it would have been interesting to expand this part of our work, i.e. the investigation 
of transcriptomic and phenotypic changes following CHX exposure, by including other 
isolates. Indeed, other strains belonging to different STs and/or harbouring lower antibiotic 
MICs might have highlighted other alterations. 
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